Document:

EX-10.1

 Exhibit 10.1 

EXECUTION VERSION 

AGREEMENT AND PLAN OF MERGER 

by and among 
 PLEX
SYSTEMS HOLDINGS, INC., A DELAWARE CORPORATION, 
 ROCKWELL AUTOMATION, INC., A DELAWARE CORPORATION, 

ROCKWELL AUTOMATION US HOLDINGS, INC., A DELAWARE CORPORATION, 

and 
 FRANCISCO PARTNERS
MANAGEMENT LLC, solely in 
 its capacity as the Representative 

June 24, 2021 
  

 Table of Contents 

 

							
	 	 	 	  	Page	 
	 ARTICLE I THE MERGER
	  	 	1	 
	 1.01
	 	The Merger	  	 	1	 
	 1.02
	 	Effect on Capital Stock	  	 	2	 
	 1.03
	 	Effect on Options	  	 	2	 
	 1.04
	 	Exchange of Company Stock	  	 	3	 
	 1.05
	 	Organizational Documents	  	 	5	 
	 1.06
	 	Directors and Officers	  	 	5	 
	 1.07
	 	Closing Calculations	  	 	6	 
	 1.08
	 	Final Closing Balance Sheet Calculation	  	 	6	 
	 1.09
	 	Post-Closing Adjustment Payment	  	 	7	 
	 1.10
	 	Escrow Account	  	 	8	 
	 1.11
	 	Dissenting Shares	  	 	8	 
	 1.12
	 	Withholding	  	 	9	 
		
	 ARTICLE II THE CLOSING
	  	 	10	 
	 2.01
	 	The Closing	  	 	10	 
	 2.02
	 	The Closing Transactions	  	 	10	 
		
	 ARTICLE III REPRESENTATIONS AND WARRANTIES OF THE COMPANY
	  	 	11	 
	 3.01
	 	Organization and Power	  	 	11	 
	 3.02
	 	Subsidiaries	  	 	11	 
	 3.03
	 	Authorization; No Breach; Valid and Binding Agreement	  	 	12	 
	 3.04
	 	Capitalization	  	 	12	 
	 3.05
	 	Financial Statements	  	 	14	 
	 3.06
	 	Absence of Certain Developments; Undisclosed Liabilities	  	 	14	 
	 3.07
	 	Real Property	  	 	15	 
	 3.08
	 	Tax Matters	  	 	15	 
	 3.09
	 	Contracts and Commitments	  	 	18	 
	 3.10
	 	Intellectual Property	  	 	19	 
	 3.11
	 	Litigation	  	 	22	 
	 3.12
	 	Governmental Consents, etc	  	 	22	 
	 3.13
	 	Employee Benefit Plans	  	 	23	 
	 3.14
	 	Insurance	  	 	24	 
	 3.15
	 	Compliance with Laws	  	 	25	 
	 3.16
	 	Environmental Matters	  	 	25	 
	 3.17
	 	Affiliated Transactions	  	 	25	 
	 3.18
	 	Employees	  	 	25	 
	 3.19
	 	Brokerage	  	 	25	 
	 3.20
	 	Vote Required	  	 	26	 
	 3.21
	 	Customers and Suppliers	  	 	26	 
	 3.22
	 	Title to and Condition and Sufficiency of Assets	  	 	27	 
	 3.22
	 	No Other Representations or Warranties	  	 	27	 

  
 i 

 Table of Contents 

(Continued) 
  

							
	 	 	 	  	Page	 
	 ARTICLE IV REPRESENTATIONS AND WARRANTIES OF THE PARENT AND THE MERGER SUB
	  	 	28	 
	 4.01
	 	Organization and Power	  	 	28	 
	 4.02
	 	Authorization	  	 	28	 
	 4.03
	 	No Violation	  	 	28	 
	 4.04
	 	Governmental Consents, etc	  	 	28	 
	 4.05
	 	Litigation	  	 	29	 
	 4.06
	 	Brokerage	  	 	29	 
	 4.07
	 	Parent Financial Resources	  	 	29	 
	 4.08
	 	Purpose	  	 	29	 
	 4.09
	 	Solvency	  	 	29	 
	 4.10
	 	No Other Representations	  	 	29	 
		
	 ARTICLE V COVENANTS OF THE COMPANY
	  	 	30	 
	 5.01
	 	Conduct of the Business	  	 	30	 
	 5.02
	 	Access to Books and Records	  	 	32	 
	 5.03
	 	Efforts to Consummate	  	 	33	 
	 5.04
	 	Exclusive Dealing	  	 	33	 
	 5.05
	 	Payoff Letters and Lien Releases	  	 	33	 
	 5.06
	 	Notification	  	 	34	 
	 5.07
	 	Certain Cooperation	  	 	34	 
	 5.08
	 	Shareholder Approval and Related Matters	  	 	35	 
	 5.09
	 	Unvested DT Options	  	 	37	 
	 5.10
	 	Capital Structure Updates	  	 	37	 
		
	 ARTICLE VI COVENANTS OF THE PARENT
	  	 	37	 
	 6.01
	 	Access to Books and Records	  	 	37	 
	 6.02
	 	Notification	  	 	38	 
	 6.03
	 	Indemnification of Officers and Directors of the Company	  	 	38	 
	 6.04
	 	Efforts to Consummate	  	 	39	 
	 6.05
	 	Employment and Employee Benefits	  	 	39	 
	 6.06
	 	No Financing Contingency	  	 	40	 
	 6.07
	 	R&W Insurance Policy	  	 	40	 
		
	 ARTICLE VII CONDITIONS TO CLOSING
	  	 	41	 
	 7.01
	 	Conditions to the Parent’s and the Merger Sub’s Obligations	  	 	41	 
	 7.02
	 	Conditions to the Company’s Obligations	  	 	43	 
		
	 ARTICLE VIII NON-SURVIVAL
	  	 	44	 
	 8.01
	 	Non-Survival	  	 	44	 
		
	 ARTICLE IX TERMINATION
	  	 	44	 
	 9.01
	 	Termination	  	 	44	 
	 9.02
	 	Effect of Termination	  	 	46	 

  
 ii 

 Table of Contents 

(Continued) 
  

							
	 	 	 	  	Page	 
		
	 ARTICLE X ADDITIONAL COVENANTS
	  	 	46	 
	 10.01
	 	Representative	  	 	46	 
	 10.02
	 	Disclosure Schedules	  	 	49	 
	 10.03
	 	Regulatory Approvals	  	 	49	 
	 10.04
	 	Tax Matters	  	 	52	 
		
	 ARTICLE XI DEFINITIONS
	  	 	52	 
	 11.01
	 	Definitions	  	 	52	 
	 11.02
	 	Other Interpretive Provisions	  	 	64	 
		
	 ARTICLE XII MISCELLANEOUS
	  	 	64	 
	 12.01
	 	Press Releases and Communications	  	 	64	 
	 12.02
	 	Expenses	  	 	65	 
	 12.03
	 	Notices	  	 	65	 
	 12.04
	 	Assignment	  	 	66	 
	 12.05
	 	Severability	  	 	67	 
	 12.06
	 	References	  	 	67	 
	 12.07
	 	Construction	  	 	67	 
	 12.08
	 	Amendment and Waiver	  	 	67	 
	 12.09
	 	Complete Agreement	  	 	67	 
	 12.10
	 	Third Party Beneficiaries	  	 	68	 
	 12.11
	 	Waiver of Trial by Jury	  	 	68	 
	 12.12
	 	Parent Deliveries	  	 	68	 
	 12.13
	 	Delivery by Facsimile or Email	  	 	68	 
	 12.14
	 	Counterparts	  	 	68	 
	 12.15
	 	Governing Law	  	 	69	 
	 12.16
	 	Jurisdiction	  	 	69	 
	 12.17
	 	No Recourse	  	 	69	 
	 12.18
	 	Specific Performance	  	 	69	 
	 12.19
	 	Privilege; Conflicts of Interest	  	 	70	 
	 12.20
	 	Further Assurances	  	 	70	 

  
 iii 

 INDEX OF EXHIBITS 

 

			
	 Exhibit A    
	  	 Form of Certificate of Merger

	 Exhibit B
	  	 Form of Letter of Transmittal

	 Exhibit C
	  	 Form of Certificate of Incorporation

	 Exhibit D
	  	 Form of Bylaws

	 Exhibit E
	  	 Reference Statement

	 Exhibit F
	  	 Form of Escrow Agreement

	 Exhibit G
	  	 Surviving Company Directors and Officers

  

  
 iv 

 AGREEMENT AND PLAN OF MERGER 

THIS AGREEMENT AND PLAN OF MERGER (this “Agreement”), dated as of June 24. 2021, is made by and among Plex Systems Holdings,
Inc., a Delaware corporation, Inc. (the “Company”), Rockwell Automation, Inc., a Delaware corporation (the “Parent”), Rockwell Automation US Holdings, Inc., a Delaware corporation and wholly owned subsidiary of the
Parent (the “Merger Sub”), and Francisco Partners Management LLC, solely in its capacity as the representative for the Company’s securityholders (the “Representative”). The Parent, the Merger Sub and the
Company, and, solely in its capacity as and solely to the extent applicable, the Representative, shall be referred to herein from time to time as a “Party” and collectively as the “Parties.” Capitalized terms used
and not otherwise defined herein have the meanings set forth in Article XI below. 
 WHEREAS, the Parent desires to acquire one
hundred percent (100%) of the issued and outstanding shares of capital stock of the Company in a reverse triangular subsidiary merger on the terms and subject to the conditions set forth herein; 

WHEREAS, the boards of directors of the Company, the Parent and the Merger Sub have each (i) determined that the Merger is fair,
advisable and in the best interests of their respective companies and stockholders and (ii) approved this Agreement and the transactions contemplated hereby, including the Merger, upon the terms and subject to the conditions set forth herein;

 WHEREAS, the boards of directors of each of the Company and the Merger Sub have determined to recommend to their respective stockholders
the approval and adoption of this Agreement and the transactions contemplated hereby, including the Merger; and 
 WHEREAS, as an inducement
to Parent and Merger Sub to enter into this Agreement, certain stockholders of the Company concurrently with the execution of this Agreement have entered into Support Agreements (each, a “Support Agreement”), with Parent and Merger
Sub. 
 NOW, THEREFORE, in consideration of the mutual representations, warranties and covenants contained herein and other good and
valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties agree as follows: 
 ARTICLE I 

THE MERGER 

1.01 The Merger. 

(a) Subject to the terms and conditions hereof, at the Effective Time, the Merger Sub shall merge with and into the Company (the
“Merger”) in accordance with the General Corporation Law of the State of Delaware (the “DGCL”), whereupon the separate existence of the Merger Sub shall cease, and the Company shall be the surviving company and a
wholly-owned Subsidiary of the Parent (the “Surviving Company”). 

 (b) At the Closing, the Company and the Merger Sub shall cause a certificate of merger
substantially in the form of Exhibit A hereto (the “Certificate of Merger”) to be executed, acknowledged and filed with the Secretary of State of the State of Delaware and make all other filings or recordings required by the
DGCL in connection with the Merger. The Merger shall become effective at such time as the Certificate of Merger is duly filed with the Secretary of State of the State of Delaware or at such other time as the Parent and the Company shall agree and
specify in the Certificate of Merger (the “Effective Time”). 
 (c) From and after the Effective Time, the Merger shall
have the effects set forth in the DGCL. Without limitation, from and after the Effective Time, the Surviving Company shall succeed to all the assets, rights, privileges, immunities, powers and franchises of and be subject to all of the Liabilities,
restrictions, and duties of the Company and the Merger Sub, all as provided under the DGCL. 
 1.02 Effect on Capital Stock. Upon the
terms and subject to the conditions of this Agreement, at the Effective Time, by virtue of the Merger and without any action on the part of the Parent, the Merger Sub, the Company or the holders of any capital stock of the Parent, the Merger Sub or
the Company: 
 (a) each share of Company Stock issued and outstanding immediately prior to the Effective Time (other than Excluded Shares
and Dissenting Shares) shall be automatically cancelled, extinguished and converted into the right to receive, subject to the terms of this Agreement, an amount in cash equal to the sum of (x) the Fully-Diluted
Per-Share Closing Consideration, and (y) the Fully-Diluted Per-Share Additional Consideration; 

(b) each share of Company Stock, if any, directly or indirectly held immediately prior to the Effective Time by the Company shall be
automatically canceled and retired and shall cease to exist, and no payment shall be made with respect thereto (the “Excluded Shares”); and 

(c) each share of common stock of the Merger Sub that is issued and outstanding immediately prior to the Effective Time shall be automatically
converted into and become one (1) validly issued, fully paid and non-assessable share of common stock of the Surviving Company and shall constitute the only then issued and outstanding share of capital
stock of the Surviving Company. 
 The aggregate consideration to which holders of Company Stock become entitled pursuant to
Section 1.02(a) is referred to herein as the “Stock Merger Consideration.” 
 1.03 Effect on
Options. 
 (a) Upon the terms and subject to the conditions of this Agreement, at the Effective Time, by virtue of the Merger,
(i) each Option that is outstanding immediately prior to the Effective Time and that is either (x) not then vested or (y) not an In-the-Money Option shall
automatically be canceled and extinguished, no longer be outstanding and cease to represent the right to acquire shares of Common Stock, without any payment of any consideration therefor; (ii) each Option that is outstanding immediately prior
to the Effective Time and that is both (x) then vested and (y) an In-The-Money Option (a “vested In-The-Money Option”) shall automatically 

  
 2 

 
be canceled and extinguished, no longer be outstanding and cease to represent the right to acquire shares of Common Stock, and in consideration therefor, the holder thereof shall be entitled to
receive an amount in cash, without interest, equal to the Option Consideration; (iii) the Company Equity Plan shall terminate, and all rights under any provision of any other plan, program or arrangement providing for the issuance or grant of
any other interest with respect to the capital stock or other Equity Securities of any Group Company shall be canceled, effective as of the Effective Time, without any liability on the part of any Group Company; and (iv) no Person shall have
any right under the Company Equity Plan or under any other plan, program, agreement or arrangement with respect to the capital stock or other Equity Securities of any Group Company (except as otherwise expressly provided in this
Section 1.03) at and after the Effective Time. The Company shall, prior to the Effective Time, take all actions as are necessary in order to effectuate the actions contemplated by this Section 1.03
and to ensure that no holder of Options shall have any rights from and after the Effective Time with respect to any Options except as expressly provided in this Section 1.03; provided that such actions shall
expressly be conditioned upon the consummation of the Merger and shall be of no force or effect if this Agreement is terminated. The Company shall cooperate with the Parent, and keep the Parent fully informed, with respect to all resolutions,
actions and consents that the Company intends to adopt, take and obtain in connection with the matters described in this Section 1.03. Without limitation, the Company shall provide the Parent with a reasonable opportunity
to review and comment on all such resolutions, actions and consents and incorporate into such materials all reasonable comments that the Parent proposes. 

(b) The Closing Option Consideration payable to the holders of vested
In-the-Money Options pursuant to Section 1.03(a) above shall be paid through the Company’s payroll system promptly following the Effective
Time (and in any event within five (5) Business Days following the Closing Date), and Parent and the Representative shall make arrangements to cause any remaining portion of the Option Consideration payable to the holders of vested In-the-Money Options to be paid through the Surviving Company’s payroll system promptly (and in any event within five (5) Business Days) following each such time as
any such Option Consideration becomes payable to such holder, if any. Notwithstanding the foregoing, in the case of any payment due to any holder who is not a current or former employee of any Group Company, the Paying Agent shall make any such
payment directly to such holder rather than through the Company’s payroll system. 
 1.04 Exchange of Company Stock. 

(a) After the date of this Agreement but prior to the date on which the Information Statement is delivered to the Company Shareholders
pursuant to Section 5.08(b), the Parent shall designate, and enter into an agreement with, U.S. Bank National Association or such other bank or trust company reasonably acceptable to the Company to act as an paying agent in
the Merger (the “Paying Agent”), which agreement shall provide that the Parent shall deposit with the Paying Agent, for the benefit of holders of Company Stock immediately prior to the Effective Time, (i) as of the Effective
Time, cash in an amount equal to the portion of the Closing Cash Payment to which such holders are entitled pursuant to Section 1.02(a) and this Section 1.04, (ii) within two (2) Business Days
after the determination of the Final Cash Consideration, cash in an amount equal to the portion of the Additional Merger Consideration to which such holders are entitled pursuant to Section 1.02(a) and this
Section 1.04 (it being 

  
 3 

 
understood that, for this purpose, Additional Merger Consideration shall be calculated excluding amounts attributable to the Remaining Holdback Amount), and (iii) within two
(2) Business Days after the Parent’s receipt of the portion of the Remaining Holdback Amount that the Representative is obligated to deliver to the Parent pursuant to Section 10.01(f), cash in an amount equal to
such portion of such amount to which such holders are entitled pursuant to Section 1.02(a) and this Section 1.04. 

(b) At the time the Company provides the Information Statement to the Company Shareholders pursuant to
Section 5.08(b), the Parties shall coordinate to provide each holder of Company Stock with a Letter of Transmittal, substantially in the form of Exhibit B attached hereto and including a release of claims by Company
Shareholders in their capacity as such (a “Letter of Transmittal”). Each holder of Company Stock outstanding as of immediately prior to the Effective Time may deliver to the Paying Agent a duly executed and completed Letter of
Transmittal (and such other documents as required by the Letter of Transmittal) effective as of the Effective Time. After the Effective Time, each holder of Company Stock as of immediately prior to the Effective Time who has delivered to the Paying
Agent (or, after the period described in Section 1.04(d), the Parent) a duly executed and completed Letter of Transmittal (and such other documents as required by the Letter of Transmittal) shall be entitled to receive cash
in an amount equal to the product of the Fully-Diluted Per-Share Closing Consideration multiplied by the number of shares of Company Stock subject to the Letter of Transmittal; provided, that
subject to the effectiveness of the Merger, the Paying Agent shall pay or cause to be paid such amounts on the Closing Date (to the extent administratively practical) to any holder of Company Stock as of immediately prior to the Effective Time that
has delivered a duly executed and completed Letter of Transmittal (and such other documents as required by the Letter of Transmittal) to the Paying Agent at least three (3) Business Days prior to the Closing Date (but effective as of the
Effective Time). Except to the extent provided in the Escrow Agreement with respect to the Escrow Amount, in no event shall any holder of Company Stock as of immediately prior to the Effective Time be entitled to receive interest on any of the funds
to be received in the Merger. Any Company Stock held by a Company Shareholder that has delivered a duly executed and completed Letter of Transmittal (and such other documents as required by the Letter of Transmittal) to the Paying Agent pursuant to
this Section 1.04 prior to the Effective Time shall not be transferable on the books of the Company without the Parent’s prior written consent. At the Effective Time, the share transfer books of the Company shall be
closed, and thereafter there shall be no further registration of transfers of Company Stock on the records of the Company. From and after the Effective Time, the holders of the shares of Company Stock outstanding immediately prior to the Effective
Time shall cease to have any rights with respect thereto except as otherwise provided in this Agreement or by applicable Law. Until surrendered as contemplated by this Section 1.04 (as part of the requirements of a Letter
of Transmittal), any certificates formerly representing shares of Company Stock (“Certificates”), other than Excluded Shares and Dissenting Shares, shall be treated as having been cancelled and converted, as of the Effective Time,
into the right to receive the consideration payable in respect thereof pursuant to Section 1.02 without any interest thereon (which consideration shall be payable as set forth in this Section 1.04
and Section 1.09). If any Certificate has been lost, stolen or destroyed, then upon the making of an affidavit of that fact by the Person claiming such Certificate to be lost, stolen or destroyed, as well as a customary
indemnity, in each case, in form and substance acceptable to the Paying Agent, the Paying Agent will issue in exchange for such lost, stolen or destroyed Certificate (and delivery of a duly executed and completed the Letter of Transmittal and
related materials) the consideration payable in respect thereof pursuant to Section 1.02 without any interest thereon (which consideration shall be payable as set forth in this Section 1.04 and
Section 1.09). 

  
 4 

 (c) If any portion of the Stock Merger Consideration is to be made to a Person other than
the Person in whose name the applicable surrendered Certificate is registered, then it shall be a condition to the payment of such Stock Merger Consideration that the Certificate so surrendered shall be properly endorsed or shall be otherwise in
proper form for transfer. 
 (d) Any portion of the funds made available to the Paying Agent pursuant to
Section 1.04(a) that remains undistributed to holders of Certificates on the date that is twelve (12) months after the Effective Time shall be delivered to the Parent or its designee, and any holders of Certificates
who have not theretofore complied with this Section 1.04 shall thereafter look only to the Parent for the Stock Merger Consideration to which such holders are entitled pursuant to Section 1.02(a).
Any portion of the funds made available to the Paying Agent pursuant to Section 1.04(a) that remains unclaimed by holders of Certificates on the date that is five years after the Effective Time or such earlier date
immediately prior to such time as such amounts would otherwise escheat to or become property of any Governmental Entity shall, to the extent permitted by Law, become the property of the Surviving Company, free and clear of all claims or interests of
any Person previously entitled thereto. 
 (e) None of the Parent, the Merger Sub, the Company, the Surviving Company, the Paying Agent or
their respective representatives shall be liable to any Person in respect of any Merger Consideration required to be delivered to a public official pursuant to any applicable abandoned property, escheat or similar Law, to the extent so delivered.

 (f) The Paying Agent shall invest the funds made available to the Paying Agent pursuant to Section 1.04(a) as
directed by the Parent; provided that no gain or loss thereon shall affect the amounts payable to holders of Certificates pursuant to Section 1.02(a) and this Section 1.04. Any interest and
other income resulting from such investments shall be the property of, and shall promptly be paid to, the Parent. 
 1.05 Organizational
Documents. At the Effective Time, by virtue of the Merger and without any action on the part of the Parent, the Merger Sub, the Company or the holders of any shares of capital stock of any of the foregoing, the certificate of incorporation of
the Surviving Company shall be amended and restated in its entirety in the form attached hereto as Exhibit C, until thereafter amended in accordance with the DGCL. At the Effective Time, the bylaws of the Surviving Company shall be amended
and restated to be in the form attached hereto as Exhibit D, until thereafter amended in accordance with the DGCL. 
 1.06
Directors and Officers. From and after the Effective Time, until resignation or removal or until successors are duly elected, appointed or otherwise designated, in each case, in accordance with applicable Law, the directors and officers of
the Surviving Company at the Effective Time shall be the individuals listed on Exhibit G attached hereto, each such initial director and initial officer to hold office in accordance with the certificate of incorporation and bylaws of the
Surviving Company as in effect from and after the Effective Time. 

  
 5 

 1.07 Closing Calculations. Not less than five (5) Business Days prior to the
Closing Date, the Company shall deliver to the Parent a statement setting forth (a) the Company’s reasonable, good faith estimate of a consolidated balance sheet of the Group Companies as of the Reference Time, (b) a calculation of
the Company’s reasonable, good faith estimate of Cash (the “Estimated Cash”), Indebtedness (the “Estimated Indebtedness”), Net Working Capital (the “Estimated Net Working Capital”), and
Transaction Expenses (“Estimated Transaction Expenses”), in each case, as of the Reference Time and (c) a calculation of the Estimated Cash Consideration, the Closing Cash Payment, the Fully-Diluted Per Share Closing
Consideration and the aggregate Closing Option Consideration (the “Estimated Closing Statement”). The Estimated Closing Statement and the determinations contained therein shall be prepared in accordance with the Accounting
Principles. 
 1.08 Final Closing Balance Sheet Calculation. Within ninety (90) days after the Closing Date, the Parent shall
deliver to the Representative (a) a consolidated balance sheet of the Group Companies as of the Reference Time (the “Closing Balance Sheet”) and (b) a statement showing the Cash, Indebtedness, Net Working Capital and
Transaction Expenses, in each case, as of the Reference Time (the “Closing Statement”). The Closing Balance Sheet and the determinations contained therein shall be prepared in accordance with the Accounting Principles. The Parties
agree that the purpose of preparing the Closing Balance Sheet and determining Cash, Indebtedness, Net Working Capital and Transaction Expenses and the related purchase price adjustment contemplated by this Section 1.08 is
to measure the amount of Cash, Indebtedness, Net Working Capital and Transaction Expenses, and such processes are not intended to permit the introduction of accounting methods, policies, principles, practices, procedures, classifications or
estimation methodologies different than the Accounting Principles for the purpose of preparing the Closing Balance Sheet or making the determinations contained therein. The calculations of Cash, Indebtedness and Net Working Capital in the Closing
Statement will entirely disregard (i) any financing or refinancing arrangements entered into at any time by the Parent or its Subsidiaries or any other transaction entered into by the Parent or its Subsidiaries in connection with the
consummation of the transactions contemplated hereby, and (ii) any of the plans, transactions, fundings, payments or changes that the Parent or its Subsidiaries initiates or makes or causes to be initiated or made after the Closing with respect
to the Group Companies or their respective businesses or assets. After delivery of the Closing Statement and subject to the execution of a customary confidentiality agreement, the Representative and its accountants and other representatives shall be
permitted reasonable access at reasonable times to review the Surviving Company’s and its Subsidiaries’ books and records (including any work papers) related to the preparation of the Closing Statement. The Representative and its
accountants and other representatives may make reasonable inquiries of the Parent (it being understood the Parent will cooperate in providing any necessary corresponding inquiries of the Surviving Company, its Subsidiaries and their respective
accountants and employees) regarding questions concerning or disagreements with the Closing Statement arising in the course of their review thereof, and the Parent shall use its, and shall cause the Surviving Company and its Subsidiaries to use
their, commercially reasonable efforts to cause any such accountants and employees to cooperate with and respond to such inquiries. If the Representative has any objections to the Closing Statement based on the standards set forth in this Agreement,
the Representative shall deliver to the Parent a statement setting forth its objections thereto (an “Objections Statement”). If an Objections Statement is not delivered to the Parent within thirty (30) days following the date
of delivery of the Closing Statement, the 

  
 6 

 
Closing Statement shall be final, binding and non-appealable by the Parties. The Representative and the Parent shall negotiate in good faith to resolve any
objections set forth in any Objections Statement, but if they do not reach a final resolution within thirty (30) days after the delivery of the Objections Statement, either the Representative or the Parent may submit such dispute to
PricewaterhouseCoopers or if they are not independent pursuant to the rules and regulations of the U.S. Securities and Exchange Commission at the time, another nationally recognized independent accounting firm reasonably acceptable to the Parent and
the Representative (the “Dispute Resolution Arbiter”). Any further submissions to the Dispute Resolution Arbiter must be written and delivered to each party to the dispute. The Dispute Resolution Arbiter shall consider only those
items and amounts that are identified in the Objections Statement as being items that the Representative and the Parent are unable to resolve (except for any items or amounts with respect to which the Representative and the Parent previously
resolved through a written agreement). The Dispute Resolution Arbiter’s determination shall be based solely on the definitions of Cash, Indebtedness, Net Working Capital and Transaction Expenses contained herein and the provisions of this
Agreement, including this Section 1.08 and the Accounting Principles. The Representative and the Parent shall use their commercially reasonable efforts to cause the Dispute Resolution Arbiter to resolve all disagreements as
soon as practicable in amounts between the disputed amounts set forth in the Closing Statement and the Objections Statement. Further, the Dispute Resolution Arbiter’s determination shall be based solely on the presentations by the Parent and
the Representative that are in accordance with the terms and procedures set forth in this Agreement (i.e., not on the basis of an independent review). Absent fraud or manifest error, the resolution of the dispute by the Dispute Resolution
Arbiter shall be final, binding and non-appealable. The costs and expenses of the Dispute Resolution Arbiter shall be allocated by the Dispute Resolution Arbiter between the Parent, on the one hand, and the
Representative (on behalf of the Securityholders), on the other hand, based upon the percentage that the portion of the contested amount not awarded to each Party bears to the amount actually contested by such Party. For example, if the
Representative claims Final Cash Consideration is $1,000 greater than the amount determined by the Parent, and the Parent contests only $500 of the amount claimed by the Representative, and if the Dispute Resolution Arbiter ultimately resolves the
dispute by awarding the Representative (for the benefit of the Securityholders) $300 of the $500 contested, then the costs and expenses of arbitration shall be allocated sixty percent (60%) (i.e., 300 ÷ 500) to the Parent and forty percent
(40%) (i.e., 200 ÷ 500) to the Representative (for the benefit of the Securityholders). 
 1.09 Post-Closing Adjustment
Payment. 
 (a) If the Final Cash Consideration is greater than the Estimated Cash Consideration, the Parent (directly or through the
Paying Agent) shall promptly (but in any event within five (5) Business Days after the determination of the Final Cash Consideration) pay to (1) those Company Shareholders that have duly executed and delivered a Letter of Transmittal (and
such other documents as required by the Letter of Transmittal) as described in Section 1.04 their respective portion of the Company Shareholder Percentage of the amount of such difference and (2) the Surviving Company
(for distribution to the holders of the vested In-the-Money Options pursuant to Section 1.03(b)) the Optionholder Percentage of the amount of
such difference by wire transfer of immediately available funds to an account designated in writing by the Surviving Company (provided that, in the case of any payment due to any holder who is not a current or former employee of any Group
Company, the Paying Agent shall make any such payment directly to such holder rather than through the Company’s payroll system). 

  
 7 

 (b) If the Final Cash Consideration is less than the Estimated Cash Consideration, the
Parent and the Representative (on behalf of the Securityholders) shall promptly (but in any event within five (5) Business Days after the determination of the Final Cash Consideration) deliver a joint written instruction to the Escrow Agent to
pay to the Parent the lesser of (i) the absolute value of such difference and (ii) the amount in the Escrow Account by wire transfer of immediately available funds from the Escrow Account to one (1) or more accounts designated by the
Parent to the Representative and the Escrow Agent. The Securityholders and the Representative shall not have any liability for any amounts due pursuant to this Section 1.09(b) except to the extent of the funds available in
the Escrow Account. 
 (c) Exhibit E sets forth an illustrative statement (the “Reference Statement”) prepared in
good faith by the Company in cooperation with the Parent setting forth the various line items used (or to be used) in, and illustrating as of the date set forth therein, the calculation of Cash, Indebtedness and Net Working Capital prepared and
calculated in accordance with this Agreement. 
 1.10 Escrow Account. At the Closing, pursuant to
Section 2.02(c), the Parent shall deposit $5,000,000.00 (such amount the “Escrow Amount”) in immediately available funds into an escrow account (the “Escrow Account”) to be established and
maintained by the Escrow Agent pursuant to the terms and conditions of an escrow agreement substantially in the form of Exhibit F attached hereto, with such changes as reasonably acceptable to the Parent and the Representative, to be entered
into on the Closing Date by the Parent, the Representative and the Escrow Agent (the “Escrow Agreement”). The Escrow Amount shall serve as security for, and the sole source of payment of, the Parent’s rights pursuant to
Section 1.09(b), if any. Promptly following the determination of the Final Cash Consideration, and the making of all payments due pursuant to Section 1.09(b), if any, if there are any amounts
remaining in the Escrow Account (the “Remaining Escrow Amount”), then the Parent and the Representative shall deliver a joint written instruction to the Escrow Agent to pay to (1) the Paying Agent (for further distribution to
those Company Shareholders that have duly executed and delivered a Letter of Transmittal (and such other documents as required by the Letter of Transmittal) as described in Section 1.04) such Company Shareholders’
respective portion of the Company Shareholder Percentage of the Remaining Escrow Amount and (2) the Surviving Company (for distribution to the holders of the vested
In-the-Money Options pursuant to Section 1.03(b)) the Optionholder Percentage of the Remaining Escrow Amount by wire transfer of immediately
available funds to an account designated in writing by the Surviving Company (provided that, in the case of any payment due to a holder who is not a current or former employee of any Group Company, the amount of such payment shall be
delivered to the Paying Agent, which shall make any such payment directly to such holder rather than through the Company’s payroll system). 

1.11 Dissenting Shares. Notwithstanding anything in this Agreement to the contrary but only to the extent required by Section 262
of the DGCL, any share of Company Stock that is issued and outstanding immediately prior to the Effective Time and that is held by a Company Shareholder who did not consent to or vote (by a valid and enforceable proxy or otherwise) in favor of the
approval of this Agreement and who did not waive appraisal rights under Section 

  
 8 

 
262 of the DGCL, which Company Shareholder complies with all of the provisions of the DGCL relevant to the proper exercise and perfection of appraisal rights under Section 262 of the DGCL
(such share being a “Dissenting Share,” and such Company Shareholder being a “Dissenting Stockholder”), shall not be converted into the right to receive the consideration to which the holder of such share would be
entitled pursuant to Section 1.02 but rather, by virtue of the Merger and without any action on the part of the holder thereof, shall be converted into the right to receive only such consideration as determined to be due
with respect to such Dissenting Share pursuant to Section 262 of the DGCL. If any Dissenting Stockholder fails to perfect such stockholder’s appraisal rights under the DGCL or effectively withdraws or otherwise loses such rights with
respect to any Dissenting Shares, such Dissenting Shares shall thereupon automatically be converted, at the Effective Time, into the right to receive the consideration referred to in Section 1.02, pursuant to the exchange
procedures set forth in Section 1.04. Notwithstanding anything to the contrary contained in this Agreement, if the Merger is rescinded or abandoned, then the right of a stockholder to be paid the fair value of such
holder’s Dissenting Shares pursuant to Section 262 of the DGCL shall cease. At the Effective Time, the Dissenting Shares will no longer be outstanding and will automatically be cancelled and cease to exist, and each holder of Dissenting
Shares will cease to have any rights with respect thereto, except only those rights provided under Section 262 of the DGCL. Prior to the Closing, the Company shall give the Parent (a) prompt notice of any demand for payment of the
fair value of any shares of Company Stock (including any demand for appraisal) or any attempted withdrawal of any such demand and any other instrument served pursuant to the DGCL and received by the Company relating to any stockholder’s
appraisal rights and (b) the opportunity to participate in and direct all negotiations and proceedings with respect to any such demands. Prior to the Closing, the Company shall not make any payment with respect to, or settle or offer to settle,
or otherwise negotiate, any such demands without the prior written consent of the Parent (which consent shall not be unreasonably conditioned, withheld or delayed) 

1.12 Withholding. The Parent, the Surviving Company, the Escrow Agent and the Paying Agent shall be entitled to deduct and withhold
(without duplication) from any and all payments made under this Agreement such amounts as may be required to be deducted and withheld under any applicable law. To the extent such amounts are withheld and timely paid to the appropriate Governmental
Entity in accordance with applicable Laws, such withheld amounts shall be treated for all purposes of this Agreement as having been paid to the Person to whom such amounts would have otherwise been paid. The Parties shall use commercially reasonable
efforts to minimize or avoid any such withholding (other than withholding with respect to compensatory payments). Parent will provide prompt written notice of any intent to withhold the payment giving rise to such withholding. Provided the Company
delivers the FIRPTA Certificate, the Parent is not aware of any withholding that may apply to the payment of the Stock Merger Consideration (excluding any withholding required with respect to Option Consideration or other compensatory payments).

  
 9 

 ARTICLE II 

THE CLOSING 
 2.01
The Closing. The closing of the transactions contemplated by this Agreement (the “Closing”) shall take place on the later of (a) August 31, 2021 or (b) the fifth
(5th) Business Day following satisfaction or due waiver of all of the closing conditions set forth in Article VII hereof (other than those to be satisfied at the Closing itself, but subject
to the satisfaction or waiver of such conditions, it being understood, for the avoidance of doubt, the closing condition set forth in Section 7.01(f)(v) shall be deemed satisfied on the date of delivery of the Reference
Closing Statement to the Parent (assuming delivery occurs not less than five (5) Business Days prior to the Closing Date), as compared to the date on which the five (5) Business Day period described in
Section 1.07 lapses) or on such other date and/or time as is mutually agreeable to the Parent and the Representative. The Party intend that the Closing shall be effected, to the extent practicable, by conference call, the
electronic delivery of documents, and the prior physical exchange of certificates and other documents and instruments to be held in escrow by outside counsel to the recipient Parties pending authorization by the delivering Party (or its outside
counsel) of their release at Closing. The date and time of the Closing are referred to herein as the “Closing Date.” 

2.02 The Closing Transactions. Subject to the terms and conditions set forth in this Agreement, the Parties shall consummate the
following transactions at the Closing: 
 (a) the Company and the Merger Sub shall cause the Certificate of Merger to be executed,
acknowledged and filed with the Secretary of State of the State of Delaware and make all other filings or recordings required by the DGCL in connection with the Merger; 

(b) in accordance with Section 1.03, the Parent shall deliver the Closing Option Consideration set forth in the
Estimated Closing Statement to the Company, for the benefit of the holders of vested In-the-Money Options, by wire transfer of immediately available funds to the account
designated in writing by the Company; 
 (c) the Parent shall deposit the Escrow Amount into the Escrow Account in accordance with the
Escrow Agreement; 
 (d) the Parent shall deliver the Holdback Amount to the Representative pursuant to
Section 10.01(f); 
 (e) subject to the Company delivering to Parent payoff letters and Lien releases as described
in Section 5.05, the Parent shall repay, or cause to be repaid, on behalf of the Group Companies, all amounts necessary to discharge the Estimated Indebtedness in such payoff letters by wire transfer of immediately
available funds to the account(s) of the obligees as set forth in the Estimated Closing Statement; 
 (f) the Parent and the Company shall
make such other deliveries as are required by Article VII hereof; 
 (g) the Parent shall pay, or cause to be paid, on behalf of the
Company, the Estimated Transaction Expenses set forth in the Estimated Closing Statement by wire transfer of immediately available funds to the account(s) of the obligees as set forth in the Estimated Closing Statement; and 

(h) the Parent shall pay (directly or through the Paying Agent) that portion of the Stock Merger Consideration that is payable on the Closing
Date pursuant to Section 1.04. 

  
 10 

 ARTICLE III 

REPRESENTATIONS AND WARRANTIES OF THE COMPANY 

Except as qualified by the Disclosure Schedules, the Company represents and warrants to the Parent and the Merger Sub, as of the date hereof
and as of the Closing, as follows: 
 3.01 Organization and Power. The Company is a corporation duly organized, validly existing and
in good standing under the Laws of the State of Delaware, and the Company has all requisite power and authority necessary to own, lease and operate its properties and to carry on its businesses as now conducted. The Company is duly licensed or
qualified to do business and is in good standing in every jurisdiction in which its ownership or lease of property or the conduct of business as now conducted requires it to be licensed or qualified, except where the failure to be so licensed or
qualified has not had and would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect. The copies of the Organizational Documents that have been made available to the Parent prior to the date of this
Agreement are correct and complete copies of such instruments as currently in effect. Neither any Group Company nor, to the knowledge of the Company, any Securityholder is in material breach or default of any Organizational Documents. 

3.02 Subsidiaries. Schedule 3.02 accurately sets forth each Subsidiary of the Company, its name, place of incorporation or
formation, and the record and beneficial ownership of all capital stock or other Equity Securities issued thereby. Except for the Subsidiary Securities owned of record and beneficially by Persons as specified in Schedule 3.02, no Equity
Securities of any Subsidiary of the Company are issued, outstanding, or owned by any Person. Without limitation, there are no options, warrants, rights, convertible or exchangeable securities, equity security rights, equity appreciation rights,
equity-based performance units, or Contracts of any kind to which any Group is party or otherwise bound (i) obligating any Group Company to deliver or sell, or cause to be delivered or sold, any Equity Securities of, or any security convertible
or exercisable for or exchangeable into any Equity Securities of, any Subsidiary of the Company, (ii) obligating any Group Company to deliver, grant, extend, or enter into any such option, warrant, call, right, security, unit, or Contract,
(iii) giving any Person the right to receive any economic benefit or right similar to or derived from the economic or governance benefits and rights occurring to holders of Equity Securities of any Subsidiary the Company, or (iv) giving
any Person the right to vote or otherwise approve (or disapprove) decisions in respect of any Subsidiary of the Company. Except for the capital stock and other Equity Securities owned by other Persons as set forth in Schedule 3.02, the
Company owns all of the capital stock and other Equity Securities of each of the Subsidiaries identified on Schedule 3.02 free and clear and all Liens (including any restriction on the right to vote, sell or otherwise dispose of the capital
stock and other Equity Securities). Each of the Subsidiaries identified on Schedule 3.02 is duly organized, validly existing and in good standing under the Laws of the jurisdiction of its incorporation or organization, has all requisite power
and authority to own, lease and operate its properties and to carry on its businesses as now conducted and is duly licensed or qualified to do business and is in good standing in every jurisdiction in which its ownership or lease of property or the
conduct of its businesses as now conducted requires it to be licensed or qualified, except where the failure to be so licensed or qualified has not had and would not reasonably be expected to have, individually or in the aggregate, a Material
Adverse Effect. Neither the Company nor any of its Subsidiaries owns or holds the right to acquire any stock, partnership interest or joint venture interest or other equity ownership interest or other security in any corporation, organization or
entity that is not a Group Company. 

  
 11 

 3.03 Authorization; No Breach; Valid and Binding Agreement. 

(a) The Company has full corporate power and authority to execute and deliver and perform this Agreement and to consummate the transactions
contemplated hereby, subject, in the case of the consummation of the Merger, to the Shareholder Approval. The execution, delivery and performance of this Agreement by the Company and the consummation of the transactions contemplated hereby have been
duly and validly authorized by all requisite corporate action, and, subject to obtaining the Shareholder Approval in the case of the Merger, no other corporate proceedings on its part are necessary to authorize the execution, delivery or performance
of this Agreement or the consummation of the transactions contemplated hereby. 
 (b) Except as set forth on Schedule 3.03(b), the
execution, delivery, performance and compliance with the terms and conditions of this Agreement by the Company and the consummation of the transactions contemplated hereby and thereby do not and shall not violate, conflict with, result in any breach
of, or constitute a default (with or without notice or lapse of time, or both) under, or give rise to a right of, or result by its terms in the, termination, amendment, cancellation or acceleration of any obligation or the loss of a material benefit
under, or to increased, additional, accelerated or guaranteed rights or entitlements of any Person under, or create any obligation to make a payment to any other Person under, or result in the creation of a Lien on, or the loss of, any assets of any
Group Company pursuant to, (i) any of the provisions of the Organizational Documents (or equivalent organizational documents) of any Group Company, (ii) any Material Contract or Permit or (iii) any Law or Order to which any of the
Group Companies is subject, except where the failure of any of the representations and warranties contained in clause (iii) above to be true would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect.

 (c) This Agreement has been duly executed and delivered by the Company, and assuming that this Agreement is a valid and binding
obligation of the Parent and the Merger Sub, this Agreement constitutes a valid and binding obligation of the Company, enforceable in accordance with its terms, except as enforceability may be limited by bankruptcy Laws, other similar Laws affecting
creditors’ rights and general principles of equity affecting the availability of specific performance and other equitable remedies. 

3.04 Capitalization. 

(a) The authorized capital stock of the Company consists of 234,501,127 shares of common stock, par value $0.001 per share (the
“Common Stock”), and 183,093,027 shares of preferred stock, par value 0.001 per share (the “Preferred Stock” and together with the Common Stock, the “Company Stock”), of such Preferred Stock
161,299,900 are designated Series A Preferred Stock and 21,793,127 are designated Series B Preferred Stock. Of the authorized capital stock of the Company, as of the date hereof, (i) 5,289,656 shares of Common Stock were issued and outstanding, (ii)
161,299,900 shares of Series A Preferred Stock were issued and outstanding and (iii) 21,793,126.8911 shares of Series B Preferred Stock were issued and outstanding. Each outstanding share of Preferred Stock is convertible into one (1) share of
Common Stock. 

  
 12 

 (b) All the outstanding shares of Company Stock, and all outstanding shares of capital stock
and other Equity Securities of the Subsidiaries of the Company (“Subsidiary Securities”), have been duly and validly issued and are fully paid and non-assessable, are not subject to
rescission, are not subject to preemptive or similar rights, and were offered and issued in accordance with applicable Law, including the registration or qualification requirements of the Securities Act of 1933, as amended, and any relevant foreign
and state securities Laws or pursuant to valid exemptions therefrom. 
 (c) As of the date hereof, the outstanding shares of Company Stock
are held of record and beneficially by the Persons, and in the amounts, set forth on Schedule 3.04(c). Except for the Company Stock owned of record and beneficially by Persons as specified in Schedule 3.04(c) and for the Options set
forth in Schedule 3.04(d) and subject to adjustments for which notice is given in accordance with Section 5.10, no Equity Securities of the Company are issued, outstanding, or owned by any Person. Without limitation,
except for the exercise rights that attach to the Options that are listed on Schedule 3.04(d) and for the conversion rights that attach to the Preferred Stock that is listed on Schedule 3.04(c) and subject to
Section 5.09, there are no options, warrants, rights, convertible or exchangeable securities, equity security rights, equity appreciation rights, equity-based performance units, or Contracts of any kind to which any Group
Company is party or otherwise bound (i) obligating the Company to deliver or sell, or cause to be delivered or sold, any Equity Securities of, or any security convertible or exercisable for or exchangeable into any Equity Securities of, the
Company, (ii) obligating the Company to deliver, grant, extend, or enter into any such option, warrant, call, right, security, unit, or Contract, (iii) giving any Person the right to receive any economic benefit or right similar to or
derived from the economic or governance benefits and rights occurring to holders of Equity Securities of the Company, or (iv) giving any Person the right to vote or otherwise approve (or disapprove) decisions in respect of the Company. 

(d) Schedule 3.04(d) sets forth (as of the date hereof) all outstanding Options, including with respect to each Option, the holder, the
service relationship of such holder at the time of grant (i.e., director, employee, or consultant of a Group Company) as well as the country in which the holder worked from the time of grant through the date hereof (or, if earlier, the date on which
the holder terminated his or her employment or service with the Group Companies), the status of such holder (i.e., active or terminated), the option type designated by the Company at the time of the grant (i.e., incentive stock option or non-qualified stock option), whether the Option permits early exercise, the number of shares of Common Stock subject thereto, the grant date, the exercise price and the vesting schedule (including any acceleration
provisions) for such Option, and the date on which such Option expires. 
 (e) No Securityholder is entitled to any preemptive or similar
rights to subscribe for shares of Company Stock that would survive the Closing. No Person other than the Company is entitled to any preemptive or similar rights to subscribe for Subsidiary Securities. Except as set forth in Schedule 3.04(e),
neither any Group Company nor, to the knowledge of the Company, any Securityholder is a party to any Contract relating to the repurchase, redemption, issuance, ownership, voting, sale, registration, transfer or disposition of, or the declaration or
payment of any dividend or other distribution on, any securities of any Group Company. There are no accrued by unpaid dividends or other distributions in respect of any Company Stock. 

  
 13 

 3.05 Financial Statements. The Company’s unaudited consolidated balance sheet as
of March 31, 2021 (the “Latest Balance Sheet”) and the related statement of income for the three-month period ended March 31, 2021 and the Company’s audited consolidated balance sheets and statements of operations,
stockholders’ equity and cash flows for the fiscal years ended December 31, 2020, December 31, 2019 and December 31, 2018 have been prepared in accordance with GAAP, consistently applied, and present fairly in all material
respects the financial condition and results of operations of the Group Companies (taken as a whole) as of the times and for the periods referred to therein, subject in the case of the unaudited financial statements to (i) the absence of
footnote disclosures and similar presentation items and (ii) changes resulting from normal year-end adjustments that have not been and are not expected to be material in amount. There are no “off-balance sheet arrangements” (within the meaning of Item 303 of Regulation S-K promulgated by the U.S. Securities and Exchange Commission) with respect to any
Group Company. 
 3.06 Absence of Certain Developments; Undisclosed Liabilities. 

(a) Except as set forth on Schedule 3.06(a), during the period from the date of the Latest Balance Sheet to the date of this Agreement,
the Group Companies have conducted their respective businesses in the Ordinary Course of Business and none of the Group Companies has: 

(i) suffered a Material Adverse Effect; 

(ii) effected any recapitalization, reclassification, distribution, equity split or like change in its capitalization; 

(iii) subjected any material portion of its properties or assets to any material Lien, except for Permitted Liens; 

(iv) sold, assigned, licensed, leased or transferred any material portion of its assets, except in the Ordinary Course of
Business; 
 (v) sold, assigned, licensed, leased or transferred any patents, trademarks, trade names, copyrights or other
Company IP, except in the Ordinary Course of Business; 
 (vi) made any capital investment in, or any loan to, any other
Person (other than a Group Company); 
 (vii) amended or authorized the amendment of its organizational documents; 

  
 14 

 (viii) suffered any material damage, destruction or other casualty loss with
respect to material property owned by any Group Company that is not covered by insurance; or 
 (ix) taken any other action
that would have required the consent of the Parent under Section 5.01(c), (d), (g), (k), (m), (n), (o), (p), or (q) if such action occurred after the date of this
Agreement. 
 (b) No Group Company has any material Liability except for commercial Liabilities (i) accrued or specifically
reserved against in the Latest Balance Sheet, (ii) incurred in the Ordinary Course of Business since the date of the Latest Balance Sheet (none of which relates to breach of Contract), (iii) incurred in connection with this Agreement or the
transactions contemplated hereby (none of which relates to breach of Contract), (iv) incurred in the Ordinary Course of Business in the performance of the executory Contracts to which any Group Company is party (none of which relates to breach of
Contract) or (v) disclosed in Schedule 3.06(b). 
 3.07 Real Property. 

(a) Schedule 3.07(a) sets forth a list of all real property to which any Group Company has a leasehold interest (collectively, the
“Leased Realty”). The Company has provided the Parent with copies of all Leases. No Group Company subleases any of the Leased Realty. 

(b) The Company or one of its Subsidiaries possesses valid leasehold interests in the Leased Realty pursuant to the leases (and any related
amendments) set forth on Schedule 3.07(a) (the “Leases”), free and clear of any Liens except Permitted Liens. Each Lease is in full force and effect and enforceable against the Company or its applicable Subsidiary party to
such Lease and, to the knowledge of the Company, each other party thereto in accordance with its terms. To the knowledge of the Company, no event has occurred or condition exists that constitutes, or after notice or lapse of time or both would
constitute, a material default under any of the Leases. 
 (c) There is no Owned Real Property. No Group Company has owned real property in
the last ten (10) years. 
 3.08 Tax Matters. 

(a) The Group Companies have timely filed all material Tax Returns that are required to be filed by them (taking into account any extensions
of time to file). All such Tax Returns are correct and complete in all material respects. All material Taxes due, owing, or payable by the Group Companies have been fully paid or properly accrued. The unpaid Taxes of the Group Companies as of the
date of the Latest Balance Sheet have been accrued as of such date in accordance with GAAP, as in effect on such date and applied on a basis consistent with past practice. 

  
 15 

 (b) All material Taxes required to be deducted or withheld by any Group Company have been
deducted and withheld and, to the extent required, have been timely paid to the proper Governmental Entity, and the Group Companies have complied with all material information reporting and backup withholding provisions of applicable Law (including
completing and timely filing all forms and Tax Returns required with respect thereto). 
 (c) No Group Company is, as of the date hereof,
the subject of a Tax audit with respect to any material Taxes of any such Group Company. There are (i) no claims, deficiencies or assessments for Taxes asserted or threatened in writing by any Governmental Entity to any Group Company which have
not been paid or resolved, and (ii) to the knowledge of the Company, no ongoing legal proceedings, audits or examinations of any material Taxes or material Tax Returns of any Group Company and no such audit or examination is threatened in
writing by any Governmental Entity to any Group Company. 
 (d) No Group Company (i) is, or has ever been, a member of an affiliated
group filing a consolidated U.S. federal income Tax Return other than a group of which a Group Company was the common parent, or (ii) has any current material liability for Taxes of any Person (other than the Group Companies) under Treasury
Regulations Section 1.1502-6 (or any similar provision of state, local or foreign Law) or as a transferee or successor. No Group Company owns an interest in a partnership for U.S. federal income Tax
purposes. 
 (e) No Group Company (i) is a party to or bound by any written Tax allocation, sharing or indemnity agreement or
arrangement (other than pursuant to a commercial agreement entered into in the Ordinary Course of Business the primary purpose of which is unrelated to Tax), (ii) has any outstanding agreements, consents or waivers extending the statutory period of
limitations applicable to the payment or assessment of any Taxes to any Governmental Entity, other than pursuant to extensions of time to file Tax Returns obtained in the Ordinary Course of Business. No Group Company has entered into any closing
agreement in respect of material Taxes with any Governmental Entity. No Group Company has been a party to a “listed transaction,” as such term is defined in Treasury Regulations
Section 1.6011-4(b). 
 (f) Within two (2) years prior to the date hereof, no claim has
been made by any Tax authority, in a jurisdiction where any Group Company has not filed a Tax Return, that it is or may be subject to Tax by such jurisdiction. No Group Company has any voluntary disclosure agreements or similar programs with respect
to Taxes pending with any Governmental Entity. 
 (g) No Group Company has within the last two (2) years prior to the date hereof
distributed stock of another Person, or has had its stock distributed by another Person, in a transaction that was purported or intended to be governed in whole or in part by Section 355 or Section 361 of the Code. 

(h) No Group Company will be required to include any material item of income in, or exclude any material item or deduction from, taxable
income for any taxable period or portion thereof beginning after the Closing Date, as a result of: (i) any adjustment under Section 481 of the Code (or any similar provision of state, local or foreign Law) by reason of a change in a method
of accounting made by such Group Company prior to the Closing Date; (ii) an installment sale or open transaction made on or prior to the Closing Date by such Group Company outside of the Ordinary Course of Business; (iii) a prepaid amount
received or deferred revenue accrued on or before the Closing Date by such Group Company outside of the Ordinary 

  
 16 

 
Course of Business; (iv) any closing agreement under Section 7121 of the Code (or any similar provision of state, local or foreign Law) executed by such Acquired Company prior to the
Closing; (vi) like-kind exchange under Section 1031 of the Code entered into by a Group Company on or prior to the Closing Date (excluding any gain recognized on the subsequent disposition of such property); (vii) “global intangible low-taxed income” or Subpart F income imposed pursuant to Sections 951 or 951A of the Code (or any similar provision of state, local or foreign Law) with respect to an interest in a “controlled foreign
corporation” (within the meaning of Section 957 of the Code) (“CFC”) held by such Group Company prior to the Closing for the taxable year of the Group Companies that includes the Closing Date (assuming for this purpose that the
current taxable year of such CFC ends at the end of the Closing Date); and (viii) election under Section 965(h) of the Code made by a Group Company prior to the Closing. 

(i) Each Group Company has collected all material sales, value-added or use Taxes required to be collected, and has remitted, or will remit on
a timely basis, such amounts to the appropriate Governmental Entity (or has timely and properly collected and maintained all material resale certificates, exemption certificates and other documentation required to qualify for any exemption from the
collection or payment of sales or use Taxes imposed or due in connection with the business of the Group Companies). 
 (j) Each Group
Company is in material compliance with the provisions of Section 263A and 482 of the Code (or any similar applicable provision of state, local or foreign Law). 

(k) No Group Company has granted any power of attorney that is currently in effect with respect to Tax matters outside the Ordinary Course of
Business, which power of attorney will remain in effect after the Closing. Each Group Company is in material compliance with the terms and conditions of (i) all applicable Tax exemptions or incentive programs that the Group Company may have
claimed or participated in that are not automatically available to similarly situated taxpayers without signing a Contract, or (ii) any Contract such Group Company has entered into with a Governmental Entity, and the consummation of the
transactions contemplated by this Agreement will not have any adverse effect on such compliance or result in any claw back of any such benefits or incentives described in clause (i)-(ii) above. 

(l) Each Group Company has disclosed on its respective U.S. federal income Tax Returns, as applicable, all positions taken therein that could
give rise to a substantial understatement of federal income Tax within the meaning of Section 6662 of the Code. No Group Company has requested or received a Tax ruling, private letter ruling, technical advice memorandum, competent authority
relief or similar agreement from any Governmental Entity. 
 (m) Except as set forth on Schedule 3.08(m), no Group Company has
(i) deferred the payment of any payroll Taxes pursuant to the COVID-19 Laws for any Pre-Closing Tax Period to any taxable period beginning after the Closing Date,
which deferral is still in effect, (ii) claimed any employee retention tax credit pursuant to Section 2301 of the CARES Act (including any subsequent amendment), or (iii) claimed any tax credit for employee leave pursuant to the
Families First Coronavirus Respect Act, (including any subsequent amendment). 

  
 17 

 (n) No Person that is subject to taxation in the United States holds share(s) of any Company
Stock that are, as of the date hereof, subject to a substantial risk of forfeiture within the meaning of Section 83 of the Code with respect to which a valid election under Section 83(b) of the Code has not made. 

(o) The Company is not, and has not been, a United States real property holding corporation (as defined in Section 897(c)(2) of the Code)
during the five year period ending on the Closing Date. 
 3.09 Contracts and Commitments(a) . Except for any Leases or as set
forth on Schedule 3.09(a), and except for agreements entered into by any Group Company after the date hereof in accordance with Section 5.01, no Group Company is party to any: 

(i) indenture or other Contract relating to the borrowing of money or other Indebtedness or Other Debt-Like Instruments or to
mortgaging, pledging or otherwise placing a Lien on any material portion of the assets of the Group Companies; 
 (ii)
guaranty of any obligation for borrowed money or other Indebtedness, Other Debt-Like Instruments or other material guaranty; 

(iii) lease or other Contract under which it is lessee, or holds or operates any personal property owned by any other party,
for which the aggregate rental and other compensation exceeds $250,000 (excluding the Leases); 
 (iv) lease or other
Contract under which it is lessor of or permits any third party to hold or operate any personal property for which the aggregate rental and other compensation exceeds $250,000 (excluding the Leases); 

(v) Contract or group of related Contracts with any Specified Customer or Specified Supplier; 

(vi) Contracts relating to any pending or completed business acquisition or divestiture by any Group Company within the last
five (5) years or to any pending or completed transfer of ownership of or exclusive rights to any material Intellectual Property Rights to any Person; 

(vii) Intellectual Property Agreement relating to the use of any third party Intellectual Property Rights by a Group Company
(other than unmodified commercially available software for which the annual cost does not exceed $250,000); 
 (viii)
Contract including covenants by any Group Company not to compete or conduct business in any territory or otherwise prohibiting or limiting the freedom of any Group Company (or, after the Closing, of the Parent or any of its Subsidiaries) to engage
in any business with any Person or in any geographic area, to compete with any Person or to solicit customers or employees; 

  
 18 

 (ix) any Contract obligating any Group Company to purchase or otherwise
obtain any product, right or service exclusively from a single party or sell or otherwise provide any good, right or service exclusively to a single party, or granting any Person “most favored nation” or similar status with respect to
products, rights or services; 
 (x) (A) any partnership, joint venture, strategic alliance or joint development
Contract or (B) any Contract that involves any sharing of revenues, profits or losses with one or more Persons; or 

(xi) any Contract with any employee of any Group Company, providing for compensation of $250,000 or more, per annum, other
than offer letters providing for at-will employment, in the standard form used by the applicable member of the Group Company, that such Group Company can terminate without notice or Liability. 

(b) The Parent either has been supplied with, or has been given access to, a true and correct copy of all written Contracts (and a true and
correct summary of all oral Contracts) that are listed or required to be listed on Schedule 3.09(a) and all Leases (collectively, the “Material Contracts”) prior to the date of this Agreement. 

(c) No party to any Material Contract has given written notice of termination or non-renewal of such
Material Contract that remains pending. 
 (d) Each material Contract to which any Group Company is party or bound is in full force and
effect and (i) is enforceable against the applicable Group Company in accordance with its terms and (ii) to the knowledge of the Company, against each other party thereto in accordance with its terms (except as enforceability may be
limited by bankruptcy Laws, other similar Laws affecting creditors’ rights and general principles of equity affecting the availability of specific performance and other equitable remedies). No Group Company has, in any material respect,
violated or breached, or committed any default under, any material Contract to which such Group Company is party or bound. To the knowledge of the Company, no other Person has materially violated or breached, or committed any material default under,
any material Contract to which any Group Company is party or bound. No event has occurred and is continuing through any Group Company’s actions or inactions or, to the knowledge of the Company, through any other Person’s actions or
inactions that will result in a material violation or breach or default of any of the provisions of any material Contract to which any Group Company is party or bound. 

(e) All Company Shareholders are party to that certain Second Amended and Restated Stockholders Agreement, dated as of June 9, 2014, by
and among the Company and its stockholders. 
 3.10 Intellectual Property. 

(a) Schedule 3.10(a) sets forth a correct and complete list of all issuances, registrations and applications pertaining to Intellectual
Property Rights owned by, filed in the name of, or exclusively licensed to any Group Company as of the date hereof are set forth on (collectively, “Registered IP”). All Registered IP are subsisting, enforceable and valid. 

  
 19 

 (b) The Group Companies own all right, title and interest in or have the right to use, and
will continue to have the right to use immediately after the Closing, all Technology and Intellectual Property Rights needed to conduct their businesses as currently conducted, free and clear of all Liens, other than Permitted Liens. 

(c) Neither the execution, delivery, or performance of this Agreement (or any of the ancillary agreements) nor the consummation of any of the
transactions contemplated by this Agreement (or any of the ancillary agreements) will, with or without notice or lapse of time, result in, or give any other Person the right or option to cause, declare, or require: (i) a loss or impairment of,
payment of any additional amounts with respect to, or the consent of any other Person in respect to any Company IP or any Intellectual Property Rights or Technology licensed from another Person under an Intellectual Property Agreement; (ii) the
release, disclosure, or delivery of any Company IP by or to any escrow agent or other Person, including, without limitation, pursuant to the terms of any source code escrow agreement; or (iii) the grant, assignment, or transfer to any other
Person of any license or other right or interest under, to, or in any of the Company IP. 
 (d) Each Person who is or was an employee or
independent contractor of any Group Company and who is or was involved in the creation or development of any Company IP has signed a valid, enforceable agreement containing an assignment of all Technology and Intellectual Property Rights to a Group
Company (or such Technology and Intellectual Property Rights are owned by a Group Company by operation of law) and confidentiality provisions protecting the Company IP. No Group Company is under any obligation, whether written or otherwise, to
develop any software code for any third party (including any customer or end user) whereby such third party will own or have an exclusive license to such software code. 

(e) Except as set forth on Schedule 3.10(e), during the three (3) year period prior to the date of this Agreement, no Group
Company has received any written notices of infringement or misappropriation from any third party with respect to any third-party Intellectual Property Rights or contesting the use or ownership of any Company IP, nor are there any claims pending
against any Group Company alleging infringement or misappropriation of any third party’s Intellectual Property Rights or contesting the use or ownership of any Company IP. The conduct of the business of the Group Companies, the Company IP, and,
to the Company’s knowledge, the Intellectual Property Rights licensed under the Intellectual Property Agreements, have not during the six (6) year period prior to the date of this Agreement infringed, misappropriated, diluted or otherwise
violated, and do not currently infringe, dilute, misappropriate or otherwise violate, the Intellectual Property Rights of any Person. To the Company’s knowledge, no other Person has infringed, misappropriated, diluted, or otherwise violated any
Company IP or is currently infringing, misappropriating, diluting, or otherwise violating any Company IP. 
 (f) The Company takes
commercially reasonable steps to maintain the confidentiality of its trade secrets and other material proprietary information. No Group Company has disclosed any trade secret or other material proprietary information to any third party except
pursuant to a valid confidentiality or non-disclosure agreement obligating any such third party not to disclose any such trade secret or proprietary information. 

  
 20 

 (g) No funding from any Governmental Entity was used in the development of any Company IP
and no Governmental Entity has a claim or right to claim any right in such Company IP. 
 (h) The Group Companies have all right, title and
interest in and to any computer programs, operating systems, applications, firmware, source code, object code, application programming interfaces, data files, databases, protocols, specifications or other computer software and any documentation of
any of the foregoing included in the Company IP (collectively, “Company Proprietary Software”), free and clear of all Liens other than Permitted Liens. Except as set forth on Schedule 3.10(h), a Group Company has developed
the Company Proprietary Software through the efforts of its employees and the Company Proprietary Software does not incorporate any contributions made by a third party developer, contractor or consultant. The source code for the Company Proprietary
Software is and has been maintained in confidence and is not maintained (or required to be maintained) in a software escrow for any customer or other Person. The Company has actual possession of the source code and system documentation of the
Company Proprietary Software and tools actually used for the development, maintenance, implementation, and use of the Company Proprietary Software. The Company has not received notice from any Person claiming any right, title or interest in the
Company Proprietary Software. 
 (i) No Group Company has used any Open Source Software (y) in a manner that the license pursuant to
which such Open Source Software is used would grant to any Person any right to or immunities under any of the Company IP, or (z) under any license requiring any Group Company to disclose or distribute the source code to any of the Company
Proprietary Software, to license or provide the source code to any of the Company Proprietary Software for the purpose of making derivative works, or to make available for redistribution to any Person the source code to any of the Company
Proprietary Software at no or minimal charge, in each case excluding the source code licensed to the Group Company under the Open Source Software license. 

(j) To the Company’s knowledge, none of the Company Proprietary Software (i) contains any bug, defect, or error that materially
adversely affects the use, functionality, or performance of such Company Proprietary Software other than those discovered and corrected in the normal course of support and maintenance procedures; or (ii) currently fails to comply in any
material respect with any applicable warranty, other contractual commitment, or other standards set forth by a Group Company relating to the use, functionality, or performance of such Company Proprietary Software. 

(k) The electronic data processing, information, record keeping, communications, telecommunications, hardware, proprietary and third-party
software, networks, peripherals, and computer systems, including any outsourced systems and processes, and Intellectual Property Rights in the foregoing which are used by a Group Company (collectively, “Technology Systems”) are
sufficient for the operation of the businesses of the Group Companies as currently conducted. There has not been any material malfunction with respect to any of the Technology Systems that has not been remedied or replaced in all material respects.
The Technology Systems are either owned by, or licensed or leased to, the Group Companies. The Group Companies are in compliance with the terms and conditions of all license Contracts in relating to the Technology Systems, including any seat license
requirements. No action will 

  
 21 

 
be necessary as a result of the transaction effected by this Agreement to enable use of the Technology Systems to continue to the same extent and in the same manner that it has been used prior to
the Closing. To the Company’s knowledge, no contractor to a Group Company is in breach of any obligations owed under a license, lease, or other Contract with such Group Company by which such contractor provides, supports, maintains, or is
otherwise responsible for the Technology Systems. 
 (l) Each Group Company has undertaken commercially reasonable efforts, as required
under the Data Security Requirements to protect, safeguard, and maintain the confidentiality, integrity, and security of the Technology Systems, the products and services of each Group Company, and all information, data, and transactions stored or
contained therein or transmitted thereby, including Personal Information (collectively, the “Company Data”), against any material unauthorized or improper use, access, acquisition, disclosure, transmittal, interruption,
modification, or corruption, which policies and procedures have been provided or disclosed to the Parent. To the Company’s knowledge, each Group Company has abided by material applicable opt-outs related
to Personal Information and Company Data required by the Security Requirements. To the Company’s knowledge, the Group Companies and the conduct of their businesses are in material compliance with, and have been in material compliance with, all
Data Security Requirements for the last three (3) years. 
 (m) Except as set forth in Schedule 3.10(m), to the Company’s
knowledge, during the last three (3) years, no Group Company has experienced any breach of security or other unauthorized access by a third party to the confidential or proprietary information, including Personal Information, in such Group
Company’s possession, custody, or control. 
 (n) The Group Companies have all data use rights necessary to host, use, copy, transmit
and display any manufacturing or other data created by or from operation of any Company Proprietary Software or the performance of any services related to the business as currently conducted. 

3.11 Litigation. Except as set forth on Schedule 3.11, there is no material legal action, suit, arbitration, claim,
investigation or proceeding (whether federal, state, local or foreign) (“Action”) pending or, to the knowledge of the Company, threatened against any Group Company, their respective directors or officers (in such capacity) or their
respective properties, assets or business. Except as set forth on Schedule 3.11, no Group Company is subject to any material settlement, stipulation, order, writ, judgment, injunction, decree, ruling, determination or award of any court or of
any other Governmental Entity (“Order”). 
 3.12 Governmental Consents, etc. Except for (i) the
applicable requirements of the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (the “HSR Act”), and (ii) the filing of the Certificate of Merger with the Secretary of State of the State of Delaware, (a) no Group
Company is required to submit any material notice, report or other filing with any Governmental Entity in connection with the execution, delivery or performance of this Agreement or the consummation of the transactions contemplated hereby and
(b) no material consent, approval or other authorization of any Governmental Entity is required to be obtained by any Group Company in connection with the execution, delivery or performance of this Agreement or the consummation by the Company
of any transaction contemplated hereby. 

  
 22 

 3.13 Employee Benefit Plans. 

(a) Schedule 3.13(a) sets forth, as of the date hereof, each material Company Plan. With respect to each material Company Plan, the
Company has provided or made available to the Parent or its representatives prior to the date hereof true and complete copies, as applicable, of: (i) the plan and trust documents and the most recent summary plan description, (ii) the most
recent annual report (Form 5500 series), (iii) the most recent financial statements, (iv) the most recent favorable determination letter or opinion letter from the Internal Revenue Service with respect to each Company Plan intended to qualify
under Section 401(a) of the Code, and (v) any Contracts between the Company or any of its Subsidiaries and any third party related to the insurance, funding, administration or operation of any Company Plan. 

(b) No Company Plan is a Multiemployer Plan or a plan that is subject to Title IV of ERISA, and no Company Plan provides health or other
welfare benefits to former employees of the Group Companies other than health continuation coverage pursuant to COBRA or other applicable Law. 

(c) Except as set forth on Schedule 3.13(c), each Company Plan has been maintained and administered in compliance in all material
respects with its terms and the applicable requirements of ERISA, the Code and any other applicable Laws. All reports and information required to be filed with any Governmental Authority or provided to participants, beneficiaries and/or alternate
payees, in each case related to any Company Plan, have been timely filed or disclosed, and when filed or disclosed, were correct and complete. Each Company Plan that is intended to be qualified within the meaning of Section 401(a) of the Code
has received a favorable determination letter or is the subject of a favorable opinion letter from the Internal Revenue Service on the form of such Company Plan on which the Company can rely and, to the knowledge of the Company, nothing has
occurred, whether by action or failure to act, that would reasonably be expected to affect the qualified status of any such Company Plan. The Company has not filed nor is considering filing an application under the IRS Employee Plan Compliance
Resolution System or the DOL Voluntary Fiduciary Correction Program or Delinquent Filer Voluntary Compliance Program relating to any Company Plan. 

(d) No material liability under Title IV of ERISA has been or, to the knowledge of the Company, is reasonably expected to be incurred by the
Group Companies. 
 (e) The Group Companies have not engaged in any transaction with respect to any Company Plan that would be reasonably
likely to subject the Group Companies to any material Tax or penalty (civil or otherwise) imposed by ERISA, the Code or other applicable Law. No Company Plan is under, and neither the Company nor any of its Subsidiaries has received any notice of,
an audit or investigation by the Internal Revenue Service, Department of Labor, Pension Benefit Guaranty Corporation, or any other Governmental Entity. No Action has been threatened in writing, instituted, or, to the knowledge of the Company, is
anticipated against any Company Plan (other than routine claims for benefits), any trustee or fiduciary thereof, or any of the assets of any trust of any Company Plan. Neither the Company nor any of its Subsidiaries are required to provide any gross-up, make-whole, or other additional payments with respect to taxes, interest, or penalties imposed under Section 409A or Section 4999 of the Code. No event has occurred, and to the knowledge of the
Company, no condition or circumstances exist, that could reasonably be expected to subject the Company or Company Plan to penalties or excise taxes under Sections 4980D, 4980H, or 4980I of the Code or of any provision under the Affordable Care Act.

  
 23 

 (f) Except as may be set forth in the terms of the Options or as set forth in Schedule
3.13(f), neither the execution and delivery of this Agreement nor the consummation of the transactions contemplated hereby would (either alone or in conjunction with any other event) (i) reasonably be expected to cause the accelerated
vesting, funding or delivery of, or increase the amount or value of, any payment or benefit to any employee, officer or director of the Group Companies, (ii) require the Company or any of its Subsidiaries to fund any liabilities or place in
trust or otherwise set aside any amounts in respect of any Company Plan or (iii) limit or restrict the right of the Company or any of its Subsidiaries to merge, amend or terminate any Company Plan. 

(g) Neither the execution and delivery of this Agreement, nor the consummation of the transactions contemplated hereby, either alone or in
combination with another event, has or could result in the payment of any amount that could, individually or in combination with any other such payment, constitute an “excess parachute payment” as defined in Section 280G of the Code
(or any similar provision of state, local, or foreign Law) or an excise Tax to the recipient of such payment pursuant to Section 4999 of the Code (or any similar provision of state, local, or foreign Law). 

(h) Except as would not have a Material Adverse Effect, each Company Plan maintained outside the jurisdiction of the United States, or that
covers any employee residing or working outside the United States (a “Foreign Benefit Plan”), which is required to be registered or approved by any Governmental Entity, has been so registered and approved and, to the knowledge of
the Company, has been maintained in good standing with applicable requirements of Governmental Entities, and if intended to qualify for special tax treatment, to the knowledge of the Company, there are no existing circumstances or events that have
occurred that could reasonably be expected to affect adversely the special tax treatment with respect to such Foreign Benefit Plans. 
 3.14
Insurance. The Company has made available to the Parent correct and complete copies of all Group Company property and casualty insurance policies currently in force (collectively, the “Group Company Insurance Policies”). All
of the Group Company Insurance Policies (a) are in full force and effect and are valid, outstanding and enforceable policies (and will continue to be in full force and effect and valid, outstanding and enforceable following the Closing) and
(b) have not been subject to any lapse in coverage. No Group Company is in material default with respect to its obligations under any of the Group Company Insurance Policies or has taken any action or failed to take any action that, with notice
or the lapse of time, would constitute such a material default, or permit termination or material modification, of any of the Group Company Insurance Policies. No Group Company has received notice of default under any Group Company Insurance Policy
or notice of any pending or threatened termination or cancellation, coverage limitation or reduction or material premium increase with respect to any Group Company Insurance Policy. To the knowledge of the Company, there is no basis for denial of
any pending claim under any Group Company Insurance Policy. 

  
 24 

 3.15 Compliance with Laws. Each of the Group Companies is and has been in compliance
with all applicable Laws, in each case, in all material respects. All approvals, filings, permits, variances, exemptions and licenses of Governmental Entities (collectively, “Permits”) required to conduct, and material to, the
business of the Group Companies are in the possession of the Group Companies, are in full force and effect and have been and are being complied with in all material respects. No suspension, modification, nonrenewal or cancellation of any of such
Permits is pending or, to the knowledge of the Company, threatened. 
 3.16 Environmental Matters. 

(a) Each Group Company is and has been in compliance with all applicable Environmental Laws (which compliance includes, but is not limited to,
the possession by any Group Company of all permits and other governmental authorizations required under applicable Environmental Laws, and compliance with the terms and conditions thereof) in all material respects. 

(b) There is no material Environmental Claim pending or, to the knowledge of the Company, threatened against any Group Company. 

3.17 Affiliated Transactions. Except as set forth on Schedule 3.17, no officer, member of the board of directors or Affiliate of
any Group Company or any individual in such officer’s or director’s immediate family is a party to any Contract or transaction with any Group Company with payments in excess of $150,000 or has any interest in any property used by any Group
Company with a value in excess of $150,000. 
 3.18 Employees. Each Group Company is in compliance in all material respects with all
applicable Laws relating to employment, labor and wage and hour matters. No Group Company is a party to any collective bargaining agreement or other Contract with any labor organization or other representative of any employees of a Group Company
(including a works council), nor is any such Contract presently being negotiated, nor, to the knowledge of the Company, are there any union or other organizing activities involving the employees of any Group Company to authorize representation by
any labor organization. There have been and are no material strikes, work stoppages, slowdowns, lockouts, arbitrations or grievances, or other material labor disputes, pending or, to the knowledge of the Company, threatened against or involving any
employees of the Group Companies or the Group Companies. 
 3.19 Brokerage. Except for fees and expenses of Persons listed on
Schedule 3.19 (which, for the avoidance of doubt, constitute Transaction Expenses), there are no claims for, and no Group Company has any Liability with respect to, brokerage commissions, finders’ fees or similar compensation in
connection with the transactions contemplated by this Agreement based on any agreement made by or on behalf of any Group Company for which the Parent or the Surviving Company would be liable following the Closing. 

  
 25 

 3.20 Vote Required. 

(a) The Shareholder Approval is the only vote or consent of any class or series of Company Stock required to approve this Agreement and the
transactions contemplated by this Agreement, including the Merger. The Board of Directors of the Company, by resolutions duly adopted by unanimous vote at a meeting duly called and held and not subsequently rescinded or modified in any way, has duly
(a) determined that this Agreement and the Merger are fair to and in the best interests of the Company and its stockholders, (b) approved this Agreement and the Merger and the other Contemplated Transactions and (c) recommended that
the stockholders of the Company adopt this Agreement and directed that such matter be submitted to a vote by the Company’s stockholders (the “Company Recommendation”). The Company is not a foreign corporation of the type
described in Section 2115(a) of the California Corporations Code, and Section 2115(b) of the California Corporations Code does not apply to the Company. 

(b) None of the information contained or incorporated by reference in the Shareholder Communication Materials (other than any such information
provided by, or on behalf of, Parent or Merger Sub) will (taking into account all amendments or supplements thereto) contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary in
order to make the statements therein, in light of the circumstances under which they were made, not materially misleading. 
 (c) The
Company has taken all action required to be taken by it in order to exempt this Agreement and the Merger and the other transactions contemplated by this Agreement from, and this Agreement and the Merger and the other transactions contemplated by
this Agreement are exempt from, any anti-takeover or similar provisions of the Organizational Documents and the requirements of any “moratorium,” “control share,” “fair price,” “affiliate transaction,”
“business combination” or other anti-takeover Laws and regulations of any jurisdiction (collectively, “Takeover Laws”). The Company has taken all action required to be taken by it in order to make this Agreement, the
Merger and the other transactions contemplated hereby comply with, and this Agreement, the Merger and the other transactions contemplated hereby do comply with, the requirements of any provisions of the Organizational Documents and any applicable
agreements between the Company, on the one hand, and any Securityholder, on the other hand, concerning “business combination,” “fair price,” “voting requirement,” “constituency requirement” or other similar or
related provisions. 
 3.21 Customers and Suppliers. 

(a) Schedule 3.21(a) sets forth a list of the Group Companies’ top ten (10) customers (the “Specified
Customers”) for the fiscal year ended December 31, 2020 (determined on a consolidated basis based on the amount of revenues recognized by the Group Companies). Except as set forth in Schedule 3.21(a), since January 1, 2021,
(i) no Specified Customer has canceled or terminated, in its entirety, or notified any Group Company that it intends to materially change or modify its customer relationship with any Group Company in a way that would materially change the revenue
associated with such Specified Customer and (ii) no Group Company has had any material dispute with any Specified Customer. 
 (b)
Schedule 3.21(b) sets forth a list of the Group Companies’ top ten (10) suppliers, including licensors (the “Specified Suppliers”), for the fiscal year ended December 31, 2020 (determined on a consolidated
basis based on the amount paid by the Group Companies). Since January 1, 2021, (i) no Specified Supplier has canceled or otherwise terminated, in its entirety, or notified any Group Company that it intends to materially change or modify its
supply relationship with any Group Company and (ii) no Group Company has had any material dispute with any Specified Supplier. 

  
 26 

 3.22 Title to and Condition and Sufficiency of Assets. 

(a) The Group Companies have good and marketable fee title to (or, as applicable, a valid and subsisting leasehold interest or license rights
in) all of the assets made or used by them, free and clear of all Liens other than Permitted Liens. None of the Group Companies is using any material assets that are not owned, licensed or leased by it. The title of the Group Companies to its
material assets will not be affected by the transactions contemplated by this Agreement. 
 (b) The real and tangible personal property
owned, licensed or leased by the Group Companies are in good operating condition and repair, are free from material defect, and are adequate for the uses to which they are currently being put. None of such real and tangible personal property is in
need of (or in the course of receiving) maintenance, repair or replacement, except for ordinary, routine maintenance and repair. 
 (c) The
assets owned, licensed or leased by the Group Companies comprise all assets, tangible and intangible, that are used in or necessary for the conduct of the businesses of the Group Companies as currently conducted. The Group Companies have all assets,
tangible and intangible, that the Group Companies used, held for use or acquired for use during the six-month period immediately preceding the date of this Agreement, other than assets sold, licensed or
consumed in the Ordinary Course of Business. 
 3.22 No Other Representations or Warranties. NOTWITHSTANDING ANY PROVISION OF THIS
AGREEMENT TO THE CONTRARY, EXCEPT FOR THE REPRESENTATIONS AND WARRANTIES EXPRESSLY MADE BY THE COMPANY IN THIS ARTICLE III OR IN THE CERTIFICATES OR OTHER INSTRUMENTS DELIVERED PURSUANT HERETO, NEITHER ANY GROUP COMPANY NOR ANY PERSON ACTING
ON BEHALF OF ANY GROUP COMPANY MAKES ANY REPRESENTATION OR WARRANTY WITH RESPECT TO THE GROUP COMPANIES OR THEIR RESPECTIVE BUSINESSES, OPERATIONS, ASSETS, LIABILITIES, CONDITION (FINANCIAL OR OTHERWISE) OR PROSPECTS, NOTWITHSTANDING THE DELIVERY OR
DISCLOSURE TO THE PARENT, THE MERGER SUB OR ANY OF THEIR RESPECTIVE SUBSIDIARIES OR REPRESENTATIVES OF ANY DOCUMENTATION, FORECASTS, PROJECTIONS OR OTHER INFORMATION WITH RESPECT TO ANY ONE OR MORE OF THE FOREGOING. EXCEPT FOR THE REPRESENTATIONS
AND WARRANTIES EXPRESSLY MADE BY THE COMPANY IN THIS ARTICLE III OR IN THE CERTIFICATES OR OTHER INSTRUMENTS DELIVERED PURSUANT HERETO, ALL OTHER REPRESENTATIONS AND WARRANTIES, WHETHER EXPRESS OR IMPLIED, ARE EXPRESSLY DISCLAIMED BY THE
COMPANY. 

  
 27 

 ARTICLE IV 

REPRESENTATIONS AND WARRANTIES OF 

THE PARENT AND THE MERGER SUB 

The Parent and the Merger Sub, jointly and severally, represent and warrant to the Company, as of the date hereof and as of the Closing, as
follows: 
 4.01 Organization and Power. The Parent is a corporation duly organized, validly existing and in good standing under the
Laws of the State of Delaware, with full corporate power and authority to enter into this Agreement and perform its obligations hereunder. The Merger Sub is a corporation duly organized, validly existing and in good standing under the Laws of the
State of Delaware, with full corporate power and authority to enter into this Agreement and perform its obligations hereunder. There are no pending, or to the knowledge of the Parent, threatened, actions for the dissolution, liquidation or
insolvency of either the Parent or the Merger Sub. 
 4.02 Authorization. The execution, delivery and performance of this Agreement
by the Parent and the Merger Sub and the consummation of the transactions contemplated hereby have been duly and validly authorized by all requisite corporate action, and no other proceedings on their part are necessary to authorize the execution,
delivery or performance of this Agreement. This Agreement has been duly executed and delivered by the Parent and the Merger Sub and, assuming that this Agreement is a valid and binding obligation of the Company and the Representative, this Agreement
constitutes a valid and binding obligation of the Parent and the Merger Sub, enforceable in accordance with its terms, except as enforceability may be limited by bankruptcy Laws, other similar Laws affecting creditors’ rights generally and
general principles of equity affecting the availability of specific performance and other equitable remedies. 
 4.03 No Violation.
Neither the Parent nor the Merger Sub is subject to or obligated under any provision of its certificate of incorporation, its bylaws, any applicable Law, any material Contract, any material Permit, or any Order, in each case, which would be breached
or violated in any material respect by the Parent’s or the Merger Sub’s execution, delivery or performance of this Agreement or the consummation of the transactions contemplated hereby. 

4.04 Governmental Consents, etc. Except for (i) the applicable requirements of the HSR Act, (ii) the filing of
the Certificate of Merger with the Secretary of State of the State of Delaware and (iii) the applicable requirements of applicable securities Laws and any rule or regulation of any applicable national securities exchange, (a) neither the
Parent nor the Merger Sub is required to submit any material notice, report or other filing with any Governmental Entity in connection with the execution, delivery or performance by it of this Agreement or the consummation of the transactions
contemplated hereby, and (b) no material consent, approval or authorization of any Governmental Entity is required to be obtained by the Parent or the Merger Sub in connection with its execution, delivery and performance of this Agreement or
the consummation of the transactions contemplated hereby. 

  
 28 

 4.05 Litigation. As of the date hereof, there is no Action pending or, to the
Parent’s knowledge, threatened (in writing or otherwise) against the Parent or the Merger Sub at Law or in equity, or before or by any Governmental Entity, that would have a Parent Material Adverse Effect. 

4.06 Brokerage. Except as set forth in a Contract with Morgan Stanley & Co. LLC, there are no claims for brokerage
commissions, finders’ fees or similar compensation in connection with the transactions contemplated by this Agreement based on any agreement made by or on behalf of the Parent or the Merger Sub. 

4.07 Parent Financial Resources. The Parent has, or has access to, and will have available on the Closing Date, sufficient immediately
available funds, in cash, to make payment of all amounts to be paid by it hereunder on and after the Closing Date and all of the Parent’s related fees and expenses arising as a result of the transactions contemplated by this Agreement. The
obligations of the Parent and the Merger Sub under this Agreement are not subject to any conditions regarding the ability of the Parent or any of its Subsidiaries to obtain any financing for the consummation of the transactions contemplated hereby.

 4.08 Purpose. The Merger Sub is a newly organized corporation, formed solely for the purpose of engaging in the transactions
contemplated by this Agreement. The Merger Sub has not engaged in any business activities or conducted any operations other than in connection with the transactions contemplated by this Agreement. The Merger Sub is a wholly owned Subsidiary of the
Parent. 
 4.09 Solvency. Immediately after giving effect to the transactions contemplated by this Agreement and subject to the
accuracy of the representations and warranties set forth Article III, the Surviving Company and each of its Subsidiaries will be able to pay their respective debts as they become due and shall own property that has a fair saleable value
greater than the amounts required to pay the probable liability of their respective debts (including a reasonable estimate of the amount of all known contingent Liabilities). Immediately after giving effect to the transactions contemplated by this
Agreement and subject to the accuracy of the representations and warranties set forth Article III, the Surviving Company and each of its Subsidiaries will have adequate capital to carry on their respective businesses. The Parent is not
transferring property and incurring an obligation in connection with the transactions contemplated by this Agreement with the intent to hinder, delay or defraud either present or future creditors of any Group Company. 

4.10 No Other Representations. In entering into this Agreement, each of the Parent and the Merger Sub has relied upon its own
investigation and analysis, the representations and warranties of the Company expressly contained in Article III and in the certificates or other instruments delivered pursuant hereto (collectively, the “Company
Representations”) and the representations and warranties of certain Securityholders expressly contained in Support Agreements, and each of the Parent and the Merger Sub acknowledges that, other than as set forth in this Agreement and in the
certificates or other instruments delivered pursuant hereto, none of the Group Companies or any of their respective Subsidiaries makes or has made any representation or warranty, either express or implied, (a) as to the accuracy or completeness
of any of the information provided or made available to the Parent, the Merger Sub or any of their respective Subsidiaries or representatives prior to the execution of this Agreement or (b) with respect to any projections, forecasts, estimates,
plans or budgets of future revenues, expenses or 

  
 29 

 
expenditures, future results of operations (or any component thereof), prospects, future cash flows (or any component thereof) or future financial condition (or any component thereof) of any
Group Company, in each case heretofore or hereafter delivered to or made available to the Parent, the Merger Sub or any of their respective Subsidiaries or representatives. Without limiting the generality of the foregoing, other than as set forth in
this Agreement and in the certificates or other instruments delivered pursuant hereto, (i) none of the Group Companies or any of their respective Subsidiaries has made, and shall not be deemed to have made, any representations or warranties in
the materials relating to the business, assets or Liabilities of the Group Companies made available to the Parent, any of its Subsidiaries or any of their respective representatives, including due diligence materials, memoranda or similar materials,
or in any presentation of the business of the Group Companies by management of any Group Company in connection with the transactions contemplated hereby, and (ii) no statement contained in any such materials or made in any such presentation
shall be deemed a representation or warranty hereunder. It is understood that, other than as set forth in this Agreement and in the certificates or other instruments delivered pursuant hereto, cost estimates, projections or other predictions, any
data, any financial information or any offering or other memoranda, offering materials, presentations or similar materials made available to the Parent, the Merger Sub or any of their respective Subsidiaries or representatives by or on behalf of a
Group Company are not, and shall not be deemed to be or to include, representations or warranties of any Group Company. Except as expressly and specifically set forth in the Company Representations, each of the Company and its Subsidiaries, and its
and their respective Subsidiaries’ representatives, expressly disclaim any and all other representation and warranties, and the Parent expressly disclaims reliance on any and all such other representations or warranties (if any), express or
implied. It is understood and agreed that nothing in this Agreement shall prohibit, limit or restrict the rights of any Party in the case of Fraud (provided, that only a Person who commits such Fraud shall be responsible for such Fraud). 

ARTICLE V 
 COVENANTS
OF THE COMPANY 
 5.01 Conduct of the Business. From the date hereof until the earlier of the termination of this Agreement
and the Closing, except (i) as set forth on Schedule 5.01 of the Disclosure Schedules, (ii) as the Parent shall have provided its prior written consent (which consent shall not be unreasonably withheld, conditioned or delayed and
may be via email), (iii) as reasonably necessary to ensure that it complies with applicable Laws, including a change in applicable Laws relating to or resulting from any Contagion Event or COVID-19 Measure, or
(v) as expressly required by this Agreement, (1) the Company shall, and shall cause its Subsidiaries to, conduct their respective businesses in the Ordinary Course of Business and use commercially reasonable efforts to preserve intact the
businesses, properties, assets, rights, employees and goodwill of the Group Companies consistent with past practice; provided, that, notwithstanding the foregoing, the Company may use available cash to repay any Indebtedness under Contracts
existing as of the date of this Agreement and the Group Companies may liquidate their short-term and long-term corporate bond and similar security investments into Cash, and (2) the Company shall not, and shall cause its Subsidiaries not to:

  
 30 

 (a) except for issuances as may result from the exercise of Options outstanding as of the
date of this Agreement or for issuances of replacement certificates for shares of Company Stock and except for issuance of new certificates for shares of Company Stock in connection with a permitted transfer of Company Stock by the holder thereof,
issue, sell, grant, pledge, encumber or deliver any of its, or any of its Subsidiaries’, equity securities or issue, sell or grant any securities convertible into, or options with respect to, or warrants to purchase or rights to subscribe for,
any of its or any of its Subsidiaries’ equity securities, or issue, sell, grant, pledge, encumber or deliver any other Equity Securities; 

(b) effect any recapitalization, reclassification, distribution, equity split or like change in its capitalization or declare, set aside, make
or pay any dividend (other than any dividend by any Group Company to another Group Company); 
 (c) amend its Organizational Documents or
any of its Subsidiaries’ organizational documents; 
 (d) make any redemption or purchase of its, or any of its Subsidiaries’,
Equity Securities (other than with respect to the repurchase of Company Stock (including any Options) from former employees of a Group Company to the extent required by agreements or any Company Plan, in each case, existing as of the date of this
Agreement); 
 (e) sell, assign, license, lease, encumber or transfer any material assets, except in the Ordinary Course of Business and
Permitted Liens; 
 (f) sell, assign, lease, transfer, encumber or license any Company IP, except in the Ordinary Course of Business and
Permitted Liens; 
 (g) place any Company Proprietary Software into a source code escrow; 

(h) enter into, materially amend or voluntarily terminate any Material Contract, other than in the Ordinary Course of Business; 

(i) make any capital or similar investment in, or any loan to, any other Person (other than a Group Company); 

(j) make any capital expenditures in excess of $250,000 in the aggregate, except for capital expenditures paid with Cash prior to the Closing
Date or leases which are treated as Indebtedness hereunder; 
 (k) make any loan to any of its officers and employees, except pursuant to
any agreement set forth on the Disclosure Schedules; 
 (l) except as required under the terms of any Company Plan or applicable Law:
(1) grant any incentive awards or, other than in the Ordinary Course of Business, make any increase in the salaries, bonuses or other compensation and benefits under any Company Plan payable by a Group Company to any of its employees, officers
or directors; (2) terminate or amend any Company Plan; or (3) adopt or enter into any plan, policy or arrangement for the current or future benefit of any officer or director of any Group Company that would be a Company Plan if it were in
existence as of the date hereof; 

  
 31 

 (m) commence or settle any Action outside the Ordinary Course of Business; 

(n) make or change any material election in respect of Taxes, (ii) make any material change in any method, practice or policy of
accounting used by the Group Companies in the preparation of the financial statements or Tax Returns of the Group Companies, (iii) settle or compromise any claim or assessment of Taxes with any Governmental Entity relating to any Group Company,
(iv) consent to any extension or waiver of the limitation period applicable to any Tax claim or assessment relating to any Group Company (other than extensions to file Tax Returns obtained in the Ordinary Course of Business), or (v) fail
to make any material estimated Tax payment; 
 (o) directly or indirectly acquire, by merging or consolidating with, or by purchasing an
equity security in, or by any other manner, any Person or division, business or equity interest in any Person; 
 (p) make any changes in
accounting methods, principles or practices, except insofar as may be required by a change in GAAP; or 
 (q) grant credit and other sales
or license terms to any customer on terms or in amounts materially more favorable than those that have been provided to customers in the ordinary course of business consistent with past practice or effect any other material change in any material
policies or practices relating to the billing or collection of accounts receivable and similar amounts; or 
 (r) commit or agree, in
writing or otherwise, to take any of the foregoing actions. 
 Nothing contained in this Agreement shall give the Parent or the Merger Sub, directly or
indirectly, the right to control or direct the Company’s or any of its Subsidiaries’ operations prior to the Closing, and the Group Companies’ failure to take any action prohibited by subclauses (a)-(r) of this
Section 5.01 shall not be a breach of this Section 5.01 or any other covenant of this Agreement. 

5.02 Access to Books and Records. From the date hereof until the earlier of the termination of this Agreement and the Closing, the
Company shall provide the Parent and its authorized representatives (the “Parent’s Representatives”) with reasonable access during normal business hours, and upon reasonable notice, to the offices, properties,
personnel, and books and records of the Group Companies in order for the Parent to have the opportunity to make such investigation as it shall reasonably desire in connection with the consummation of the transactions contemplated hereby,
provided that, if the Company provides the Parent with written notice of an objection with respect to the identity of a third party to be included as one of the Parent’s Representatives, the Parent will consider the Company’s
objection in good faith. All requests for access to employees shall be coordinated through the individuals listed under the applicable heading on Schedule 5.02(a) and all requests for contracts with or (with respect to the transactions
contemplated by this Agreement) access to customers of the Group Companies shall 

  
 32 

 
be coordinated through the individuals listed on Schedule 5.02(b). In exercising access rights under this Section 5.02, the Parent and the Parent’s
Representatives shall (i) not be permitted to interfere unreasonably with the conduct of the business of any Group Company, (ii) only access personal information relating to employees of any Group Company to the extent necessary for, and
only for the purposes of, the completion of the transactions contemplated hereby and (iii) not contact or communicate with, directly or indirectly, any of the Group Companies’ customers, vendors, suppliers, distributors or sales
representatives without the Company’s prior written consent (other than, to the extent applicable, regarding matters unrelated to the transactions contemplated hereby). Notwithstanding anything herein to the contrary, no such access or
examination shall be permitted to the extent that it would require any Group Company to disclose information subject to attorney-client privilege or attorney work product privilege, violate any third party confidentiality obligations to which any
Group Company is bound as of the date of this Agreement, or violate any applicable Law. In any such case, the Company shall use its reasonable best efforts to make appropriate substitute disclosure arrangements. The Parent acknowledges that the
Parent is and remains bound by the Confidentiality Agreement between Parent and Plex Systems, Inc. dated January 28, 2020, as amended on May 25, 2021 (the “Confidentiality Agreement”). Notwithstanding anything contained
herein to the contrary, no access or examination provided pursuant to this Section 5.02 shall qualify or limit any representation or warranty set forth herein or the conditions to Closing set forth in
Section 7.01(a). 
 5.03 Efforts to Consummate. Subject to the terms and conditions herein provided, from
the date hereof until the earlier of the termination of this Agreement and the Closing, the Company shall use reasonable best efforts to take, or cause to be taken, all action and to do, or cause to be done, all things reasonably necessary, proper
or advisable to consummate and make effective as promptly as practicable the transactions contemplated by this Agreement (including the satisfaction, but not a waiver, of the closing conditions set forth in Section 7.02);
provided, that (a) such efforts shall not require agreeing to any obligations or accommodations (financial or otherwise) binding on a Group Company in the event the Closing does not occur and (b) any obligations or accommodations
(financial or otherwise) binding on a Group Company shall require the prior written consent of the Parent. 
 5.04 Exclusive Dealing.
During the period from the date of this Agreement through the Closing or the earlier termination of this Agreement, the Company shall not, and shall cause its Subsidiaries and the representatives of the Company and/or its Subsidiaries not to, take
any action to initiate, solicit or engage in discussions or negotiations with, or provide any information to, any Person (other than the Parent and the Parent’s Representatives) concerning any Acquisition Transaction. The Company shall, and
shall cause its Subsidiaries and the representatives of the Company and/or its Subsidiaries to, cease and cause to be terminated any existing discussions, communications or negotiations with any Person (other than the Parent and its authorized
Representatives) with respect to any Acquisition Transaction. 
 5.05 Payoff Letters and Lien Releases. Not less than two
(2) Business Days prior to the Closing Date, the Company shall deliver to the Parent customary payoff letters (which will include customary Lien releases and similar documentation effective upon receipt of applicable payoff amounts) in
connection with the repayment of the Indebtedness in accordance with Section 2.02(d). 

  
 33 

 5.06 Notification. From the date hereof until the earlier of the termination of this
Agreement and the Closing, if the Company becomes aware of, or there occurs after the date of this Agreement, any fact or condition that constitutes a breach of any representation or warranty made by the Company in Article III, or of any
covenant that would cause the conditions set forth in Section 7.01(a) or (b), as applicable, not to be satisfied, the Company shall disclose to the Parent such breach. 

5.07 Certain Cooperation. 

(a) The Parent may undertake efforts to procure and/or amend one or more third party debt financing arrangements in connection with the
Contemplated Transactions (the “Debt Financing”). Prior to the Closing, the Company shall, and shall cause its Subsidiaries and the Representatives of the Company and its Subsidiaries to, provide reasonable cooperation in connection
with the Debt Financing (and/or any substitute or related debt financing transactions), including reasonable assistance with the preparation of customary offering documents, bank information memoranda, securities offering material, prospectuses and
other pertinent information (including historical and pro forma financial statements and information) regarding the Company and its Subsidiaries, that Purchaser may reasonable request; provided, that, nothing in this
Section 5.07 shall require any such cooperation to the extent that it would (1) require the Company or its Subsidiaries to waive or amend any terms of this Agreement, (2) require the Company or any of its
Subsidiaries to (x) agree to pay any commitment or other fee or reimburse any expenses in connection with the Debt Financing prior to the Closing or (y) give any indemnity, pledge any collateral or take any similar action that is not
contingent on the Closing, (3) unreasonably interfere with the ongoing business or operations of the Company and its Subsidiaries, (4) require any of the Company or its Subsidiaries to take any action that would (v) jeopardize any
attorney-client privilege, (w) violate its respective Organizational Documents or certificates of incorporation or bylaws (or comparable documents), (x) violate any applicable Law, (y) other than with respect to the payoff of existing
Indebtedness contemplated pursuant to the payoff letters to be delivered pursuant to Section 5.05 (and related Lien release and similar documentation), constitute a material default under, or give rise to any right of
termination, cancellation or acceleration of any material right or obligation of the Company or any of its Subsidiaries or to a loss of any material benefit to which the Company or any of its Subsidiaries is entitled under any provision of any
material agreement binding upon the Company or any of its Subsidiaries or (z) result in the creation or imposition of any Lien on any asset of the Company or any of its Subsidiaries (except any Lien on any of their respective assets that
becomes effective only upon the Closing), (5) require the Company or any of its Subsidiaries, or their respective directors, managers, officers, general or limited partners, employees, counsel, financial advisors, auditors, agents or other
authorized representatives, to enter into or approve any Debt Financing or other definitive agreement or document related to the Debt Financing that is effective prior to the Closing, (6) result in any directors, officers, employees, counsel,
financial advisors, auditors, agents and other authorized representatives of the Company or any of its Subsidiaries incurring any personal liability with respect to any matters relating to the Debt Financing, or (7) cause any condition to
Closing set forth in Article VII to fail to be satisfied or otherwise result in any breach of this Agreement by the Company. 

  
 34 

 (b) The Parent shall promptly reimburse the Company for all reasonable out-of-pocket costs and expenses (including reasonable and out-of-pocket attorneys’ fees)
incurred by the Company and its Subsidiaries in connection with the cooperation of the Company and its Subsidiaries pursuant to Section 5.07(a) (and in no event shall any of such expenses or costs be Transaction Expenses).
The Parent shall indemnify, defend and hold harmless the Company and its Subsidiaries, and their authorized representatives, from and against any and all Losses actually suffered by any of them in connection with the Debt Financing and/or the
arrangement thereof (including any arising from or relating to the actions and cooperation contemplated by this Section 5.07), except as a result of the bad faith, willful misconduct, or breach of this Agreement by the
Company. 
 (c) Notwithstanding anything to the contrary herein, (i) it is understood and agreed that the Company’s obligations
under this Section 5.07 shall be deemed to be satisfied for purposes of the condition precedent set forth in Section 7.01(b), and (ii) the obligations of the Parent and the Merger Sub under
this Agreement are not subject to any conditions regarding the ability of the Parent to obtain the Debt Financing prior to the Closing. 

5.08 Shareholder Approval and Related Matters. 

(a) Promptly after the execution and delivery of this Agreement and in compliance with applicable Law, the Company shall (i) submit to
Company Shareholders this Agreement and the transactions contemplated by this Agreement, including the Merger, for approval and adoption by the Company Shareholders and (ii) take all action reasonably necessary to seek the Shareholder Approval,
including through a consent of Company Shareholders in compliance with Section 228 of the DGCL within one (1) Business Day following the date of this Agreement. 

(b) If the Company receives the Shareholder Approval through a consent of Company Shareholders in accordance with Section 228 of the DGCL
(a “Stockholder Written Consent”), the Company shall provide the Parent with a correct and complete copy of the executed Stockholder Written Consent evidencing the Shareholder Approval upon receipt thereof. As promptly as
practicable after the Company’s receipt of the Shareholder Approval through the Stockholder Written Consent (but not less than thirty (30) days prior to the Closing), the Company shall (i) comply with its obligations under
Section 228(e) and 262 of the DGCL (and Section 1.10 of the Company’s bylaws) with respect to the transactions contemplated by the Merger Agreement, including the Merger and, concurrently therewith, provide the applicable Company
Shareholders with an information statement with respect to the Merger, which shall, among other disclosures, include notice of appraisal rights as described in Section 262(d) of the DGCL (the “Information Statement”), and
(ii) cooperate with any Company Shareholders that seek to invoke and cause the application of Section 3.4 of that certain Second Amended and Restated Stockholders Agreement, dated as of June 9, 2014, by and among the Company and the
Company Shareholders, in connection with the Merger (the “Drag-Along Rights”). 
 (c) The Company agrees that all materials
to be submitted to the Company Shareholders after the execution and delivery of this Agreement in connection with the approval and adoption of the Merger and this Agreement, including all communications described in Section 228(e) and 262 of
the DGCL, all communications regarding the Shareholder Approval, the Information Statement, all communications regarding appraisal and similar rights and all communications regarding the Drag-Along Rights (collectively, the “Shareholder 

  
 35 

 
Communication Materials”), shall include information regarding the Company, the terms of the Merger and this Agreement and the Company Recommendation and shall otherwise comply with
applicable Law. The Company shall provide the Parent with a reasonable opportunity to review and comment on the Shareholder Communication Materials and incorporate into the Shareholder Communication Materials all reasonable comments that the Parent
proposes. Notwithstanding anything to the contrary in this Agreement, the Company shall not include in the Shareholder Communication Materials any information with respect to the Parent the form and content of which has not been approved by the
Parent prior to such inclusion. 
 (d) Prior to the Closing Date, if required to avoid the imposition of Taxes under Section 4999 of
the Code or the loss of deduction under Section 280G with respect to any payment or benefit in connection with any of the Contemplated Transactions, as promptly as practicable after the execution and delivery of this Agreement, but no later
than two (2) Business Days prior to the Closing Date, the Company shall submit to the voting stockholders (in a manner reasonably satisfactory to the Parent) for execution and approval by such stockholders as is required by the terms of
Section 280G(b)(5)(B) of the Code a written consent in favor of a single proposal to render the parachute payment provisions of Section 280G of the Code and the Treasury Regulations thereunder (collectively,
“Section 280G”) inapplicable to any payments or benefits to be provided as a result of or in connection with the Contemplated Transactions that might result, separately or in the aggregate, in the payment of any
amount or the provision of any benefit that would not be deductible by reason of Section 280G or that would be subject to an excise Tax under Section 4999 of the Code (determined without regard to the exceptions contained in
Section 280G(b)(4)) or any corresponding or similar provision of any state, local or foreign Law (together, the “Section 280G Payments”) to an individual who executed a Parachute Payment Waiver (as defined
below) or the payment of which is otherwise contingent on such stockholder approval. Any such stockholder approval shall be sought by the Company in a manner that satisfies all applicable requirements of Section 280G(b)(5)(B) of the Code and
the Treasury Regulations thereunder, including Q-7 of Section 1.280G-1 of such Treasury Regulations. The Company agrees that: (i) in the absence of such
stockholder approval, no Section 280G Payments shall be made to an individual who executed a Parachute Payment Waiver; and (ii) promptly after execution of this Agreement, and prior to the submission to the stockholders of the written
consent described herein and any related disclosure of the Section 280G Payments, the Company shall use commercially reasonable efforts to seek from each Person who is reasonably expected to receive any Section 280G Payment a waiver, in
form and substance satisfactory to Parent (the “Parachute Payment Waivers”) and shall deliver the executed Parachute Payment Waivers to Parent. The form and substance of all stockholder approval documents contemplated by this
Section 5.08(c), including the waivers, disclosure statement and written consent, and any mathematical analysis of the Section 280G Payments, shall be subject to the prior review and approval of the Parent (such
approval not to be unreasonably withheld, conditioned or delayed). The Company shall provide such documentation and information to Parent for its review and approval prior to soliciting waivers from the “disqualified individuals,” and the
Company shall implement all reasonable comments from the Parent thereon. In addition, prior to the Closing, the Company shall provide evidence reasonably satisfactory to the Parent of the outcome of the vote of the stockholders contemplated above.

  
 36 

 (e) If the Company becomes aware that the representations and warranties set forth in
Section 3.20(c) are or become untrue, the Company shall promptly take all action to cure the inaccuracy or breach. 

5.09 Unvested DT Options. Schedule 5.09 lists each Option that has a “double-trigger” feature and absent the action
provided for in this Section 5.09, would remain unvested at Closing (a “DT Option”). Prior to the mailing of the Information Statement to the Company Shareholders before the Closing Date, the Board of
Directors of the Company shall approve the conversion of, and the Company shall cause the plan administrator of the Company Equity Plan to convert, each DT Option into the right to receive a cash payment upon a Qualifying Termination (as defined in
Schedule 5.09) equal to the amount set forth opposite the name of each holder of the DT Options and shall notify each holder of the DT Options of the conversion and that the Parent is not assuming the DT Options, such that, on and after the
Closing, the DT Option shall no longer be exercisable for Equity Securities of any Person; provided that such actions shall expressly be conditioned upon the consummation of the Merger and shall be of no force or effect if this Agreement is
terminated. 
 5.10 Capital Structure Updates. If, after the execution and delivery of this Agreement and prior to the
Effective Time, (x) any Company Shares are issued as a result of an Optionholder’s exercise an Option listed in Schedule 3.04(c) or as a result of a Company Shareholder’s conversion of shares of Preferred Stock listed in
Schedule 3.04(c) or (y) a Company Shareholder transfers any of its Company Shares listed on Schedule 3.04(c), the Company shall provide the Parent with written notice thereof within two (2) Business Days and, in any event,
prior to the Closing. The Company shall cooperate to provide the Parent with a correct and complete list of Company Shareholders and related holdings of Company Shares (including stock certificate numbers), and Company Optionholders and related
vested in-the-money Options, as of the immediately prior to the Effective Time. 

ARTICLE VI 

COVENANTS OF THE PARENT 

6.01 Access to Books and Records. From and after the Closing until the six (6) year anniversary of the Closing Date and except for
(x) information that, if provided, would cause the forfeiture of attorney-client or attorney work product privilege of the Parent or any of its Subsidiaries and (y) information that, in the reasonable opinion of outside legal counsel to
the Parent, would be reasonably expected to result in a violation of any Contract, Law or Order, the Parent and the Surviving Company shall provide the Representative and its authorized representatives, during normal business hours and in a manner
so as not to unreasonably interfere with the normal business operations of Parent and its Subsidiaries, with reasonable access (for the purpose of examining and copying), during normal business hours, upon reasonable notice, to the books and records
of the Group Companies then in their respective possession with respect to periods or occurrences prior to or on the Closing Date (or in connection with indemnification obligations referenced in Section 10.01(f) after the Closing Date as well)
to the extent such access is reasonably required in connection with any Action brought by or against a third party or is with respect to the indemnification obligations referenced in Section 10.01(f). 

  
 37 

 6.02 Notification. From the date hereof until the earlier of the termination of this
Agreement and the Closing Date, if the Parent becomes aware of, or if there occurs after the date of this Agreement, any fact or condition that constitutes a breach of any representation or warranty made in Article IV or any covenant that, in
either case, would cause the conditions set forth in Section 7.02(a) or (b), as applicable, not to be satisfied as of the Closing Date, the Parent shall disclose to the Company such breach. 

6.03 Indemnification of Officers and Directors of the Company. 

(a) From and after the Closing and notwithstanding any amendment occurring after the Closing without the consent of the applicable D&O
Indemnified Party, Parent shall, or shall cause the Surviving Company to, to the fullest extent permitted by applicable Law, indemnify, defend and hold harmless, and provide advancement of expenses to, each Person who is now, or has been at any time
prior to the date hereof or who becomes prior to the Closing, an officer, director or employee of a Group Company (each, a “D&O Indemnified Party”), in each case, to the same extent that such Persons are indemnified or have the
right to advancement of expenses as of the date hereof by the Group Companies pursuant to their respective organizational documents in existence on the date hereof or indemnification agreements of the Company set forth in Schedule 6.03(a).

 (b) For a period of six (6) years after the Closing and at all times subject to applicable Law, the Surviving Company shall cause to
be maintained in effect the current policies of directors’ and officers’ liability insurance maintained by the Group Companies as of the date hereof (provided that the Parent or the Surviving Company may substitute such policies
with a substantially comparable insurer of at least the same coverage and amounts containing terms and conditions that are no less advantageous to the insured in any material respect) with respect to claims arising from facts or events that occurred
prior to the Closing. Notwithstanding the foregoing, prior to the Closing and in satisfaction of the Parent’s foregoing obligations under this Section 6.03, each of the Parent and the Company, if so elected by the
Parent, shall be permitted to purchase (at the Parent’s expense, and without duplication) a six (6) year “tail” prepaid directors’ and officers’ liability insurance policy, effective as of the Closing, providing, for a
period of six (6) years after the Closing, the coverage and amounts, and terms and conditions, contemplated by the foregoing sentence of this Section 6.03(b). If the Parent elects to purchase a “tail”
directors’ and officers’ liability insurance policy, the Group Companies shall provide reasonable assistance, including by obtaining quotations for such “tail,” and reasonable cooperation in providing any information or
documentation necessary for the procurement of such “tail,” as requested by the Parent. From and after the Closing, Parent shall, and shall cause the Group Companies to, continue to honor its obligations (as applicable) under any such
insurance procured pursuant to this Section 6.03(b), and shall not take (or cause to be taken) any action or omission that would reasonably be expected to result in the cancellation thereof. 

(c) The Surviving Company or any of its Subsidiaries shall pay all reasonable
out-of-pocket expenses, including reasonable attorneys’ fees, that are incurred by the D&O Indemnified Parties in enforcing the indemnity and other obligations
set forth in this Section 6.03. 

  
 38 

 (d) If the Surviving Company or any of its successors or assigns proposes to
(i) consolidate with or merge into any other Person and the Surviving Company shall not be the continuing or surviving corporation or entity in such consolidation or merger or (ii) transfer all or substantially all of its properties and
assets to any Person, then, and in each case, proper provision shall be made prior to or concurrently with the consummation of such transaction so that the successors and assigns of the Surviving Company shall, from and after the consummation of
such transaction, assume the indemnification and other obligations set forth in this Section 6.03. 
 (e) With
respect to any indemnification obligations of the Parent and/or Surviving Company pursuant to this Section 6.03, Parent and the Surviving Company shall be the indemnity of first resort with respect to all indemnification
obligations of the Surviving Company pursuant to this Section 6.03 (i.e., their obligations to an applicable D&O Indemnified Party are primary and any obligation of any other Person to advance expenses or to
provide indemnification and/or insurance for the same expenses or Liabilities incurred by such D&O Indemnified Party are secondary). 

(f) The provisions of this Section 6.03 shall survive the consummation of the Merger and the Effective Time and
(i) are intended to be for the benefit of, and shall be enforceable by, each D&O Indemnified Party, and his or her heirs and representatives and shall be binding on all successors and assigns of the Parent and the Surviving Company and
(ii) are in addition to, and not in substitution for, any other rights to indemnification or contribution that any such Person may have by Contract or otherwise. 

6.04 Efforts to Consummate. Subject to the terms and conditions herein provided, from the date hereof until the earlier of the
termination of this Agreement and the Closing Date, the Parent and the Merger Sub shall use reasonable best efforts to take, or cause to be taken, all actions and to do, or cause to be done, all things reasonably necessary, proper or advisable to
consummate and make effective as promptly as practicable the transactions contemplated by this Agreement (including the satisfaction, but not waiver, of the Closing conditions set forth in Article VII); provided, that such efforts
shall not require agreeing to any obligations or accommodations (financial or otherwise) binding on the Parent or any of its Subsidiaries in the event the Closing does not occur. 

6.05 Employment and Employee Benefits(a) . 

(a) Parent shall, or shall cause an Affiliate of Parent to, provide each Continuing Employee with, during the period commencing on the Closing
Date and ending on the one year anniversary of the Closing Date, with base salary or hourly wages, bonus compensation and benefits (excluding any nonqualified retirement or equity-based benefits) substantially comparable, in the aggregate, to those
provided by the Group Companies immediately prior to the Closing. 

  
 39 

 (b) For purposes of eligibility and vesting in any employee benefit plan maintained by
Parent or any of its Subsidiaries in which Continuing Employees are eligible to participate following the Closing (the “Parent Plans”), to the extent permitted by the Parent Plans, Parent shall credit each Continuing Employee with
his or her years of service with the Group Companies to the same extent as such employee was entitled immediately prior to the Closing to credit for such service under any similar Company Plan (other than for purposes of benefit accrual under any
Parent Plan that is a defined benefit pension plan), except where such crediting would result in duplication of benefits. Parent shall use commercially reasonable efforts to (i) not deny Continuing Employees (or any covered dependent thereof)
coverage on the basis of pre-existing condition exclusions and actively at work requirements and similar limitations, eligibility waiting periods, and evidence of insurability requirements to the extent such
conditions were waived or satisfied under similar Company Plans immediately prior to the Closing and (ii) credit such Continuing Employees (or a covered dependent thereof) for any deductibles, co insurance, and out of pocket expenses paid on or
prior to the Closing Date in satisfying any deductibles, co insurance, and maximum out of pocket expenses in the applicable plan year to which such deductibles and out of pocket expenses relate as if such amounts had been paid in accordance with the
applicable Parent Plan, but only to the extent such amounts were taken into account for each such purpose under the Company Plans in which such Continuing Employee (or covered dependent thereof) participated immediately prior to the Closing. 

(c) The Parties acknowledge and agree that all provisions contained in this Section 6.05 are included for the sole
benefit of the respective Parties and shall not create any right (i) in any other Person, including any employee, officer, independent contractor, former employee or any participant or any beneficiary thereof in any Company Plan or Parent Plan,
or (ii) to continued employment with the Group Companies or Parent. After the Closing, notwithstanding the foregoing in this Section 6.06, nothing contained in this Section 6.06 is intended to
be or shall be considered to be an amendment or adoption of any plan, program, agreement, arrangement or policy of Parent nor shall it interfere with the Parent’s, or any of its Subsidiaries’ right to amend, modify or terminate any Parent
Plans or any other employee benefits plan maintained by the Parent or any of its Subsidiaries or to terminate the employment of any employee of Parent or its Subsidiaries for any reason. 

6.06 No Financing Contingency. Purchaser acknowledges and agrees that Purchaser’s obligation to consummate the transaction
contemplated hereby is not contingent upon Purchaser’s ability to obtain financing, and that the Closing will not be deferred to allow Purchaser time to obtain financing. 

6.07 R&W Insurance Policy. If Buyer obtains a Buyer-side Representation and Warranty Insurance Policy (a “R&W Insurance
Policy”) it shall provide that the insurer(s) thereunder shall waive any right subrogate or otherwise make or bring any claim or proceeding against Representative, any Securityholder or any of their respective Affiliates (other than the
Group Companies) or any past, present or future equity holder, director, manager, member, officer, employee, advisor, agent or representative of any of the foregoing in their capacity as such based upon, arising out of, relating to or resulting from
this Agreement or the transactions contemplated hereby, or the negotiation, execution or performance of this Agreement, other than in the case of Fraud against the Person who committed such Fraud, and then only to the extent of such Fraud, and such
Persons shall be express third-party beneficiaries of such provision. The Parent shall be solely responsible for all costs to procure, maintain and make claims under any R&W Insurance Policy, including all premiums, retention amounts, taxes,
expenses and costs of any nature whatsoever. At the request of the Parent, the Group Companies shall use 

  
 40 

 
commercially reasonable efforts to provide reasonable assistance and cooperation, including the provision of any reasonable information and documents requested by the insurer underwriting any
R&W Insurance Policy. The obligations of the Parent and the Merger Sub under this Agreement are not subject to any conditions regarding the ability of Parent to obtain any R&W Insurance Policy prior to the Closing. 

6.08 Release. Effective as of the Closing, each of Parent and its Subsidiaries (including the Group Companies) and their respective
successors and assigns hereby fully and unconditionally releases, acquits and forever discharges the current and former directors and officers of the Company and its Subsidiaries, and the Company Shareholders and their respective current and former
directors, officers and employees in their capacity as such, from any and all manner of actions, causes of actions, claims, obligations, demands, damages, costs, expenses, compensation or other relief, whether known or unknown, whether in law or
equity, to the extent arising out of or relating to or accruing from their capacity as directors, officers or stockholders of the Company prior to the Closing; provided, however, that nothing in this Section 6.08 shall be
deemed to release, acquit, discharge or waive any rights (a) in respect of Fraud, (b) under any Support Agreement, Letter of Transmittal, Stockholder Written Consent or other Transaction Document or (c) in respect of claims against
any Person who is a former or current employee of a Group Company to the extent arising out of such person’s employment by a Group Company. 

ARTICLE VII 

CONDITIONS TO CLOSING 

7.01 Conditions to the Parent’s and the Merger Sub’s Obligations. The obligations of the Parent
and the Merger Sub to consummate the transactions contemplated by this Agreement, including the Merger, are subject to the satisfaction (or, if permitted by applicable Law, waiver by the Parent and the Merger Sub in writing) of the following
conditions: 
 (a) (i) The Company Fundamental Representations shall be true and correct in all respects (other than de
minimis inaccuracies) at and as of the Closing Date as though made at and as of the Closing Date (except to the extent expressly made as of an earlier date, in which case only as of such date) and (ii) all other representations and
warranties of the Company contained in Article III of this Agreement shall be true and correct (without giving effect to any limitation as to “materiality” or “Material Adverse Effect” set forth therein) at and as of the
Closing Date as though made at and as of the Closing Date (except to the extent expressly made as of an earlier date, in which case only as of such date), except, in the case of this clause (ii), where the failure of such representations and
warranties to be so true and correct (giving effect to the applicable exceptions set forth in the Disclosure Schedules but without giving effect to any limitation as to “materiality” or “Material Adverse Effect” qualifiers that
may be set forth therein) has not had and would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect; 

  
 41 

 (b) The Company shall have performed and complied with in all material respects all of the
covenants and agreements required to be performed by it under this Agreement at or prior to the Closing; 
 (c) The Merger shall have been
approved and this Agreement shall have been adopted by the affirmative vote of holders of a majority of the votes entitled to be cast with respect to Company Stock in accordance with the DGCL and the Organizational Documents (the
“Shareholder Approval”); 
 (d) The applicable waiting periods or approvals, if any, under the HSR Act shall have expired,
been terminated, or otherwise been obtained; 
 (e) No Governmental Entity of competent authority and jurisdiction shall have issued an
Order or enacted a Law that remains in effect and which makes illegal or otherwise prohibits the performance of this Agreement or the consummation of any of the transactions contemplated hereby; 

(f) The Company shall have delivered to the Parent each of the following: 

(i) a certificate of an authorized officer of the Company in his or her capacity as such, dated as of the Closing Date,
certifying, representing and warranting that the conditions specified in Sections 7.01(a), (b) and (g) have been satisfied; 

(ii) certified copies of resolutions of the requisite shareholders of the Company for the Shareholder Approval approving the
consummation of the transactions contemplated by this Agreement; 
 (iii) certified copies of resolutions duly adopted by
the Company’s board of directors authorizing the execution, delivery and performance of this Agreement and the other agreements contemplated hereby, and the consummation of all transactions contemplated hereby and thereby; 

(iv) a duly executed certificate that satisfies the requirements of Treasury Regulation Sections 1.897-2(h) and 1.1445-2(c)(3) confirming that the Company is not, nor has it been within five years of the date of the certification, a “United States real property
holding corporation” as defined in Section 897 of the Code (the “FIRPTA Certificate”) and a notice addressed to the Internal Revenue Service, signed by the Company, that satisfies the requirements of Treasury Regulation Section 1.897-2(h)(2) to be submitted by Parent to the Internal Revenue Service as agent for the Company; provided, however, that if the Company fails to deliver the FIRPTA Certificate and the notice described
in the foregoing sentence, Parent’s sole remedy shall be to withhold from payments made under this Agreement any withholding required by applicable Law; 

(v) the Estimated Closing Statement in accordance with Section 1.07; 

(vi) the Certificate of Merger in accordance with Section 2.02(a); and 

  
 42 

 (vii) the other documents described in
Section 5.05; 
 (g) there shall not have been a Material Adverse Effect which has occurred since the date hereof
and is continuing; and 
 (h) the Escrow Agreement shall have been executed and delivered by the Representative and the Escrow Agent. 

If the Closing occurs, all Closing conditions set forth in this Section 7.01 that have not been fully satisfied as
of the Closing shall be deemed to have been waived by the Parent and the Merger Sub (it being understood the same shall not affect claims in the case of Fraud). 

7.02 Conditions to the Company’s Obligations. The obligation of the Company to consummate the transactions
contemplated by this Agreement, including the Merger, is subject to the satisfaction (or, if permitted by applicable Law, waiver by the Company in writing) of the following conditions: 

(a) (i) The Parent Fundamental Representations shall be true and correct in all respects (other than de minimis
inaccuracies) at and as of the Closing Date as though made at and as of the Closing Date and (ii) all other representations and warranties of the Parent and the Merger Sub contained in Article IV of this Agreement shall be true and
correct (without giving effect to any limitation as to “materiality” or “Parent Material Adverse Effect” set forth therein) at and as of the Closing Date as though made at and as of the Closing Date (except to the extent
expressly made as of an earlier date, in which case only as of such date), except, in the case of this clause (ii), where the failure of such representations and warranties to be so true and correct (without giving effect to any limitation as to
“materiality” or “Parent Material Adverse Effect” set forth therein) has not had, and would not have, a Parent Material Adverse Effect; 

(b) The Parent and the Merger Sub shall have performed and complied with in all material respects all the covenants and agreements required to
be performed by them under this Agreement at or prior to the Closing; 
 (c) The Shareholder Approval shall have been obtained; 

(d) The applicable waiting periods or approvals, if any, under the HSR Act shall have expired, been terminated, or otherwise been obtained;

 (e) No Governmental Entity of competent authority and jurisdiction shall have issued an Order or enacted a Law that remains in effect and
which makes illegal or otherwise prohibits the performance of this Agreement or the consummation of any of the transactions contemplated hereby; 

(f) The Parent shall have delivered to the Company each of the following: 

(i) a certificate of an authorized officer of the Parent and the Merger Sub in his or her capacity as such, dated as of the
Closing Date, stating that the preconditions specified in Sections 7.02(a) and (b) have been satisfied; 

  
 43 

 (ii) certified copies of resolutions of the requisite holders of the voting
shares of the Merger Sub approving the consummation of the transactions contemplated by this Agreement; and 
 (iii)
certified copies of the resolutions duly adopted by the Parent’s board of directors (or its equivalent governing body) and the Merger Sub’s board of directors authorizing the execution, delivery and performance of this Agreement (in each
case, which may be redacted to remove any matters not otherwise required by this provision); and 
 (g) the Escrow Agreement shall have been
executed and delivered by the Parent and the Escrow Agent. 
 If the Closing occurs, all closing conditions set forth in this
Section 7.02 that have not been fully satisfied as of the Closing shall be deemed to have been waived by the Company (it being understood the same shall not affect claims in the case of Fraud). 

ARTICLE VIII 
 NON-SURVIVAL 
 8.01 Non-Survival. None of the
representations and warranties of any Party contained in this Agreement shall survive the Closing. None of the covenants of any Party contained in this Agreement that are required to be performed by such Party solely before the Closing shall survive
the Closing. Unless otherwise indicated, the covenants and agreements set forth in this Agreement that by their terms are required to be performed, in whole or in part, after the Closing shall survive the Closing until they have been performed or
satisfied. The Parent and its Subsidiaries disclaim any right to bring a claim against any of the Securityholders or the Representative for breach or inaccuracy of the representations or warranties of the Company set forth in this Agreement after
the Closing (for the avoidance of doubt, excluding a claim for breach or inaccuracy of the representations and warranties expressly set forth in any Support Agreement or any Letter of Transmittal). The Parent and its Subsidiaries shall not avoid
such limitation on liability or claims by seeking damages for breach of contract or tort or pursuant to any other theory of liability, all of which are hereby waived. Notwithstanding anything in this Agreement to the contrary, including, for the
avoidance of doubt, this Section 8.01, (a) nothing shall relieve any Person from any liability for Fraud; provided, however, that only the Person who commits such Fraud shall be responsible for such Fraud, and
(b) nothing shall prohibit, restrict, limit or otherwise affect the ability of the Parent or any of its Subsidiaries (including, for this purpose, the Group Companies) to make claims or otherwise seek recourse under the R&W Insurance
Policy. 
 ARTICLE IX 

TERMINATION 
 9.01
Termination. This Agreement may be terminated at any time prior to the Closing: 
 (a) by the mutual written consent of the Parent
and the Company; 

  
 44 

 (b) by the Parent, if any of the representations or warranties of the Company set forth in
Article III shall not be true and correct, or if the Company has failed to perform any covenant or agreement on the part of the Company set forth in this Agreement (including an obligation to consummate the Closing), such that the conditions
to Closing set forth in either Section 7.01(a) or (b) would not (in the absence of a waiver) be satisfied and, in the case of any breach capable of being cured prior to the Outside Date, the breach or breaches
causing such representations or warranties not to be true and correct, or the failures to perform any covenant or agreement, as applicable, are not cured within the earlier of twenty (20) Business Days after the Company becomes aware of the
breach, breaches or failures or the Outside Date; provided, that neither the Parent nor the Merger Sub is then in breach of this Agreement such that the conditions to Closing set forth in either Section 7.02(a) or
(b) would not (in the absence of a waiver) be satisfied; 
 (c) by the Company, if any of the representations or warranties of
the Parent or the Merger Sub set forth in Article IV shall not be true and correct, or if the Parent or the Merger Sub has failed to perform any covenant or agreement on the part of the Parent or the Merger Sub, respectively, set forth in
this Agreement (including an obligation to consummate the Closing), such that the conditions to Closing set forth in either Section 7.02(a) or (b) would not (in the absence of a waiver) be satisfied and, in the
case of any breach capable of being cured prior to the Outside Date, the breach or breaches causing such representations or warranties not to be true and correct, or the failures to perform any covenant or agreement, as applicable, are not cured
within the earlier of twenty (20) Business Days after the Parent becomes aware of such breach, breaches or failures or the Outside Date; provided, that the Company is not then in breach of this Agreement such that the conditions to
Closing set forth in either Section 7.01(a) or (b) would not (in the absence of a waiver) be satisfied; 

(d) by the Parent or the Company, if the transactions contemplated by this Agreement shall not have been consummated on or prior to
October 31, 2021 (such date, the “Outside Date”) and the Party seeking to terminate this Agreement pursuant to this Section 9.01(d) shall not have (provided that if such Party is the Parent,
neither the Parent nor the Merger Sub shall have) breached in any material respect its obligations under this Agreement in any manner that shall have proximately caused the failure to consummate the transactions contemplated by this Agreement on or
before the Outside Date; provided, that if any Party brings any Action pursuant to Section 12.18 to enforce specifically the performance of the terms and provisions hereof by any other Party, the Outside Date shall
automatically be extended pursuant to Section 12.18(b); 
 (e) by the Parent or the Company if (i) the Merger
shall not have been consummated on the date required by Section 2.01, (ii) all of the conditions to the Closing set forth in Article VII would be satisfied or waived at the time of such termination if the Closing
were held at the time of such termination (other than conditions that, by their nature, are to be satisfied at the Closing) and (iii) the terminating Party stood ready, willing and able to consummate the Merger on the date required by
Section 2.01 and at the time of termination; or 
 (f) by Parent, if, within one (1) Business Day of the date
of this Agreement, the Stockholder Written Consent shall not have been executed by the requisite Company Shareholders so as to constitute and evidence the Shareholder Approval and delivered to Parent. 

  
 45 

 9.02 Effect of Termination. In the event this Agreement is validly terminated
by either the Parent or the Company as provided above, the provisions of this Agreement shall immediately become void and of no further force and effect (other than the last two (2) sentences of Section 5.02, this
Section 9.02, Section 10.01, Article XI and Article XII hereof, which shall survive the termination of this Agreement (other than the provisions of
Section 12.18, which shall terminate)), and there shall be no liability under this Agreement on the part of either the Parent, the Merger Sub, the Company, the Representative or the Securityholders to one another;
provided, that no such termination shall relieve any Party hereto from any liability or damages resulting from a willful or intentional breach prior to such termination of any of such Party’s representations, warranties, covenants or
agreements set forth in this Agreement or from Fraud. Without limiting the Company’s rights under any other provision of this Agreement (including the Company’s right to specific performance pursuant to
Section 12.18), the Company may, on behalf of the Securityholders, petition a court to award damages in connection with any willful or intentional breach by the Parent and/or the Merger Sub of this Agreement. The Company
may, additionally, on behalf of the Securityholders, enforce such award and accept damages for such breach. For all purposes of this Agreement, the failure of a Party to consummate the Closing for any reason when required pursuant to the terms of
this Agreement after satisfaction or waiver of the conditions set forth in Article VII shall, in each case, be a willful and intentional breach of this Agreement by such Party that (i) is not capable of being cured, (ii) has
prevented consummation of the transactions contemplated hereby, and (iii) gives rise to the other Party’s termination right pursuant to Sections 9.01(b), (c) and/or (e) (as applicable). No termination of this Agreement
shall affect the obligations contained in the Confidentiality Agreement, all of which obligations shall survive termination of this Agreement in accordance with their terms. 

ARTICLE X 

ADDITIONAL COVENANTS 

10.01 Representative. 

(a) Appointment. In addition to the other rights and authority granted to the Representative elsewhere in this Agreement and the Escrow
Agreement, upon and by virtue of the approval of the requisite holders of Company Stock of this Agreement, and pursuant to each Letter of Transmittal, all of the Securityholders collectively and irrevocably constitute and appoint the Representative
as their agent and representative to act from and after the date hereof and to do any and all things and execute any and all documents that may be necessary, convenient or appropriate to facilitate the consummation of the transactions contemplated
by this Agreement and/or the Escrow Agreement, including: (i) execution of the documents and certificates pursuant to or in connection with this Agreement (including the Escrow Agreement and all documents and certificates pursuant to the Escrow
Agreement); (ii) receipt of payments under or pursuant to this Agreement and/or the Escrow Agreement (including the Holdback Amount) and disbursement thereof to the Securityholders and others, as contemplated by this Agreement, the Escrow Agreement
and/or an indemnification agreement among the Representative, the Parent and the Merger Sub; (iii) payment of amounts due to the Parent pursuant to Section 1.08 or 1.09; (iv) receipt and forwarding of notices
and communications pursuant to this Agreement; (v) administration of the provisions of this Agreement; (vi) giving or agreeing to, on behalf of all or any of the Securityholders, any and all consents, waivers,

  
 46 

 
amendments or modifications deemed by the Representative, in its sole and absolute discretion, to be necessary or appropriate under this Agreement and/or the Escrow Agreement and the execution or
delivery of any documents that may be necessary or appropriate in connection herewith and/or therewith, including executing, on behalf of each such Securityholder, any indemnification agreements for the benefit of Parent, the Surviving Company
and/or their respective Subsidiaries with respect to any Group Company or the Contemplated Transactions; (vii) amending this Agreement and/or the Escrow Agreement or any of the instruments to be delivered to the Parent and/or the Merger Sub
pursuant to this Agreement and/or the Escrow Agreement; (viii) (A) disputing or refraining from disputing, on behalf of each Securityholder relative to any amounts to be received by such Securityholder under this Agreement and/or the Escrow
Agreement or any agreements contemplated hereby and thereby, any claim made by the Parent and/or the Merger Sub under this Agreement or other agreements contemplated hereby, (B) negotiating and compromising, on behalf of each such
Securityholder, any indemnification claims and any dispute that may arise under, and exercising or refraining from exercising any remedies available under, this Agreement or any other agreement contemplated hereby (including paying any
indemnification obligations out of the Holdback Amount), and (C) executing, on behalf of each such Securityholder, any settlement agreement, release or other document with respect to such dispute or remedy; and (ix) engaging attorneys,
accountants, agents or consultants on behalf of the Securityholders in connection with this Agreement or any other agreement contemplated hereby and paying any fees related thereto. 

(b) Authorization. Notwithstanding Section 10.01(a), in the event that the Representative is of the opinion
that it requires further authorization or advice from the Securityholders on any matters concerning this Agreement or any other agreement contemplated hereby, the Representative shall be entitled to seek such further authorization from the
Securityholders prior to acting on their behalf. In such event, each Securityholder shall vote in accordance with the pro rata portion of the Merger Consideration paid to such Securityholder in accordance with this Agreement and the authorization of
a majority of such Persons shall be binding on all of the Securityholders and shall constitute the authorization of the Securityholders. The appointment of the Representative is coupled with an interest and shall be irrevocable by any Securityholder
in any manner or for any reason. This authority granted to the Representative shall not be affected by the death, illness, dissolution, disability, incapacity or other inability to act of any principal pursuant to any applicable Law. Francisco
Partners Management LLC hereby accepts its appointment as the initial Representative. 
 (c) Actions by the Representative; Resignation;
Vacancies. The Purchaser, the Merger Sub, the Surviving Company and the Escrow Agent may rely upon any act or omission (including any decision, consent or instruction) of the Representative with respect to the transactions contemplated by this
Agreement and/or any other agreement contemplated hereby as being the act or omission (including any decision, consent or instruction) of the Securityholders. The Purchaser, the Merger Sub, the Surviving Company and the Escrow Agent are hereby
relieved from any liability to any Person for any acts done by them in accordance with any act or omission (including any decision, consent or instruction) of the Representative. The Representative may resign from its position as Representative at
any time by written notice delivered to the Parent and the Securityholders. If there is a vacancy at any time in the position of the Representative for any reason, such vacancy shall be filled by a majority vote in accordance with the method set
forth in Section 10.01(b) above. 

  
 47 

 (d) No Liability. All acts of the Representative hereunder in its capacity as such
shall be deemed to be acts on behalf of the Securityholders and not of the Representative individually. The Representative shall not be liable to the Company, the Parent or the Merger Sub, solely in its capacity as the Representative, for any
liability of a Securityholder in connection with this Agreement. The Representative shall not be liable to the Securityholders, in his or its capacity as the Representative, for any liability of a Securityholder or otherwise, or for any error of
judgment, or any act done or step taken or omitted by it in good faith, or for any mistake in fact or Law, or for anything that it may do or refrain from doing in connection with this Agreement except in the case of the Representative’s gross
negligence or willful misconduct. The Representative may seek the advice of legal counsel in the event of any dispute or question as to the construction of any of the provisions of this Agreement or its duties hereunder, and it shall incur no
liability in its capacity as the Representative to the Securityholders and shall be fully protected relative to claims of the Securityholders with respect to any action taken, omitted or suffered by it in good faith in accordance with the advice of
such counsel. The Representative shall not by reason of this Agreement have a fiduciary relationship in respect of any Securityholder, except in respect of amounts received on behalf of the Securityholders. 

(e) Indemnification; Expenses. Each Securityholder shall, only to the extent of such Securityholder’s Pro Rata Percentage,
indemnify and defend the Representative and hold the Representative harmless against any Loss, damage, cost, Liability or expense actually incurred without fraud, gross negligence or willful misconduct by the Representative and arising out of or in
connection with the acceptance, performance or administration of the Representative’s duties under this Agreement. Any expenses or taxable income incurred by the Representative in connection with the performance of its duties under this
Agreement shall not be the personal obligation of the Representative but shall be payable by and attributable to the Securityholders based on each such Person’s Pro Rata Percentage. Notwithstanding anything to the contrary in this Agreement,
the Representative shall be entitled and is hereby granted the right to set off and deduct, in respect of amounts due to Securityholders, any unpaid or non-reimbursed expenses and unsatisfied Liabilities
incurred by the Representative in connection with the performance of its duties hereunder from amounts actually delivered to the Representative pursuant to this Agreement (including the Remaining Holdback Amount to be paid to the Securityholders).
Additionally, in connection with any unpaid or non-reimbursed expenses and unsatisfied Liabilities incurred by the Representative in connection with the performance of its duties hereunder, the Representative
shall be entitled and is hereby granted the right to direct any funds that would otherwise be actually payable to the Securityholders from the Escrow Account or the Remaining Holdback Amount to itself no earlier than the date such payments are
actually made. The Representative may also from time to time submit invoices to the Securityholders covering such expenses and Liabilities and, upon the request of any Securityholder, shall provide such Securityholder with an accounting of all
expenses and Liabilities paid. 
 (f) Holdback Amount. The Representative shall have the right to maintain the Holdback Amount, from
which the Representative may satisfy any indemnification obligations of the Securityholders with respect to the Contemplated Transactions, as such indemnification obligations are set forth in a written agreement between the Representative (acting on
behalf of the Securityholders), the Parent and the Merger Sub (or, after the Effective Time, the Surviving Company). At such time (if any) that a portion of the Holdback Amount is no longer required to

  
 48 

 
be maintained as security for, or the payment of, any such indemnification obligations in accordance with such written agreement (the “Remaining Holdback Amount”), the
Representative shall deliver to (i) the Parent (for further distribution directly or indirectly through the Paying Agent to those Company Shareholders that have duly executed and delivered a Letter of Transmittal (and such other documents as
required by the Letter of Transmittal) as described in Section 1.04) such Company Shareholders’ respective portion of the Company Shareholder Percentage of the Remaining Holdback Amount and (ii) the Surviving
Company (for distribution to the holders of the vested In-the-Money Options pursuant to Section 1.03(b)) the Optionholder Percentage of the
Remaining Holdback Amount by wire transfer of immediately available funds to an account designated in writing by the Surviving Company. 

10.02 Disclosure Schedules. All Disclosure Schedules attached hereto (each, a “Schedule” and, collectively, the
“Disclosure Schedules”) are incorporated herein and expressly made a part of this Agreement as though completely set forth herein. All references to this Agreement herein or in any of the Disclosure Schedules shall be deemed to
refer to this entire Agreement, including all Disclosure Schedules. The Disclosure Schedules have been arranged for purposes of convenience in separately numbered sections corresponding to the sections of this Agreement; however, any item disclosed
in any part, subpart, section or subsection of the Disclosure Schedule referenced by a particular section or subsection in this Agreement shall be deemed to have been disclosed with respect to every other section and subsection in this Agreement
with respect to which the relevance of such disclosure to such other section or subsection is reasonably apparent on its face, notwithstanding the omission of an appropriate cross-reference. Any item of information, matter or document disclosed or
referenced in, or attached to, the Disclosure Schedules shall not (a) be used as a basis for interpreting the terms “material”, “Material Adverse Effect” or other similar terms in this Agreement or to establish a standard of
materiality, (b) represent a determination that such item or matter did not arise in the Ordinary Course of Business, (c) be deemed or interpreted to expand or narrow the scope of the Company’s, the Parent’s or the Merger
Sub’s respective representations and warranties, obligations, covenants, conditions or agreements contained herein, (d) constitute, or be deemed to constitute, an admission of liability or obligation regarding such matter relative to a
third party, (e) constitute, or be deemed to constitute, an admission to any third party concerning such item or matter or (f) constitute, or be deemed to constitute, an admission or indication by the Company, the Parent or the Merger Sub
that such item meets any or all of the criteria set forth in this Agreement for inclusion in the Disclosure Schedules. No disclosure in the Disclosure Schedules relating to any possible breach or violation of any agreement or Law shall be construed
as an admission or indication to any third party that any such breach or violation exists or has actually occurred. Capitalized terms used in the Disclosure Schedules and not otherwise defined therein have the meanings given to them in this
Agreement. 
 10.03 Regulatory Approvals. 

(a) Each of the Parties agrees to use reasonable best efforts to take, or cause to be taken, all actions, and to do, or cause to be done, and
to assist and cooperate in doing, all things necessary, proper or advisable under applicable antitrust Laws or investment screening Laws to consummate and make effective the Contemplated Transactions, which actions include (i) using reasonable
best efforts to obtain as promptly as practicable each consent, permit and order of any Governmental Entity that may be, or become, necessary under applicable antitrust 

  
 49 

 
Laws or investment screening Laws for the consummation of the Contemplated Transactions (collectively, “Governmental Approvals”), (ii) cooperating in determining which filings
are required or advisable to obtain the Governmental Approval of, or any exemption by, any Governmental Entity, (iii) furnishing all information and documents required by or advisable under applicable legal requirement in connection with
Governmental Approvals of, or filings with, any Governmental Entity, (iv) filing, or causing to be filed, as promptly as practicable following the execution and delivery of this Agreement, applicable notifications with the necessary
Governmental Entities, (v) using reasonable best efforts to obtain as promptly as practicable the termination of any waiting period under the HSR Act, foreign direct investment laws or investment screening Laws, and (vi) defending any
actions, whether judicial or administrative, under any such Laws challenging this Agreement or the consummation of the Transactions, including seeking to have any Order entered by any court or other Governmental Entity vacated or reversed. In
furtherance and not in limitation of the foregoing, each party agrees that it will use its reasonable best efforts to file or cause to be made (A) as promptly as practicable, but in any event no later than fifteen (15) Business Days
following the date of this Agreement, any required notification and report forms under the HSR Act with the United States Federal Trade Commission (the “FTC”) and the United States Department of Justice (the “DOJ”)
and (B) as promptly as practicable and advisable (with each party considering in good faith any views or input provided by the other party with respect to the timing thereof). 

(b) In connection with, and without limiting, the efforts referenced in Section 10.03(a), the parties shall
(i) furnish to the other, and the Company shall cause the Group Companies to furnish to Parent, such necessary information and reasonable assistance as the other may request in connection with its preparation of any filing or submission that is
necessary under the HSR Act or any other applicable antitrust Law or investment screening Laws, (ii) permit the other party to review any filing or submission prior to forwarding to the FTC, the DOJ and other Governmental Entities (except where
such material is confidential to a party in which case it will be provided, subject to applicable legal requirement, to the other party’s counsel on an “external counsel” basis, and such filings or submissions may be redacted
(A) to remove references concerning the valuation of Parent, Company or any of their respective Subsidiaries, (B) as necessary to comply with contractual arrangements and (C) as necessary to address reasonable legal privilege
concerns) and accept any reasonable comments made by that other party, (iii) keep each other apprised of the status of any communications with, and any inquiries or requests for additional information from, any Governmental Entities and comply
as promptly as practicable with any such inquiry or request and (iv) agree not to, and the Company shall cause the Group Companies not to, participate in any substantive meeting or discussion, either in person or by telephone or
videoconference, with any Governmental Entity in connection with the Contemplated Transactions, unless (A) it consults with the other party in advance and (B) gives the other party or its representatives the opportunity to attend and
participate; provided that a party shall not be required to give the other party the opportunity to attend and participate to the extent (1) prohibited by such Governmental Entity or (2) such Governmental Entity requests to
communicate exclusively with one party. Whether or not the Contemplated Transactions are consummated, Parent shall be responsible for the payment of all filing fees in connection with obtaining any approvals or making the notifications or filings
required pursuant to this Section 10.03. 

  
 50 

 (c) Further, and without limiting the generality of the rest of this
Section 10.03, Parent and the Merger Sub shall use their reasonable best efforts to avoid or eliminate each and every impediment under Governmental Approval or other Law that may be asserted by any Governmental Entity or
private party with respect to this Agreement so as to make effective as promptly as practicable the Contemplated Transactions (including to avoid or defend any suit or proceeding), which would otherwise have the effect of preventing or delaying the
Closing beyond the Outside Date. The steps involved in the preceding sentence shall include, without limitation, (i) defending through litigation on the merits, including appeals, any claim asserted in any court or other proceeding by any
party; or (ii) agreeing to take any other action as may be required by a Governmental Entity in order (A) to obtain all necessary consents, approvals and authorizations as soon as reasonably possible, and in any event before the Outside
Date, (B) to avoid the entry of, or to have vacated, lifted, dissolved, reversed or overturned any decree, judgment, injunction or other Order, whether temporary, preliminary or permanent, that is in effect in any Actions and that prohibits,
prevents or restricts consummation of the Contemplated Transactions, or (C) to effect the expiration or termination of any waiting period, which would otherwise have the effect of preventing or delaying the Closing beyond the Outside Date. At
the request of the Parent, the Company shall agree to take any action with respect to the Company or any of its Subsidiaries in the two preceding sentences; provided that any such action is conditioned upon (and shall not be completed prior
to) the consummation of the Contemplated Transactions. The Parent shall not, and shall cause each of its Affiliates not to, take any action that is intended to or that would reasonably be expected to adversely affect the ability of any of the
Parties hereto from obtaining (or cause delay in obtaining) any necessary Government Approvals required for the Contemplated Transactions, from performing its covenants and agreements under this Agreement, or from consummating the Contemplated
Transactions as required by this Agreement. Without limiting the foregoing, the Parent shall, and the Parent shall cause its Affiliates to, (i) propose, negotiate, commit to and effect, by consent decree, hold separate orders, or otherwise, the
sale, divestiture, disposition, or license of any assets, properties, products, product lines, services, businesses, or rights of Parent or its Affiliates or, effective as of the Effective Time, the Surviving Company, or their respective
Subsidiaries or any interest or interests therein, and (ii) otherwise take or commit to take any action that limits its freedom of action with respect to, or its ability to retain, any of the assets, properties, products, product lines
services, or businesses of the Parent or its Affiliates, or effective as of the Effective Time, the Surviving Company or their respective Subsidiaries or any interest or interests therein, in order to avoid the entry of, or to effect the dissolution
of, any Order in any Action with respect to any Government Approval, or any impediment under any Governmental Approval, that would otherwise have the effect of preventing the consummation of the Contemplated Transactions. 

(d) Except as specifically required by this Agreement, Parent shall not, directly or indirectly, acquire or agree to acquire by merging or
consolidating with, or by purchasing a substantial portion of the assets of or equity in, or by any other manner, any business of any Person or other business organization or division thereof, or otherwise acquire or agree to acquire any assets, if
the entering into of a definitive agreement relating to, or the consummation of, such acquisition, merger or consolidation would reasonably be expected to (i) impose any material delay in the obtaining of, or increase the risk of not obtaining,
any Governmental Approval of any Governmental Entity necessary to consummate the Contemplated Transactions or the expiration or termination of any applicable waiting period by the Outside Date, (ii) increase the risk of any Governmental Entity
entering an order prohibiting the 

  
 51 

 
Contemplated Transactions, or (iii) increase the risk of not being able to remove any such order on appeal or otherwise; provided, however that Parent (directly or indirectly) may
take any of the preceding actions so long as the assets acquired or licensed are not, or the Person or business organization or division thereof in which equity is acquired is not, engaged in the sale or development of application software for sale
to manufacturers. 
 10.04 Tax Matters. Parent shall not, and shall not permit any of its Affiliates (including, after the Closing
for the avoidance of doubt, the Group Companies) to, make an election under Section 338 of the Code (or any comparable applicable provision of state, local or foreign Tax law) with respect to the transactions contemplated by this Agreement.

 ARTICLE XI 

DEFINITIONS 
 11.01
Definitions. For purposes hereof, the following terms when used herein shall have the respective meanings set forth below: 

“Accounting Principles” means, in accordance with GAAP as in effect at the date of the financial statement to which it refers
or, if there is no such financial statement, then as of the Closing Date, using and applying the same accounting principles, practices, procedures, policies and methods (with consistent classifications, judgments, elections, inclusions, exclusions
and valuation and estimation methodologies) used and applied by the Group Companies in the preparation of the Latest Balance Sheet and as utilized in the preparation of the Reference Statement. To the extent the Latest Balance Sheet and/or the
Reference Statement are inconsistent with GAAP, the accounting principles, practices, procedures, policies and methods used in the preparation of the Latest Balance Sheet or set forth on the Reference Statement shall control. To the extent that the
Latest Balance Sheet is inconsistent with the Reference Statement, the accounting principles, practices, procedures, policies and methods set forth on the Reference Statement shall control. In any event, the Accounting Principles (i) shall be
based on facts and circumstances as they exist prior to the Closing and shall exclude the effect of any act, decision or event occurring on or after the Closing, and (ii) shall follow the defined terms contained in this Agreement. 

“Acquisition Transaction” means any proposal or offer from any Person or “group” (as defined in Section 13(d)
of the Securities Exchange Act of 1934, as amended), other than the Parent and its Subsidiaries, relating to any direct or indirect (i) sale or possible sale or other disposition of all or a material portion of the assets of any Group Company,
(ii) sale or possible sale or other disposition of all or any portion of the equity securities of any Group Company, whether such equity securities constitute newly issued or previously outstanding equity securities (other than the issuance of
Company Stock upon the exercise of Options existing as of the date of this Agreement), (iii) merger, consolidation, share exchange, recapitalization, liquidation, dissolution, business combination or similar transaction involving any Group Company,
or (iv) other transaction that is inconsistent with the transactions contemplated by this Agreement. 

  
 52 

 “Additional Merger Consideration” means, as of any date of determination,
without duplication, any purchase price adjustments arising under Section 1.09(a) payable to the Securityholders, the Remaining Escrow Amount, if any, and the Remaining Holdback Amount, if any. 

“Affiliate” of any particular Person means any other Person controlling, controlled by or under common control with such
particular Person, where “control” means the possession, directly or indirectly, of the power to direct the management and policies of a Person, whether through the ownership of voting securities, contract or otherwise. 

“Affordable Care Act” means the Patient Protection and Affordable Care Act of 2010, as amended, and all regulations
thereunder and rulings issued with respect thereto. 
 “Base Consideration” means $2,220,000,000.00. 

“Business Day” means a day that is neither a Saturday or Sunday, nor any other day on which banking institutions in San
Francisco, California or New York, New York are authorized or obligated by Law to close. 
 “CARES Act” means the
Coronavirus Aid, Relief and Economic Security Act of 2020. 
 “Cash” means, as of the Reference Time (before taking into
account the consummation of the transactions contemplated hereby), cash and cash equivalents of the Group Companies on hand or in bank accounts, including deposits in transit but excluding cash subject to any legal or contractual restriction on the
ability to freely transfer or use such cash for any lawful purpose, minus the aggregate amount of outstanding and unpaid checks issued by or on behalf of the Group Companies as of such time, in each case as determined in accordance with the
Accounting Principles. 
 “Certificate of Incorporation” means the Second Amended and Restated Certificate of Incorporation
of the Company, filed with the Secretary of State of the State of Delaware on June 9, 2014, amended on October 15, 2014, amended May 11, 2015, amended on December 21, 2018, and amended on March 4, 2019. 

“Closing Cash Payment” means the Estimated Cash Consideration minus the sum of the Escrow Amount and the Holdback Amount.

 “Closing Option Consideration” means, for each vested
In-the-Money Option, the amount equal to the product obtained by multiplying (A) the amount by which the Fully-Diluted
Per-Share Closing Consideration exceeds the exercise price of such vested In-the-Money Option and (B) the aggregate number
of shares of Common Stock subject to such vested In-the-Money Option (rounded down to the nearest whole cent). 

“COBRA” means Part 6 of Subtitle B of Title I of ERISA, Section 4980B of the Code and any similar state Law. 

“Code” means the U.S. Internal Revenue Code of 1986, as amended. 

  
 53 

 “Company Equity Plan” means the Plex Systems Holdings, Inc. Stock Incentive
Plan, as amended. 
 “Company Fundamental Representations” means the representations and warranties of the Company set
forth in Sections 3.01, 3.02, 3.03(a), 3.03(c), 3.04, 3.19, 3.20(a) and 3.20(b). 

“Company IP” means all Intellectual Property Rights and Technology owned by or purported to be owned by any Group Company.

 “Company Plan” means (i) an “employee benefit plan” within the meaning of Section 3(3) of ERISA,
(ii) a stock bonus, stock purchase, stock option, restricted stock, stock appreciation right or similar equity-based plan or (iii) any other employment, severance, deferred-compensation, retirement, welfare-benefit, bonus, incentive or
fringe benefit plan, policy, program, agreement or arrangement sponsored, maintained, contributed to, or required to be contributed to by any of the Group Companies for the benefit of any employee of the Group Companies, other than any schemes or
arrangements mandated by a government outside of the United States. 
 “Company Shareholder” means a holder of Company
Stock. 
 “Company Shareholder Percentage” means the quotient of (a) the sum of (i) the aggregate number of
shares of Common Stock issued and outstanding immediately prior to the Effective Time and (ii) the aggregate number of shares of Common Stock for which all of the shares of Preferred Stock issued and outstanding immediately prior to the
Effective Time would be converted into if converted immediately prior to the Effective Time divided by (b) the Fully-Diluted Number. 

“Contagion Event” means the public outbreak and ongoing effects of a contagious disease, epidemic or pandemic (including COVID-19). 
 “Contemplated Transactions” means the transactions contemplated by this
Agreement and the other Transaction Documents. 
 “Continuing Employee” means each employee of a Group Company who is
employed as of immediately prior to the Closing Date and who continues in employment with Parent or one of its Affiliates (including, following the Closing, the Group Companies) following the Closing. 

“Contract” means any legally binding agreement, contract, arrangement, lease, loan agreement, security agreement, license,
indenture or other instrument or obligation to which the party in question is a party, whether oral or written, other than any Company Plan. 

“COVID-19” means
SARS-CoV-2 or COVID-19, and any variants thereof. 

  
 54 

 “COVID-19 Laws” means
(a) Presidential Proclamation 9994 of March 13, 2020 Declaring a National Emergency Concerning the COVID-19 Outbreak, (b) the CARES Act, (c) the Families First Coronavirus Response Act of
2020, (d) Presidential Memorandum of August 8, 2020, Deferring Payroll Tax Obligations in Light of the Ongoing COVID-19 Disaster, 85 FR 49587, (e) H.R. 133 – Consolidated Appropriations Act, 2021,
(f) H.R. 1319—American Rescue Plan Act of 2021, Public Law No: 117-2, and (g) any related Laws, Orders, rules, rulings, proclamations, regulations, guidelines or FAQs issued or enacted by a
Governmental Authority. 
 “COVID-19 Measures” means any quarantine, “shelter
in place,” “stay at home,” social distancing, shutdown, closure, sequester or other legal requirement, directive, guideline or recommendation by any Governmental Entity, including the Centers for Disease Control and Prevention and the
World Health Organization, in connection with or in response to COVID-19, including the Coronavirus Aid, Relief, and Economic Security Act (CARES), The Families First Coronavirus Response Act and the American
Rescue Plan Act. 
 “Credit Agreements” means those certain Credit Agreement, dated as of March 27, 2017, by and among
Plex Systems, Inc., as the Borrower, Plex Systems Holdings, Inc., as Holdings, and the lenders party thereto from time to time, as Lenders, and PNC Bank, National Association as administrative agent and collateral agent. 

“Data Security Requirements” means, collectively, all of the following relating to privacy, confidentiality, security, or
security breach notification requirements and applicable to any Group Company, to the conduct of the business of the Group Companies, or to any of the Technology Systems or data owned or held by a Group Company: (i) any Group Company’s
rules, policies, and procedures; (ii) all Laws; (iii) Contracts into which a Group Company has entered or by which it is otherwise bound; and (iv) industry standards for the business of the Group Companies. 

“Data Center Leases” means those capital lease obligations of the Group Companies that are recognized on the Latest Balance
Sheet in accordance with GAAP and are specifically for the lease of equipment physically located in the Group Companies’ four data center locations. 

“Environmental Claim” means any claim, action, cause of action, investigation or written notice by any person or entity
alleging potential liability (including, without limitation, potential liability for investigatory costs, cleanup costs, governmental response costs, natural resources damages, property damages, personal injuries, or penalties) arising out of, based
on or resulting from (a) the presence, Release or threatened Release of any Hazardous Materials at any location, whether or not owned or operated by the Company, or (b) circumstances forming the basis of any violation or alleged violation
of any Environmental Law. 
 “Environmental Laws” means all federal, state, local and foreign Laws and regulations relating
to pollution or protection of human health or the environment, including, without limitation, laws relating to Releases or threatened Releases of Hazardous Materials or otherwise relating to the manufacture, processing, distribution, use, treatment,
storage, transport or handling of Hazardous Materials. 

  
 55 

 “Equity Securities” means (a) any partnership interests, (b) any
membership or limited liability company interests or units, (c) any shares of capital stock, (d) any other interest or participation that confers on a Person the right to receive a share of the profits and losses of, or distribution of
assets of, the issuing entity, (e) any subscriptions, calls, warrants, options, or commitments of any kind or character relating to, or entitling any Person to purchase or otherwise acquire membership interests or units, capital stock, or any
other equity securities, (f) any securities convertible into or exercisable or exchangeable for partnership interests, membership interests or units, capital stock, or any other equity securities or (g) any other interest classified as an
equity security of a Person. 
 “ERISA” means the Employee Retirement Income Security Act of 1974, as amended. 

“Escrow Agent” means U.S. Bank National Association or such other entity as the Parent and the Representative agree in
writing. 
 “Estimated Cash Consideration” means (i) the Base Consideration, minus (ii) the amount of
Estimated Indebtedness, plus (iii) the amount, if any, by which the Estimated Net Working Capital exceeds the Target Net Working Capital Amount, minus (iv) the amount, if any, by which Estimated Net Working Capital is
less than the Target Net Working Capital Amount, plus (v) the amount of Estimated Cash, minus (vi) the amount of the Estimated Transaction Expenses, plus (vii) the aggregate dollar amount of the exercise
prices for all vested In-the-Money Options. 

“Excluded Payroll Taxes” means the employer’s share of any Taxes due under Section 3111(a) of the Code in the case
of any employee (i) who remains employed by the Group Companies through the Closing Date and (ii) whose wages from the Group Companies for the 2020 Tax year exceeded $142,800. 

“Final Cash Consideration” means (i) the Base Consideration, minus (ii) the amount of Indebtedness as
finally determined pursuant to Section 1.08, plus (iii) the amount, if any, by which the Net Working Capital as finally determined pursuant to Section 1.08 exceeds the Target Net
Working Capital Amount, minus (iv) the amount, if any, by which the Net Working Capital as finally determined pursuant to Section 1.08 is less than the Target Net Working Capital Amount, plus (v) the
amount of Cash as finally determined pursuant to Section 1.08, minus (vi) the amount of the Transaction Expenses as finally determined pursuant to Section 1.08, plus
(vii) the aggregate dollar amount of the exercise prices for all vested In-the-Money Options. 

“Fraud” means, with respect to a Person, an actual and intentional misrepresentation of a representation or warranty
contained in Article III or Article IV of this Agreement or in a certificate delivered pursuant to Section 7.01(f)(i) or 7.02(f)(i), provided that, (a) such representation or warranty was
materially false and misleading at the time such representation or warranty was made, (b) the Person making such representation or warranty had actual knowledge (and not imputed or constructive knowledge) that such representation or warranty
was false and misleading when made, (c) such Person had the specific intent to deceive another Person and induce such other Person to enter into this Agreement or consummate the Transactions, as applicable, and (d) such other Person
reasonably relied upon such false or inaccurate representation or warranty contained in this Agreement. For the avoidance of doubt, “Fraud” does not include any other form of fraud or misrepresentation (whether reckless, negligent,
constructive or otherwise). 

  
 56 

 “Fully-Diluted Per-Share Additional
Consideration” means the quotient of the Additional Merger Consideration divided by the Fully-Diluted Number. 

“Fully-Diluted Per-Share Closing Consideration” means quotient of the Closing Cash
Payment divided by the Fully-Diluted Number. 
 “Fully-Diluted Number” means the sum of (i) the aggregate number of
shares of Common Stock issued and outstanding immediately prior to the Effective Time, (ii) the aggregate number of shares of Common Stock for which all of the shares of Preferred Stock issued and outstanding immediately prior to the Effective
Time would be converted into if converted immediately prior to the Effective Time and (iii) the aggregate number of shares of Common Stock underlying all vested
In-the-Money Options issued and outstanding as of immediately prior to the Effective Time. 

“GAAP” means United States generally accepted accounting principles consistently applied. 

“Governmental Entity” means any federal, national, state, foreign, provincial, local or other (i) government or any
governmental, quasi-governmental, regulatory, administrative or self-regulatory authority, agency, bureau, board or commission, (ii) court or tribunal, (iii) judicial or arbitral body (whether public or private), (iv) stock exchange,
(v) organization, entity, body or individual exercising, or entitled to exercise, any executive, legislative, judicial, administrative, regulatory, police, military or taxing authority or power, or (vi) department, political subdivision,
tribunal or other instrumentality of the foregoing. 
 “Group Company(ies)” means the Company and each of its direct and
indirect Subsidiaries. 
 “Hazardous Materials” means all substances defined as Hazardous Substances, Oils, Pollutants or
Contaminants in the National Oil and Hazardous Substances Pollution Contingency Plan, 40 C.F.R. § 300.5, or defined as such by, or regulated as such under, any Environmental Law. 

“Holdback Amount” means $35,000,000.00. 

“In-the-Money Option” means an Option with an
exercise price that is less than the Fully-Diluted Per-Share Closing Consideration, determined as of immediately prior to the Effective Time. 

  
 57 

 “Indebtedness” means, as of any particular time with respect to the Group
Companies, without duplication, (i) the unpaid principal amount of, accrued interest, prepayment premiums or penalties on all indebtedness of the Group Companies for borrowed money (excluding all intercompany indebtedness between or among the
Group Companies), (ii) all obligations of the Group Companies recognized in accordance with GAAP as capital lease obligations under the Data Center Leases, (iii) the settlement amount of all interest rate swap, hedging or similar arrangements,
(iv) the amount of any drawn letters of credit or called bank guarantees, (v) any “applicable employment taxes” (as defined in Section 2302 of the CARES Act) unpaid as of the Closing that would have been due on or before the
Closing but for Section 2302 of the CARES Act, (vi) “financed charges” consistent with the accruals in the Reference Statement; (vii) “RIF related accruals” consistent with the accruals in the Reference Statement, and
(viii) all guarantees in respect of clauses (i) through (vii). Notwithstanding the foregoing, “Indebtedness” shall not include Other Debt-Like Instruments, deferred revenue, or customer advances or deposits. For purposes of
Article I of this Agreement, Indebtedness shall mean Indebtedness, as defined above, outstanding as of the Reference Time (but before taking into account the consummation of the transactions contemplated hereby). 

“Intellectual Property Agreements” means all licenses, sublicenses, consent to use agreements, settlements, coexistence
agreements, covenants not to sue, permissions, royalty agreements, and other Contracts (including any right to receive or obligation to pay royalties or any other consideration), whether written or oral, relating to any Intellectual Property Right
or Technology that is used in or necessary for the conduct of the Business as currently conducted to which any Group Company is a party, beneficiary or otherwise bound. 

“Intellectual Property Rights” means all intellectual property and industrial property rights, and all rights, interests and
protections that are associated with, similar to, or required for the exercise of, any of the foregoing, however arising, under the Laws of any jurisdiction throughout the world, including all rights in the following: (i) patents and patent
applications, including continuations, divisional, continuations-in-part, renewals, reexamination, and reissues, utility models, and other industrial property rights;
(ii) trademarks, service marks, trade dress, designs, design patents, design registrations, and logos, including common law rights, registrations and applications for registration thereof, together with all of the goodwill associated therewith;
(iii) internet domain names, whether or not trademarks, registered in any top-level domain by any authorized private registrar or Governmental Authority, web addresses, web pages, websites and content
found thereon, accounts with Twitter, Facebook and other social media companies, and URLs; (iv) copyrights (registered or unregistered), rights associated with works of authorship (including author, performer, moral and neighboring rights), and
registrations and applications for registration thereof; (v) inventions, discoveries, trade secrets, business and technical information and know-how, databases, data collections and other confidential and
proprietary information and all rights therein; and (vi) other proprietary rights in Technology. 
 “knowledge of the
Company” and “the Company’s knowledge” mean the actual knowledge of Bill Berutti, Don Clarke and Kerry Pollak as of the applicable date. 

“knowledge of the Parent” and “the Parent’s knowledge” mean the actual knowledge of Blake Moret and
Nick Gangestad as of the applicable date. 
 “Law” means any statute, law (including common law), rule, regulation,
judgment, injunction, order, decree or other restriction of any Governmental Entity. 

  
 58 

 “Liabilities” means all indebtedness, obligations and other liabilities of
a Person, contingent or otherwise. 
 “Liens” means liens, security interests, charges or encumbrances of any kind or
nature whatsoever (including any restriction on the right to vote or transfer). 
 “Losses” means any and all damages,
penalties, fines, costs, judgments or amounts paid in settlement, Liabilities, Taxes, losses, expenses and fees, including court costs and attorneys’ and other professionals’ fees and expenses and any other costs of enforcing rights under
this Agreement or, as specified therein, a Support Agreement. 
 “Material Adverse Effect” shall mean any event, change,
development or effect or combination of events, changes, developments or effects that has, or would reasonably be expected to have, individually or in the aggregate, (x) a material adverse effect on the business, assets, Liabilities, financial
condition or results of operations of the Group Companies, taken as a whole or (y) an adverse effect on the ability of the Company to consummate the transactions contemplated by this Agreement without material delay; provided that, in
the case of clause (x), no event, change, development or effect resulting or arising from or in connection with any of the following matters shall be deemed, either alone or in combination, to constitute or contribute to, or be taken into
account in determining whether there has been a Material Adverse Effect: (a) any changes in national, international, foreign or domestic economic or political conditions in general (including changes therein after the date of this Agreement),
including (i) acts of war, riots, civil unrest, sabotage, terrorism (other than cyberterrorism or cybercrime) or military actions or any escalation or worsening of any of the same, (ii) changes in any financial, debt, credit, capital or
banking markets or conditions in general, and (iii) changes in interest, currency or exchange rates or tariffs or any trade wars, (b) any act of God, including any hurricane, flood, tornado, fire, explosion, weather event, earthquake,
landslide, other natural disaster, any Contagion Event or other public outbreak of illness or similar public health event (whether human or animal), (c) changes or proposed changes in Laws (or standards, interpretations or enforcement thereof) after
the date of this Agreement, whether or not related to a Contagion Event or other public health emergency, (d) changes in GAAP or standards, interpretations or enforcement thereof after the date of this Agreement, (e) changes in the general
condition of the industries in which the Group Companies operate, (f) the failure of the Group Companies to meet any internal or published projections, estimates or forecasts of revenues, goals, earnings or other measures of financial or
operating performance for any period (for the avoidance of doubt, any underlying cause for any such failure shall not be excluded by this clause (f) unless otherwise excluded by any of the other clauses of this proviso), (g) any effect
directly resulting from the announcement, pendency or consummation of the transactions contemplated by this Agreement or compliance with the terms of this Agreement, including any breach by Parent of any of its obligations under this Agreement or
the identity of Parent or its Affiliates, (h) the effect of any action taken or omission to act by Parent with respect to the transactions contemplated by this Agreement, including any communication or disclosure by Parent or any of its
Affiliates of its plans or intentions with respect to the Group Companies, including losses or threatened losses of, or any adverse change in the relationship with, employees, customers, suppliers, vendors, resellers, distributors, financing
sources, licensors, licensees or others having relationships with the Group Companies directly caused by the same, or (i) the effect of any action taken or omission to act by a Group 

  
 59 

 
Company expressly required by this Agreement or with the written consent (or at the written request) of Parent; provided that to the extent that any event in the foregoing
clauses (a)-(e) has a materially disproportionate impact on the Group Companies, taken as a whole, as compared to the adverse impact such event has on other Persons operating in the same industries as the Group Companies operate, then the
incremental effect of such event shall be taken into account in determining whether a Material Adverse Effect has occurred. For purposes of Section 7.01(g), if and to the extent, prior to Closing, there occurs an adverse
change with respect to items disclosed in the Disclosure Schedule, the extent of such change may be taken into account in determining whether there is or would reasonably be expected to be a Material Adverse Effect, but only the extent of such
change may be taken into account in determing whether there is or would reasonably be expected to be a Material Adverse Effect. 

“Merger Consideration” means, collectively, the Stock Merger Consideration and the aggregate Option Consideration. 

“Multiemployer Plan” has the meaning set forth in Section 3(37) of ERISA. 

“Net Working Capital” means the current assets of the Company, as of the Reference Time (consisting solely of the line item
current asset accounts specified in Exhibit E), minus the current liabilities of the Company, as of the Reference Time (consisting solely of the line item current liability accounts specified in Exhibit E). For the avoidance of
doubt, Net Working Capital shall (a) be prepared and calculated in accordance with the Accounting Principles, (b) exclude as assets (but not the use thereof) all income Tax assets and include all current Tax liabilities, and
(c) exclude all Cash, Indebtedness and Excluded Payroll Taxes. 
 “Non-Recourse
Party” means, with respect to a Party to this Agreement, any of such Party’s former or current directors, officers, equity holders, controlling persons, Affiliates, employees, agents, representatives, members, managers, and general or
limited partners (in their capacity as such). 
 “Open Source Software” means any software that is (a) that is
distributed as free or open source software or under similar licensing or distribution models, including software licensed pursuant to any license that is a license approved by the Open Source Initiative and listed at
http://www.opensource.org/licenses, which licenses include all versions of the GNU General Public License (GPL), the GNU Lesser General Public License (LGPL), the GNU Affero GPL, the MIT license, the Eclipse Public License, the Common Public
License, the CDDL, the Mozilla Public License (MPL), the Artistic License, the Netscape Public License, the Sun Community Source License (SCSL), and the Sun Industry Standards License (SISL); or (b) licensed pursuant to any Reciprocal License,
in each case whether or not source code is available or included in such license. 
 “Option” means an outstanding and
unexercised stock option to purchase shares of Common Stock under the Company Equity Plan. 

  
 60 

 “Option Consideration” means, for each vested In-the-Money Option, the amount equal to the sum of (i) the Closing Option Consideration applicable to such vested In-the-Money Option, and (ii) the product obtained by multiplying (A) the Fully-Diluted Per-Share Additional Consideration by (B) the aggregate number of
shares of Common Stock subject to such vested In-the-Money Option (rounded down to the nearest whole cent), less applicable withholding. 

“Optionholder Percentage” means the amount, expressed as a percentage, equal to the quotient obtained by dividing
(i) the aggregate number of shares of Common Stock underlying all vested In-the-Money Options issued and outstanding as of immediately prior to the Effective Time
by (ii) the Fully-Diluted Number. 
 “Ordinary Course of Business” means the ordinary course of business of the Group
Companies, consistent with past practice in light of the circumstances prevailing at the time to the extent such past practice does not violate any applicable Law or Order, provided that any actions or inactions that are reasonably prudent or
necessary to mitigate the effects of COVID-19 or to comply with applicable Law or Order in connection with or in response to COVID-19, shall be considered to have been
taken in the Ordinary Course of Business. 
 “Organizational Documents” means the Bylaws of the Company, as amended through
the date hereof, and the Certificate of Incorporation, and that certain Second Amended and Restated Stockholders Agreement, dated as of June 9, 2014, by and among Plex Systems Holdings, Inc., as the Company, and its stockholders party thereto,
as amended. 
 “Other Debt-Like Instruments” means (a) undrawn letters of credit, (b) uncalled bank guarantees, (c) non-cancellable purchase commitments, surety bonds and performance bonds, or (d) obligations recognized in accordance with GAAP as capital lease obligations (other than the Data Center Leases). 

“Owned Real Property” means all land, together with all buildings, structures, improvements and fixtures located thereon, and
all easements and other rights and interests appurtenant thereto, owned by any Group Company. 
 “Parent Fundamental
Representations” means the representations and warranties of the Parent set forth in Sections 4.01, 4.02 and 4.06. 

“Parent Material Adverse Effect” means any change, effect, event, occurrence, state of facts or development that,
individually or in the aggregate, has had or would have a material adverse effect on the ability of the Parent or the Merger Sub to consummate the transactions contemplated hereby. 

“Permitted Liens” means (i) statutory liens for current Taxes not yet due and payable or the amount or validity of which
is being contested in good faith by appropriate proceedings by the Group Companies and for which appropriate reserves have been established in accordance with GAAP; (ii) mechanics’, carriers’, workers’, repairers’ and
similar statutory liens arising or incurred in the Ordinary Course of Business for amounts that are not delinquent and that are not, individually or in the aggregate, material; (iii) zoning, entitlement, building and other land use regulations
imposed by Governmental Entities having jurisdiction over the Leased Realty that are not violated by the current use and operation of the Leased Realty; (iv) covenants, conditions, restrictions, easements and other similar matters of record
affecting title to the Leased Realty that do not materially or unreasonably impair the occupancy or use of the Leased Realty for the purposes for which it is currently used or proposed to be used in connection with the Companies’ and their
Subsidiaries’ businesses; (v) public roads and highways; and (vi) matters that would be disclosed by an accurate survey of each parcel of real property. 

  
 61 

 “Person” means an individual, a partnership, a corporation, a limited
liability company, an association, a joint stock company, a trust, a joint venture, an unincorporated organization or other entity, or a Governmental Entity or any department, agency or political subdivision thereof. 

“Personal Information” means any information that identifies or can be used to identify a person, including, but not limited
to, name, physical address, postal address, email address or other online contact information (such as a user name, identifier or screen name), telephone number (including home and mobile telephone number), password, Social Security number,
driver’s license number or other government-issued identification number, account number, credit card information, personal financial or healthcare information, personal preferences, and all other personal information and data subject to
regulation under any applicable Law. 
 “Pre-Closing Tax Period” means any taxable
period ending on or before the Closing Date and, with respect to any Straddle Period, the portion of such taxable period ending on and including the Closing Date. 

“Pro Rata Percentage” means, with respect to any Securityholder, the quotient (expressed as a percentage) obtained by
dividing (a) the sum of (i) the aggregate number of shares of Common Stock held by such Securityholder immediately prior to the Effective Time, (ii) the aggregate number of shares of Common Stock for which the shares of Preferred
Stock held by such Securityholder immediately prior to the Effective Time would be converted into if converted immediately prior to the Effective Time and (iii) the aggregate number of shares of Common Stock underlying any vested In-the-Money Options held by such Securityholder as of immediately prior to the Effective Time by (b) the Fully Diluted Number. 

“Reference Time” means the close of business of the Group Companies on the Closing Date. 

“Release” means any release, spill, emission, discharge, leaking, pumping, injection, deposit, disposal, dispersal, leaching
or migration into the environment (including, without limitation, ambient air, surface water, groundwater and surface or subsurface strata) or into or out of any property, including the movement of Hazardous Materials through or in the air, soil,
surface water, groundwater or property. 
 “Securityholder” means a Company Shareholder or a holder of vested In-the-Money Options. 
 “Straddle Period” means
any taxable period that begins on or before the Closing Date and ends after the Closing Date. 

  
 62 

 “Subsidiary” means, with respect to any Person, any corporation of which a
majority of the total voting power of shares of stock entitled (without regard to the occurrence of any contingency) to vote in the election of directors, managers or trustees thereof is at the time owned or controlled, directly or indirectly, by
such Person or one or more of the other Subsidiaries of such Person or a combination thereof, or any partnership, association or other business entity of which a majority of the partnership or other similar ownership interest is at the time owned or
controlled, directly or indirectly, by such Person or one or more Subsidiaries of such Person or a combination thereof. For purposes of this definition, a Person is deemed to have a majority ownership interest in a partnership, association or other
business entity if such Person is allocated a majority of the gains or losses of such partnership, association or other business entity or is or controls the managing director or general partner of such partnership, association or other business
entity. 
 “Target Net Working Capital Amount” means negative $25,569,000.00. 

“Tax” or “Taxes” means any federal, state, local or foreign income, gross receipts, franchise, estimated,
alternative minimum, add-on minimum, sales, use, transfer, real property gains, escheat, unclaimed property, gross receipts, single business, unincorporated business, registration, value added, excise, natural
resources, severance, stamp, occupation, premium, windfall profit, environmental, customs, duties, real property, special assessment, personal property, capital stock, social security, employment, unemployment, disability, payroll, FICA, license,
employee or other withholding, or other tax, of any kind whatsoever, including any interest or penalties (civil or criminal) on or additions to any such taxes, whether disputed or not. 

“Tax Returns” means any return, report, information return or other document (including schedules or any related or
supporting information) filed or required to be filed with any Governmental Entity or other authority in connection with the determination, assessment or collection of any Tax or the administration of any Laws or administrative requirements relating
to any Tax. 
 “Technology” means all algorithms, application programming interfaces (APIs), apparatuses, databases and
data collections, diagrams, inventions, know-how, logos, marks, methods, network configurations and architectures, processes, proprietary information, protocols, schematics, specifications, software, firmware,
source code and object code, subroutines, user interfaces, techniques, URLs, web sites, works of authorship, and other forms of technology (whether or not embodied in any tangible form). 

“Transaction Documents” means this Agreement, the Escrow Agreement, the Support Agreements and any and all certificates,
agreements, documents or other instruments to be executed and delivered by any Person in connection with the Contemplated Transactions, any exhibits, attachments or schedules to any of the foregoing and any other written agreement that is expressly
identified as a Transaction Document, as any of the foregoing may be amended, supplemented or otherwise modified from time to time. 

“Transaction Expenses” means, to the extent not paid prior to the Closing Date, (i) all fees and expenses of the Group
Companies payable to professionals (including investment bankers, attorneys, accountants and other consultants and advisors) retained by any Group Company that performed services in connection with the Contemplated Transactions, and (ii) all
change in control bonus, transaction bonus and similar amounts to be paid to any current or former employee, director or officer of any of the Group Companies pursuant to any Contract to 

  
 63 

 
which any of the Group Companies is a party prior to the Effective Time that becomes payable as a result of the execution of this Agreement or the consummation of the transactions contemplated
hereby, together with the employer-portion of any payroll Taxes relating thereto; provided, that in no event shall “Transaction Expenses” include (a) any of the foregoing payments that are triggered (in whole or in part) by a
termination of employment by the Parent that occurs following the Closing or (b) any Excluded Payroll Taxes. 
 11.02 Other
Interpretive Provisions. 
 (a) Accounting terms that are not otherwise defined in this Agreement have the meanings given to them under
GAAP. To the extent that the definition of an accounting term defined in this Agreement is inconsistent with the meaning of such term under GAAP, the definition set forth in this Agreement shall control. 

(b) Whenever the word “or” is used in this Agreement, it shall not be deemed exclusive. 

(c) Whenever the context requires, any pronouns used herein shall include the corresponding masculine, feminine or neuter forms. 

(d) The meanings of defined terms are equally applicable to the singular and plural forms of the defined terms. 

(e) Any reference to any particular Code section or Law shall be interpreted to include any revision of or successor to that section
regardless of how it is numbered or classified. 
 ARTICLE XII 

MISCELLANEOUS 

12.01 Press Releases and Communications. No press release or public announcement related to this Agreement or the transactions
contemplated herein shall be issued or made by any Party or any Affiliate thereof without the joint approval of the Parent and the Representative, except (a) such release or announcement as may be required by Law or any rule or regulation of
any national securities exchange on which securities of the releasing Party or its Affiliates are listed, in which case the party required to issue or make the release or announcement shall, to the extent practical, allow (or cause its Affiliate to
allow) the other party reasonable time to comment on such release or announcement in advance of such issuance or the making thereof, (b) for such announcements or releases required to be made to comply with
Section 10.03 and (c) that nothing contained herein shall limit or restrict the right of the Company, the Parent or any of their respective Affiliates in respect of any Action that may arise or be commenced between the
Company, any Securityholder, on the one hand, and the Parent or any Affiliate thereof, on the other hand. Parent shall file one or more current reports on Form 8-K with the Securities and Exchange Commission
attaching a copy of this Agreement as an exhibit. Parent will provide the Company with a draft of such Form 8-K for the Company’s review prior to such filing, and shall consider in good faith any comments
provided by the Company. Notwithstanding anything herein to the contrary, (i) any Securityholder as of the date hereof that is a private equity or venture capital firm may provide 

  
 64 

 
information about the subject matter of this Agreement in connection with fundraising, marketing, informational, transactional or reporting activities at any time in each case to the extent (and
only to such extent) that such statements are not inconsistent with the previous press releases, public disclosures or public statements made by the Parties in accordance herewith and (ii) the Parent may make any public statement regarding the
transactions contemplated by this Agreement in response to questions from analysts and those attending industry conferences, in each case to the extent (and only to such extent) that such statements are not inconsistent with the previous press
releases, public disclosures or public statements made by the Parties in accordance herewith. 
 12.02 Expenses. Except as
otherwise expressly provided herein, each of the Company, the Securityholders, the Parent, the Merger Sub and the Representative shall pay all of their own fees and expenses incurred in connection with this Agreement and the transactions
contemplated by this Agreement, including the fees and disbursements of counsel, financial advisors and accountants. 
 12.03
Notices. Any notice, request, demand, waiver, consent, approval or other communication which is required or permitted hereunder shall be in writing and shall be deemed given: (a) on the date established by the sender as having been
delivered personally, (b) on the date delivered by a private courier as established by the sender by evidence obtained from the courier, (c) on the date sent by electronic mail, if sent prior to 5:00 p.m. San Francisco, California
time, or if sent later, then on the next Business Day, or (d) on the fifth (5th) Business Day after the date mailed, by certified or registered mail, return receipt requested, postage prepaid. Such communications, to be valid, must be
addressed as follows (unless another address has been previously specified in writing by such party): 
 Notices to the Parent,
Surviving Company and/or the Merger Sub: 
 ROCKWELL AUTOMATION, INC. 

1201 South Second Street 

Milwaukee, Wisconsin 53204 

Attention: Brian Shepherd 

                    Senior Vice President,
Software & Control 
 Email: brian.shepherd@rockwellautomation.com 

with a copy to (which shall not constitute notice): 

ROCKWELL AUTOMATION, INC. 

1201 South Second Street 

Milwaukee, Wisconsin 53204 

Attention: Rebecca House 

                    Senior Vice President,
Chief People and Legal Officer and 

                    Corporate Secretary

 Email: rwhouse@ra.rockwell.com 

and 

  
 65 

 FOLEY & LARDNER LLP 

777 East Wisconsin Avenue 

Milwaukee, Wisconsin 53202 

Attention: Bryan S. Schultz 

Email: brschultz@foley.com 

Notices to the Representative: 

FRANCISCO PARTNERS MANAGEMENT LLC 

One Letterman Drive 
 Building
C—Suite 410 
 San Francisco, California 94129 

Attention: Petri Oksanen and Steve Eisner 

email: oksanen@franciscopartners.com; eisner@franciscopartners.com 

with a copy to (which shall not constitute notice): 

PAUL HASTINGS LLP 
 101
California Street, Forty-Eighth Floor 
 San Francisco, California 94111 

Attention: Michael J. Kennedy 

                  Jeffrey C. Wolf 

email: mikekennedy@paulhastings.com; jeffwolf@paulhastings.com 

Notices to the Company: 

PLEX SYSTEMS HOLDINGS, INC. 

900 Tower Dr., Suite 1500 

Troy, MI 48098 
 Attention:
Chief Financial Officer 
 Email: dclarke@plex.com 

with copies to (before the Closing) (which shall not constitute notice): 

PAUL HASTINGS LLP 
 101
California Street, Forty-Eighth Floor 
 San Francisco, California 94111 

Attention: Michael J. Kennedy 

                  Jeffrey C. Wolf 

email: mikekennedy@paulhastings.com; jeffwolf@paulhastings.com 

12.04 Assignment. This Agreement and all of the provisions hereof shall be binding upon and inure to the benefit of the Parties and
their respective successors and permitted assigns, except that neither this Agreement nor any of the rights, interests or obligations hereunder may be assigned or delegated by the Parent, the Merger Sub, the Company or the Representative without the
prior written consent of the Parent, the Company (or the Surviving Company following the Closing) and the Representative. 

  
 66 

 12.05 Severability. Any term or provision of this Agreement that is invalid or
unenforceable in any situation in any jurisdiction shall not affect the validity or enforceability of the remaining terms and provisions hereof or the validity or enforceability of the offending term or provision in any other situation or in any
other jurisdiction. If the final judgment of a court of competent jurisdiction declares that any term or provision hereof is invalid or unenforceable, the Parties agree that the court making the determination of invalidity or unenforceability shall
have the power to reduce the scope, duration or area of the term or provision, to delete specific words or phrases, or to replace any invalid or unenforceable term or provision with a term or provision that is valid and enforceable and that comes
closest to expressing the intention of the invalid or unenforceable term or provision, and this Agreement shall be enforceable as so modified after the expiration of the time within which the judgment may be appealed. 

12.06 References. The table of contents and the section and other headings and subheadings contained in this Agreement and the exhibits
hereto are solely for the purpose of reference, are not part of the agreement of the Parties, and shall not in any way affect the meaning or interpretation of this Agreement or any exhibit hereto. All references to days (excluding Business Days) or
months shall be deemed references to calendar days or months. All references to “$” shall be deemed references to United States dollars. Unless the context otherwise requires, any reference to a “Section,” “Exhibit,”
“Disclosure Schedule” or “Schedule” shall be deemed to refer to a section of this Agreement, exhibit to this Agreement or a schedule to this Agreement, as applicable. The words “hereof,” “herein” and
“hereunder” and words of similar import referring to this Agreement refer to this Agreement as a whole and not to any particular provision of this Agreement. The word “including” or any variation thereof means “including,
without limitation” and shall not be construed to limit any general statement that it follows to the specific or similar items or matters immediately following it. 

12.07 Construction. The language used in this Agreement shall be deemed to be the language chosen by the Parties to express their
mutual intent, and no rule of strict construction shall be applied against any Person. The information contained in this Agreement and in the Disclosure Schedules and Exhibits hereto is disclosed solely for purposes of this Agreement, and no
information contained herein or therein shall be deemed to be an admission by any Party to any third party of any matter whatsoever (including any violation of Law or breach of contract). 

12.08 Amendment and Waiver. Any provision of this Agreement or the Disclosure Schedules hereto may be amended or waived only in a
writing signed by the Parent, the Company (or the Surviving Company following the Closing) and the Representative; provided, that after the receipt of the Shareholder Approval, no amendment to this Agreement shall be made that by Law requires
further approval by the stockholders of the Company without such further approval by such stockholders. No waiver of any provision hereunder or any breach or default thereof shall extend to or affect in any way any other provision or prior or
subsequent breach or default. 
 12.09 Complete Agreement. This Agreement and the documents referred to herein (including the
Confidentiality Agreement) contain the complete agreement among the Parties and supersede any prior understandings, agreements or representations by or among the Parties, written or oral, that may have related to the subject matter hereof in any
way, including any data room agreements, bid letters, term sheets, summary issues lists or other agreements. 

  
 67 

 12.10 Third Party Beneficiaries. Certain provisions of this Agreement are intended
for the benefit of, and shall be enforceable by, the Securityholders. Section 6.03 shall be enforceable by the D&O Indemnified Parties. In addition, (a) the Representative shall have the right, but not the
obligation, to enforce any rights of the Company (but only prior to the Closing) or the Securityholders under this Agreement, and (b) Paul Hastings LLP (“PH”) shall have the right to enforce its rights under
Section 12.19. Except as otherwise expressly provided herein, nothing expressed or referred to in this Agreement shall be construed to give any Person other than the Parties to this Agreement any legal or equitable right,
remedy or claim under this Agreement or any provision of this Agreement. 
 12.11 Waiver of Trial by Jury. THE PARTIES TO THIS
AGREEMENT EACH HEREBY WAIVES, TO THE FULLEST EXTENT PERMITTED BY LAW, ANY RIGHT TO TRIAL BY JURY OF ANY CLAIM, DEMAND, ACTION OR CAUSE OF ACTION (A) ARISING UNDER THIS AGREEMENT OR (B) IN ANY WAY CONNECTED WITH OR RELATED OR INCIDENTAL TO
THE DEALINGS OF THE PARTIES HERETO IN RESPECT OF THIS AGREEMENT OR ANY OF THE TRANSACTIONS RELATED HERETO, IN EACH CASE WHETHER NOW EXISTING OR HEREAFTER ARISING, AND WHETHER IN CONTRACT, TORT, EQUITY OR OTHERWISE. THE PARTIES TO THIS AGREEMENT EACH
HEREBY AGREES AND CONSENTS THAT ANY SUCH CLAIM, DEMAND, ACTION OR CAUSE OF ACTION SHALL BE DECIDED BY COURT TRIAL WITHOUT A JURY, AND THAT THE PARTIES TO THIS AGREEMENT MAY FILE A COPY OF THIS AGREEMENT WITH ANY COURT AS WRITTEN EVIDENCE OF THE
CONSENT OF THE PARTIES HERETO TO THE WAIVER OF THEIR RIGHT TO TRIAL BY JURY. 
 12.12 Parent Deliveries. The Parent agrees and
acknowledges that all documents or other items delivered or made available to Morgan Stanley & Co. LLC, Ernst & Young and Foley & Lardner LLP in their capacity as the Parent’s advisors or representatives shall be
deemed to be delivered or made available, as the case may be, to the Parent for all purposes hereunder. 
 12.13 Delivery by Facsimile or
Email. This Agreement and any signed agreement entered into in connection herewith or contemplated hereby, and any amendments hereto or thereto, to the extent signed and delivered by means of a facsimile machine or via electronic mail, shall be
treated in all manner and respects as an original contract and shall be considered to have the same binding legal effects as if it were the original signed version thereof delivered in person. At the request of any Party hereto or to any such
contract, each other Party hereto or thereto shall re-execute original forms thereof and deliver them to all other Parties. No Party hereto or to any such contract shall raise the use of a facsimile machine or
email to deliver a signature or the fact that any signature or contract was transmitted or communicated through the use of facsimile machine or email as a defense to the formation of a contract and each such Party forever waives any such defense.

 12.14 Counterparts. This Agreement may be executed in multiple counterparts, any one of which need not contain the signature of
more than one (1) Party, but all such counterparts taken together shall constitute one and the same instrument. 

  
 68 

 12.15 Governing Law. All issues and questions concerning the construction, validity,
interpretation and enforceability of this Agreement and the exhibits and schedules hereto shall be governed by, and construed in accordance with, the Laws of the State of Delaware, without giving effect to any choice of Law or conflict of Law rules
or provisions (whether of the State of Delaware or any other jurisdiction) that would cause the application of the Laws of any jurisdiction other than the State of Delaware. 

12.16 Jurisdiction. Any suit, Action or proceeding seeking to enforce any provision of, or based on any matter arising out of or in
connection with, this Agreement or the transactions contemplated hereby shall be brought before and determined exclusively by the Delaware Court of Chancery of the State of Delaware; provided, that if the Delaware Court of Chancery does not
have jurisdiction, any such suit, Action or proceeding shall be brought exclusively in the United States District Court for the District of Delaware or any other court of the State of Delaware, and each of the Parties hereby consents to the
jurisdiction of such courts (and of the appropriate appellate courts therefrom) in any such suit, Action or proceeding and irrevocably waives, to the fullest extent permitted by Law, any objection that it may now or hereafter have to the laying of
the venue of any such suit, Action or proceeding in any such court or that any such suit, Action or proceeding that is brought in any such court has been brought in an inconvenient forum. Process in any such suit, Action or proceeding may be served
on any Party anywhere in the world, whether within or without the jurisdiction of any such court. Without limiting the foregoing, each Party agrees that service of process on such Party as provided in Section 12.03 shall be
deemed effective service of process on such Party. 
 12.17 No Recourse. Notwithstanding any provision of this Agreement, the Parties
to this Agreement agree on their own behalf and on behalf of their respective Subsidiaries that no Non-Recourse Party of a Party to this Agreement shall have any liability under this Agreement (except in the
case of Fraud committed by such Person and, for the avoidance of doubt, liabilities of the signatories to a Letter of Transmittal, a Support Agreement or the Stockholder Written Consent arising from such documents). 

12.18 Specific Performance. 

(a) Each of the Parties acknowledges that the rights of each Party to consummate the transactions contemplated hereby are unique and
recognizes and affirms that in the event of a breach of this Agreement by any Party, money damages may be inadequate and the non-breaching Party may have no adequate remedy at Law. Accordingly, the Parties
agree that prior to a valid termination of this Agreement in accordance with this Agreement, subject to and without limiting Section 12.18(b) below (if applicable), such non-breaching
Party shall have the right, in addition to any other rights and remedies existing in its favor at Law or in equity, to enforce its rights and the other Party’s obligations hereunder not only by an Action or Actions for damages but also by an
Action or Actions for specific performance, injunctive and/or other equitable relief (without posting of bond or other security). Each of the Parties agrees that it shall not oppose the granting of an injunction, specific performance and other
equitable relief when expressly available pursuant to the terms of this Agreement, and hereby waives in any such Action (x) any defense that the other parties have an adequate remedy at Law or an award of specific performance is not an
appropriate remedy for any reason at Law or equity, and (y) any requirement under Law to post a bond, undertaking or other security as a prerequisite to obtaining equitable relief. 

  
 69 

 (b) To the extent any Party brings any Action, claim, complaint or other proceeding, in each
case, before any Governmental Entity to enforce specifically the performance of the terms and provisions of this Agreement prior to the Closing, the Outside Date shall automatically be extended to the date that is the fifth (5th) Business Day after the presiding Governmental Entity issues a final Order that is no longer subject to appeal or such later date as may be established by the presiding Governmental Entity. 

12.19 Privilege; Conflicts of Interest. Recognizing that PH has acted as legal counsel to certain of the Securityholders and their
Affiliates and the Group Companies prior to the Closing, and that PH intends to act as legal counsel to certain of the Securityholders after the Closing, in connection with the Contemplated Transactions, each of the Parent and the Surviving Company
(including, for this purpose, on behalf of the Group Companies after the Closing) hereby waives, on its own behalf, and agrees to cause its Subsidiaries to waive, any ethical conflicts that may arise in connection with PH representing any of the
Securityholders and/or their respective Affiliates (excluding the Group Companies) after the Closing as such representation may relate to the transactions contemplated herein. In addition, all communications involving attorney-client confidences
between any of the Securityholders and their respective Affiliates in the course of the negotiation, documentation and consummation of the transactions contemplated hereby shall be deemed to be attorney-client confidences that belong solely to such
Securityholder and its Affiliates (and not the Group Companies). Accordingly, the Group Companies shall not have access to the files of PH to the extent containing any such attorney-client confidences, whether or not the Closing shall have occurred.
Without limiting the generality of the foregoing, upon and after the Closing, (i) the applicable Securityholders and their respective Affiliates (and not the Group Companies) shall be the sole holders of the attorney-client privilege with
respect to such portion of the files of PH, and none of the Group Companies shall be a holder thereof, (ii) to the extent that such portion of the files of PH in constitute property of the client, only the applicable Securityholders and their
respective Affiliates (and not the Group Companies) shall hold such property rights and (iii) except as required by applicable Law, PH shall not have any duty whatsoever to reveal or disclose any such attorney-client communications or such
portion of the files of PH to any of the Group Companies by reason of any attorney-client relationship between or among PH and any of the Group Companies. Notwithstanding the foregoing, if a dispute arises between the Parent or any of its
Subsidiaries (including any Group Company) and a third party after the Closing, then the Group Companies, to the extent applicable, may assert the attorney-client privilege to prevent disclosure to such third party of such attorney-client
communications or files by PH; provided, however, that no Group Company may waive such privilege without the prior written consent of the Representative. 

12.20 Further Assurances. From time to time after the date of this Agreement, upon request of any Party and without further
consideration, each Party shall execute and deliver to the requesting Party such documents and take such action as the requesting Party reasonably requests to consummate more effectively the intent and purpose of the Parties under this Agreement and
the transactions contemplated by this Agreement. 

  
 70 

 IN WITNESS WHEREOF, the Parties have executed this Agreement and Plan of Merger on the day
and year first above written. 
  

							
	Company:	 		 	PLEX SYSTEMS HOLDINGS, INC.
				
		 		 	By:	 	 /s/ Bill Berutti

		 		 	Its:	 	 Chief Executive Officer

			
	Parent:	 		 	ROCKWELL AUTOMATION, INC.
				
		 		 	By:	 	 /s/ Blake Moret

		 		 	Its:	 	 President and CEO

			
	Merger Sub:	 		 	ROCKWELL AUTOMATION US HOLDINGS, INC.
				
		 		 	By:	 	 /s/ Rebecca W. House

		 		 	Its:	 	 President

			
	Representative:	 		 	 FRANCISCO PARTNERS MANAGEMENT LLC

solely in its capacity as the Representative

				
		 		 	By:	 	 /s/ Petri Oksanen

		 		 	Its:	 	 Manager

 [Signature Page to Agreement and Plan of Merger]EX-10.10

 Exhibit 10.10 

CERTAIN INFORMATION CONTAINED IN THIS EXHIBIT, MARKED BY [***], HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE VIVIDION THERAPEUTICS, INC. HAS DETERMINED THAT
IT IS BOTH NOT MATERIAL AND IS THE TYPE THAT VIVIDION THERAPEUTICS, INC. TREATS AS PRIVATE OR CONFIDENTIAL. 
 RESEARCH FUNDING AND
OPTION AGREEMENT 
 by and between 

THE SCRIPPS RESEARCH INSTITUTE 
 a
California nonprofit 
 public benefit corporation 

and 
 Vividion Therapeutics, Inc.,

 a Delaware corporation 
  

 RESEARCH FUNDING AND OPTION AGREEMENT 

This Agreement is entered into this 15th day of September, 2014 (the “Effective
Date”), by and between THE SCRIPPS RESEARCH INSTITUTE, a California nonprofit public benefit corporation located at 10550 North Torrey Pines Road, La Jolla, California 92037 (“TSRI”), and VIVIDION THERAPEUTICS, INC., a Delaware
corporation located at C/O Cardinal Partners 230 Nassau Street Princeton NJ 08540 (“Sponsor”), with respect to the facts set forth below. 

RECITALS 
 A. TSRI is
engaged in fundamental scientific biomedical and biochemical research including research relating to accelerated drug discovery using chemical proteomics, as more particularly described herein. 

B. Sponsor is engaged in research and development aimed at discovery of therapeutically useful compounds. 

C. Sponsor desires to provide certain funding as part of TSRI’s research activities described above. 

D. Subject to any non-exclusive rights of the U.S. Government, TSRI is willing to grant to Sponsor an
option to acquire rights and licenses to certain intellectual property arising from the Research Program. 
 E. TSRI and Sponsor are in
discussions regarding a license agreement (the “Exclusive License Agreement”), pursuant to which TSRI would grant Sponsor an exclusive license under certain technology, materials and other information existing on the Effective Date and
relating to various technologies, including TSRI’s patent and other intellectual property rights therein (collectively, the “Existing Technology”). 

AGREEMENT 
 NOW,
THEREFORE, in consideration of the mutual covenants and conditions outlined herein, TSRI and Sponsor hereby agree as follows: 
 1.
DEFINITIONS. 
 1.1 Affiliate. The term “Affiliate” shall mean any entity which directly or indirectly controls, or
is controlled by Sponsor. The term “control” as used herein means (a) in the case of corporate entities, direct or indirect ownership of at least fifty percent (50%) of the stock or shares entitled to vote for the election of
directors; or (b) in the case of non-corporate entities, direct or indirect ownership of at least fifty percent (50%) of the equity interest with the power to direct the management and policies of such non-corporate entities. Unless otherwise specified, the term Sponsor includes Affiliates. 
 1.2
Agreement Number. This Agreement is TSRI number SFP-0000. 

  
 1 

 1.3 Biological Materials. The term “Biological Materials” shall mean any
Technology in the form of tangible materials together with any progeny, mutants, or derivatives thereof developed in performance of the Research Program. 

1.4 Confidential Information. The term “Confidential Information” shall mean any and all proprietary information of TSRI or
Sponsor which may be disclosed or made available by such party (the “disclosing party”) to the other party (the “receiving party”) at any time and from time to time during the term hereof. The fact that a disclosing party may
have marked or identified as confidential or proprietary any specific information shall be indicative that such disclosing party believes such information to be confidential or proprietary, but the failure to so mark information shall not
conclusively determine that such information was or was not considered confidential information by such disclosing party. Confidential Information shall also include any information which, given the circumstances surrounding the disclosure, would be
considered confidential by the disclosing party. Information shall not be considered confidential to the extent that the receiving party can demonstrate by competent proof that such information: 

(a) Is in the public domain at the time of disclosure to the receiving party; or 

(b) After disclosure to the receiving party, becomes part of the public domain, by publication or otherwise, without any breach of this
Agreement by the receiving party; or 
 (c) Was known to the receiving party prior to the Effective Date, which knowledge was acquired
independently and not from the disclosing party (including the disclosing party’s employees); or 
 (d) Is subsequently disclosed to
the receiving party in good faith by a third party who has a right to make such disclosure. 
 If Confidential Information is required to be
disclosed by law or court order, the Party required to make such disclosure shall limit the same to the minimum required to comply with the law or court order, and shall use reasonable efforts to attempt to seek confidential treatment for that
disclosure, and prior to making such disclosure that Party shall notify the other party, not later than ten (10) days (or such shorter period of time as may be reasonably practicable under the circumstances) before the disclosure in order to
allow that other Party to comment and/or to obtain a protective or other order, including extensions of time and the like, with respect to such disclosure. 

1.5 Field. The term “Field” shall mean [***]. 

1.6 Joint Technology. The term “Joint Technology” shall mean any Technology made or developed jointly by at least one
employee or consultant of Sponsor (it being understood that, for purposes of this paragraph, no TSRI employee shall be considered a consultant of Sponsor) and at least one employee of TSRI, as determined under principles of inventorship under US
patent law. 

  
 2 

 1.7 Patent Rights. The term “Patent Rights” shall mean (a) the U.S.
patent application(s) directed to the Technology; (b) the foreign counterpart applications of the respective application(s) referenced in sub-clause (a) above; (c) divisionals, substitutions (only
those claims of such substitutions that cover the identical subject matter that is covered by the application for which it is substituted), and continuations of any applications referenced in sub-clauses
(a) and (b) above; (d) any claim(s) of a continuation-in-part application of any application set forth in sub-clauses
(a)-(c) above that covers the exact subject matter disclosed in the specification of the respective application(s) referenced in sub-clause (a) above; (e) the patents issued from the applications
referenced in sub-clauses (a)-(c) above and any reissues, reexaminations, renewals and patent term extensions of such patents; and (f) any claim(s) of a patent issued from a
continuation-in-part application referenced in sub-clause (d) above that satisfies all of the requirements of sub-clause (d), and any claim(s) of a reissue, reexamination, renewal and patent term extension of a patent issued from a
continuation-in-part application referenced in sub-clause (d) that satisfies all of the requirements of sub-clause (d); provided, however, that in all cases under sub-clauses (b) – (f) above, the Patent Rights include only the subject matter and claims
contained in the items referenced in sub-clauses (b) – (f) that are entitled to the priority date of the respective application(s) referenced in sub-clause
(a) above. 
 1.8 Principal Investigator. The term “Principal Investigator” shall mean Dr. Cravatt, together
with such replacement persons selected in accordance with the provisions of Section 2.2 hereof. 
 1.9 Research Program. The
term “Research Program” shall mean the research program to be undertaken by TSRI under the direction and control of the Principal Investigator as expressly set forth on Exhibit A hereto. 

1.10 Research Tool. The term “Research Tool” shall mean any Technology which is designed or utilized for basic research
purposes or internal drug discovery purposes and which is not utilized to produce, or incorporated into, a product. 
 1.11
Technology. The term “Technology” shall mean any invention, discovery, know-how, Biological Material, software, information and data, whether patentable or not, conceived and reduced to
practice during the performance of the Research Program. 
 1.12 TSRI Technology. The term “TSRI Technology” shall mean
any Technology, made or developed solely by one or more employees of TSRI, as determined under principles of inventorship under the patent laws of the United States of America. 

2. CONDUCT OF RESEARCH PROGRAM. 

2.1 Conduct of Research Program. TSRI hereby agrees to use reasonable efforts to perform the Research Program subject to the
provisions of this Agreement. Notwithstanding the foregoing, TSRI makes no warranties or representations regarding its ability to achieve, nor shall it be bound to accomplish, any particular research objective or results. 

2.2 Supervision of Research Program. TSRI agrees that the Research Program at TSRI shall be conducted by or under the direct
supervision of the Principal Investigator. In the event that the Principal Investigator leaves TSRI, or terminates his/her 

  
 3 

 involvement in the Research Program, TSRI shall use its best efforts to find a replacement Principal
Investigator acceptable to Sponsor, which acceptance shall not be unreasonably withheld. In the event that TSRI shall fail to appoint a replacement Principal Investigator reasonably acceptable to Sponsor, Sponsor shall have a right to terminate this
Agreement upon delivery to TSRI of written notice of termination pursuant to this Section 2.2, which notice must be delivered to TSRI not more than [***] days after delivery by TSRI to Sponsor of the name of the replacement Principal
Investigator. 
 2.3 Reports. TSRI and the Principal Investigator shall keep complete and accurate records of the results of the
Research Program. TSRI agrees to provide oral reports on a [***] basis, and Sponsor shall have the right, upon reasonable request from time to time, to discuss with TSRI, the Principal Investigator and other appropriate TSRI personnel, in person or
otherwise, the Research Program and the results thereof. TSRI agrees that within [***] days following [***] during the term of this Agreement, TSRI shall furnish Sponsor with a written report summarizing the results of the research included within
the scope of the Research Program conducted by TSRI, during the immediately preceding calendar year, including but not limited to all data, conclusions, results, observations and a detailed description of all procedures. Subject to Section 3.1,
all such reports shall be treated as Confidential Information by Sponsor. In the event that Sponsor identifies any Technology disclosed in such report as to which it would like to exercise its option and which has not been previously disclosed to
Sponsor by TSRI in accordance with Section 3.2, Sponsor shall notify TSRI of such Technology in writing. Promptly following such notification, TSRI shall provide Sponsor with a Technology Disclosure in accordance with Section 3.2. 

2.4 Financial and Staffing Obligations 

(a) Contributions of Parties to Research Program. Contributions in the form of financial support, equipment, personnel, technology and
other necessary components for the conduct of the Research Program shall be made by the parties in accordance with the terms set forth on Exhibit B. All payments due to TSRI by Sponsor shall be payable in U.S. Dollars in [***] in advance and due
within [***] days of each respective payment date. The first payment for the period starting on the Effective Date and continuing through March 31, 2015 shall be $[***] US Dollars. The amounts specified above include all expense, overhead and
other related costs due by Sponsor to TSRI in connection with the Research Program, and no other amounts shall be due or payable by Sponsor to TSRI or the Principal Investigator for performance of the Research Program. Each payment must reference
the Research Project title, Agreement Number and Principal Investigator for purposes of identification. Payments under this Section 2.4(a) shall be sent to: 

 

			
	                                    	  	 The Scripps Research Institute
 10550 North
Torrey Pines Road, TPC-7
 La Jolla, California 92037

Attn: Vice President, Sponsored Programs
 Fax
No.:

  
 4 

			
	With a copy to:	  	 The Scripps Research Institute
 10550 North
Torrey Pines Road, TPC-9
 La Jolla, California 92037

Attn: Director, Technology Development
 Fax No.:

		
	Or if payment is by wire transfer:	  	 Bank of America
 Account Number:

ABA Routing Number:
 Attn: Kathy McDowell

Bank of America
 San Diego Corporate Banking

450 B Street, Suite 100
 San Diego, California 92101

 TSRI shall not be obligated to perform any of the research specified herein or to take any other action required under this
Agreement if the funding is not provided as set forth in Exhibit B and in accordance with the payment schedule as set forth in this Section 2.4(a). Furthermore, should Sponsor fail to make the first payment to TSRI in accordance with this
Section 2.4(a), TSRI shall have the right to immediately terminate this Agreement and this Agreement shall be null and void ab initio. 

(b) Capital Equipment. Equipment purchased by TSRI with funds provided by Sponsor shall be the property of TSRI. All capital equipment
provided under this Agreement by Sponsor for the use of TSRI remains the property of the Sponsor unless other disposition is mutually agreed upon in writing by the Parties. If title to this equipment remains with the Sponsor, Sponsor is responsible
for maintenance and repair of the equipment, insuring the equipment against damage or loss, and the costs of its transportation to and from the site where it will be used. 

(c) Indirect Cost Adjustment. TSRI shall have the right to adjust the payment amounts referenced above to reflect changes in the
indirect cost rate negotiated between TSRI and the U.S. Government and that will be in effect during the quarter that the work is performed. TSRI will notify Sponsor in writing of any change in the indirect cost rate before the effective date of
such change. The corresponding direct costs will remain fixed as specified in Exhibit B. 
 3. OPTION FOR LICENSE. 

3.1 Grant of Option. Subject to the terms of this Agreement and the reservation of rights specified in Sections 4.2 and 4.3, TSRI
hereby grants to Sponsor: 

  
 5 

 (a) an exclusive option (the “Option”) to acquire an exclusive, worldwide
license, under the terms and conditions of the Exclusive License Agreement, under TSRI’s rights in the Patent Rights, to make, have made, use, offer for sale, sell, have sold and import products, processes and Biological Material in the Field.
In the event that a product, process or Biological Material utilizes a Research Tool, such Research Tool shall be made available to Sponsor solely on a non-exclusive basis. 

(b) a non-exclusive, royalty-free, non-transferable license
to make and use Technology solely for Sponsor’s internal research purposes during the performance of the Research Program. Any transfer of materials to Sponsor under this Section 3.1(b) shall require the execution of a Material Transfer
Agreement. The terms of such Material Transfer Agreement shall be materially consistent with the form Material Transfer Agreement attached hereto as Exhibit C. 

3.2 Disclosure of Technology. After Principal Investigator submits an invention disclosure covering any Technology to TSRI’s
Office of Technology Development, TSRI shall disclose such Technology in writing to Sponsor (the “Technology Disclosure”). TSRI shall use [***] to provide a Technology Disclosure that contains sufficient detail to (i) [***]; and (ii)
[***]. All such Technology Disclosures shall be maintained in confidence by Sponsor. 
 3.3 Option. Sponsor shall have a period of
[***] days from receipt of the Technology Disclosure from TSRI (“Option Period”), within which to exercise its Option with respect to the particular Technology disclosed therein. 

3.4 Exercise of Option. Sponsor shall exercise its Option by delivering to TSRI a written notice within the Option Period which
specifies the particular Technology for which the Option is being exercised. Upon such notification, Sponsor and TSRI shall prepare and execute an amendment that adds the Technology to the Exclusive License Agreement [***] and certain other terms as
may be mutually agreed by the Parties. 
 3.5 Patent Filings. [***] shall direct and control the preparation, filing and prosecution
of patent applications and patents within the Patent Rights. [***] shall pay all fees and costs incurred during the term of this Agreement (including any subsequent Option Period) associated with work performed by TSRI’s Office of Patent
Counsel and any independent counsel and related to the preparation, filing, prosecution and maintenance of the Patent Rights. Payment shall be made within [***] days after [***] receives an invoice therefor. Failure of [***] to pay patent fees and
expenses as set forth above shall immediately relieve [***] from its obligation to incur any further patent fees and expenses. [***]’s obligation to pay all patent fees and costs incurred pursuant to this Agreement shall survive the termination
or expiration of this Agreement. Both parties hereto agree that [***] may, at its sole discretion, utilize TSRI’s Office of Patent Counsel in lieu of or in addition to independent counsel for patent prosecution and maintenance of patent
application(s). [***] shall have full rights of consultation with the patent attorney so selected on all matters relating to patent application(s). 

  
 6 

 3.6 Joint Technology. The parties hereby agree that in the event that the disclosed
Technology is Joint Technology and that Sponsor does not exercise its Option to include the Technology in the Exclusive License Agreement subject to Section 3.4, both Parties shall (i) have no further obligations to each other with respect
to such Joint Technology and any resulting Patent Rights; and (ii) be free to independently license or otherwise dispose of their rights to such Joint Technology and any resulting Patent Rights on a worldwide basis without accounting to the
other Party. 
 4. INTERESTS AND RIGHTS IN INTELLECTUAL PROPERTY. 

4.1 Title. TSRI shall retain sole ownership and title to TSRI Technology and to all intellectual property rights related thereto. TSRI
shall, in the good faith exercise of its discretion, undertake reasonable efforts to preserve and maintain its ownership and title as TSRI deems appropriate. Ownership of and title to Joint Technology shall be vested jointly in TSRI and Sponsor,
with each owning an undivided interest therein. Ownership of Patent Rights shall follow inventorship under principles arising under U.S. patent law. 

4.2 Governmental Interest. TSRI and Sponsor acknowledge that TSRI has received, and expects to continue to receive, funding from the
United States Government in support of TSRI’s research activities. TSRI and Sponsor acknowledge and agree that their respective rights and obligations pursuant to this Agreement shall be subject to the rights of the United States Government,
existing and as amended, which may arise or result from TSRI’s receipt of research support from the United States Government, including but not limited to, 37 CFR 401, the NIH Grants Policy Statement and the NIH Guidelines for Obtaining and
Disseminating Biomedical Research Resources. 
 4.3 Reservation of Rights. TSRI reserves the right to use for any internal research
or educational purposes any Patent Rights, Biological Materials, or Research Tools, without TSRI being obligated to pay Sponsor any royalties or other compensation. In addition, TSRI reserves the right to grant
non-exclusive, non-commercial research and educational use licenses to other nonprofit or academic institutions to Patent Rights, Biological Materials, or Research
Tools, without the other non-profit entity being obligated to pay Sponsor any royalties or other compensation. TSRI shall have no obligation to notify or inform Sponsor of such use or licenses. 

5. CONFIDENTIALITY AND PUBLICATION. 

5.1 Treatment of Confidential Information. The parties agree that during the term of this Agreement, and for a period of [***] years after
termination or expiration of this Agreement, the receiving party will (a) maintain in confidence all Confidential Information to the same extent such party maintains its own proprietary information; (b) not disclose such Confidential
Information to any third party without the prior written consent of the disclosing party; and (c) not use such Confidential Information for any purpose except those permitted by this Agreement (and, if and to the extent applicable, the
Exclusive License Agreement). 

  
 7 

 5.2 Publications. Sponsor acknowledges that it is the general policy of TSRI to
encourage publication of research results in technical or scientific journals; and Sponsor agrees that TSRI shall have a right to publish in accordance with its general policy. TSRI shall submit to Sponsor copies of proposed publications which
describe Technology and afford Sponsor a period of [***] days to review the publication to (i) ascertain whether Sponsor’s Confidential Information would be disclosed by the publication; and (ii) ascertain whether or not submission or
presentation of the publication would preclude the parties from obtaining patent rights claiming Technology disclosed therein unless an application is filed with relevant patent authorities. If such publication discloses Sponsor’s Confidential
Information and upon Sponsor’s written request, TSRI shall remove such Confidential Information or delay publication for up to an additional [***] days to allow Sponsor to protect its Confidential Information by filing a patent application(s).
In the event that Sponsor identifies any potentially patentable Technology with respect to which it wishes to file, or have TSRI file (as applicable), patent application(s), Sponsor shall notify TSRI of such in writing. Upon such notification, TSRI
shall, at its option, either delete the enabling portion of the proposed publication or presentation, or withhold publication or delay presentation for up to an additional [***] days to allow filing of patent application(s). Absent receipt by TSRI
of any written instruction by Sponsor within the [***] day period, TSRI shall be free to publish the proposed publication. 
 5.3
Publicity. Except as otherwise provided herein or required by law, no party shall originate any publication, news release or other public announcement, written or oral, whether in the public press, stockholders’ reports, or otherwise,
relating to this Agreement or to the performance hereunder without the prior written approval of the other party, which approval shall not be unreasonably withheld. Scientific publications published in accordance with Section 5.2 of this
Agreement shall not be construed as publicity governed by this Section 5.3. 
 6. WARRANTIES. 

6.1 Limited Warranty. TSRI hereby represents and warrants that it has full right and power to enter into this Agreement. TSRI MAKES NO
OTHER WARRANTIES CONCERNING PATENT RIGHTS, TECHNOLOGY, RESEARCH TOOLS, BIOLOGICAL MATERIALS OR ANY OTHER MATTER WHATSOEVER, INCLUDING WITHOUT LIMITATION, ANY EXPRESS OR IMPLIED WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, NON-INFRINGEMENT OF THIRD PARTY RIGHTS OR ARISING OUT OF COURSE OF CONDUCT OR TRADE CUSTOM OR USAGE, AND TSRI DISCLAIMS ALL SUCH EXPRESS OR IMPLIED WARRANTIES. TSRI MAKES NO WARRANTY OR REPRESENTATION AS TO THE
VALIDITY OR SCOPE OF PATENT RIGHTS, OR THAT ANY PRODUCT, PROCESS, SERVICE, BIOLOGICAL MATERIAL, OR RESEARCH TOOL WILL BE FREE FROM AN INFRINGEMENT ON PATENTS OR OTHER INTELLECTUAL PROPERTY RIGHTS OF THIRD PARTIES, OR THAT NO THIRD PARTIES ARE IN ANY
WAY INFRINGING UPON ANY PATENT RIGHTS, TECHNOLOGY, RESEARCH TOOLS OR BIOLOGICAL MATERIALS COVERED BY THIS AGREEMENT. FURTHER, TSRI HAS MADE NO INVESTIGATION AND MAKES NO REPRESENTATION THAT THE PATENT RIGHTS, RESEARCH TOOLS OR BIOLOGICAL
MATERIALS ARE SUITABLE FOR SPONSOR’S PURPOSES. 

  
 8 

 IN NO EVENT SHALL [***] BE LIABLE TO THE OTHER PARTY FOR ANY INDIRECT, SPECIAL, INCIDENTAL, EXEMPLARY OR
CONSEQUENTIAL DAMAGES (INCLUDING, WITHOUT LIMITATION, DAMAGES FOR LOSS OF PROFITS OR EXPECTED SAVINGS OR OTHER ECONOMIC LOSSES, OR FOR INJURY TO PERSONS OR PROPERTY) ARISING OUT OF OR IN CONNECTION WITH THIS AGREEMENT OR ITS SUBJECT MATTER.
TSRI’S AGGREGATE LIABILITY, IF ANY, FOR ALL DAMAGES OF ANY KIND RELATING TO THIS AGREEMENT OR ITS SUBJECT MATTER SHALL NOT EXCEED THE AMOUNT PAID BY SPONSOR TO TSRI UNDER THIS AGREEMENT. THE FOREGOING EXCLUSIONS AND LIMITATIONS SHALL APPLY TO
ALL CLAIMS AND ACTIONS OF ANY KIND AND ON ANY THEORY OF LIABILITY, WHETHER BASED ON CONTRACT, TORT (INCLUDING, BUT NOT LIMITED TO NEGLIGENCE OR STRICT LIABILITY), OR ANY OTHER GROUNDS, AND REGARDLESS OF WHETHER A PARTY HAS BEEN ADVISED OF THE
POSSIBILITY OF SUCH DAMAGES, AND NOTWITHSTANDING ANY FAILURE OF ESSENTIAL PURPOSE OF ANY LIMITED REMEDY. THE PARTIES FURTHER AGREE THAT EACH WARRANTY DISCLAIMER, EXCLUSION OF DAMAGES OR OTHER LIMITATION OF LIABILITY HEREIN IS INTENDED TO BE
SEVERABLE AND INDEPENDENT OF THE OTHER PROVISIONS SINCE THEY EACH REPRESENT SEPARATE ELEMENTS OF RISK ALLOCATION BETWEEN THE PARTIES. 
 7.
TERM AND TERMINATION. 
 7.1 Term. Unless terminated sooner, the initial term of this Agreement shall commence on the
Effective Date and shall continue until the earlier of (a) August 31, 2017, and (b) the completion of the Research Program. 

7.2 Termination by Sponsor. Sponsor may terminate this Agreement by giving thirty (30) days advance written notice of termination
to TSRI. 
 7.3 Termination Upon Default. Except as specified in Section 7.4, the failure of a party to perform any obligation
required of it to be performed hereunder and the failure to cure within sixty (60) days (or, in the case of any failure by Sponsor to make any payment hereunder when due, within thirty (30) days) after receipt of notice from the other
party specifying in reasonable detail the nature of such default, shall constitute an event of default hereunder. Upon the occurrence of an event of default that is not cured within the applicable notice period, the
non-defaulting party may deliver to the defaulting party written notice of intent to terminate, such termination to be effective upon the date set forth in such notice. Such termination rights shall be in
addition to and not in substitution for any other remedies that may be available to the non-defaulting party serving such notice against the defaulting party. Termination pursuant to this Section 7.3
shall not relieve the defaulting party of liability and damages to the non-defaulting party for breach of this Agreement. Waiver by any party of a single default or a succession of defaults shall not deprive
such party of any right to terminate this Agreement arising by reason of any subsequent default. 
 7.4 Termination Upon Insolvency.
This Agreement may be terminated by a party upon written notice of termination to the other party (“Insolvent Party”) in the event of the filing of bankruptcy by the Insolvent Party, or the appointment of a receiver of any of the 

  
 9 

 Insolvent Party’s assets, or the making by the Insolvent Party of any assignment for the benefit of
creditors, or the institution of any involuntary bankruptcy proceedings against the Insolvent Party under any bankruptcy law that are not dismissed within sixty (60) days after institution. Termination shall be effective upon the date specified
in this notice. 
 7.5 Effect of Expiration or Termination. 

(a) Termination Upon Default of Sponsor. Upon the termination of this Agreement by reason of a default by Sponsor, neither party shall
have any further rights or obligations with respect to this Agreement, other than the rights and obligations of the parties that accrued prior to the effective date of such termination (including, without limitation, the obligation of Sponsor to
make any and all final payments accrued prior to the date of termination and the obligation of the parties to make all reports required hereunder), and except as provided below. Upon such termination of this Agreement, the parties shall continue to
abide by their non-disclosure obligations as described in Section 5.1 and each party hereto shall fulfill any other obligations incurred prior to such termination. Any such termination of this Agreement
shall not constitute the termination of any license or any other agreements between the parties which are then in effect (such as, but not limited to, the Exclusive License Agreement) except as expressly provided therein. In addition, upon such
termination, Sponsor’s Option under Section 3.1 shall be deemed automatically cancelled, and Sections 4, 6, 7, 8 and 9 shall survive any such termination. 

(b) Expiration or Termination upon Default of TSRI. Upon the expiration of this Agreement at its regularly scheduled expiration date,
or upon a termination of this Agreement on account of a default by TSRI, then TSRI shall make the disclosures required by Section 3.2 for Technology conceived or reduced to practice up to the date of said expiration or termination; Sponsor
shall have the right to exercise its option with respect to said Technology in accordance with the schedule and procedures specified in Sections 3.3 and 3.4 above; and any non-exclusive licenses that have been
granted under Section 3.1 shall survive. Additionally, each party shall perform all other obligations up to the date of said expiration or termination; the parties shall continue to abide by their
non-disclosure obligations described in Section 5.1; and any previously existing license agreements or other agreements between the parties (such as, but not limited to, the Exclusive License Agreement)
shall continue in effect. No such expiration or termination of this Agreement shall affect the rights and obligations of the parties that accrued prior to the effective date of such expiration or termination. In addition, upon such expiration or
termination, Sections 4, 6, 7, 8 and 9 shall survive. 
 8. ASSIGNMENT; SUCCESSORS. 

8.1 Assignment. Any and all assignments of this Agreement or any rights granted hereunder by Sponsor are void except to an Affiliate
of Sponsor, without the prior written consent of TSRI. 
 8.2 Binding Upon Successors and Assigns. Any and all assignments of this
Agreement or any rights granted hereunder by Sponsor without the prior written consent of TSRI are void, except that, without the prior written consent of TSRI, (a) Sponsor may assign this Agreement and its rights and obligations hereunder to
an Affiliate of Sponsor; and 

  
 10 

 (b) Sponsor may assign this Agreement and its rights and obligations hereunder in connection with the
transfer or sale of all or substantially all of Sponsor’s business or assets to a third party, whether by merger, sale of stock, sale of assets or otherwise, subject to Section 8.2 hereof. 

9. GENERAL PROVISIONS. 

9.1 Independent Contractors. The relationship between TSRI and Sponsor is that of independent contractors. TSRI and Sponsor are not
joint venturers, partners, principal and agent, master and servant, employer or employee, and have no other relationship other than independent contracting parties. TSRI and Sponsor shall have no power to bind or obligate each other in any manner,
other than as is expressly set forth in this Agreement. 
 9.2 Arbitration. Any controversy or claim arising out of or relating to
this Agreement, or the breach thereof, shall be settled by binding confidential arbitration in accordance with the Commercial Arbitration Rules of the American Arbitration Association (“AAA”), and the procedures set forth below. In the
event of any inconsistency between the Rules of AAA and the procedures set forth below, the procedures set forth below shall control. Judgment upon the award rendered by the arbitrators may be enforced in any court having jurisdiction thereof. 

(a) Location. The location of the arbitration shall be in the County of San Diego. TSRI and Sponsor hereby irrevocably submit to the
exclusive jurisdiction and venue of the American Arbitration Association arbitration panel selected by the parties and located in San Diego County, California for any dispute regarding this Agreement, and to the exclusive jurisdiction and venue of
the federal and state courts located in San Diego County, California for any action or proceeding to enforce an arbitration award or as otherwise provided in Section 9.2(e) below, and waive any right to contest or otherwise object to such
jurisdiction or venue. 
 (b) Selection of Arbitrators. The arbitration shall be conducted by a panel of three neutral arbitrators
who are independent and disinterested with respect to the parties, this Agreement, and the outcome of the arbitration. Each party shall appoint one neutral arbitrator, and these two arbitrators so selected by the parties shall then select the third
arbitrator, and all arbitrators must have at least ten (10) years experience in mediating or arbitrating cases regarding the same or substantially similar subject matter as the dispute between TSRI and Sponsor. If one party has given written
notice to the other party as to the identity of the arbitrator appointed by the party, and the party thereafter makes a written demand on the other party to appoint its designated arbitrator within the next ten days, and the other party fails to
appoint its designated arbitrator within ten days after receiving said written demand, then the arbitrator who has already been designated shall appoint the other two arbitrators. 

(c) Discovery. The arbitrators shall decide any disputes and shall control the process concerning these
pre-hearing discovery matters. Pursuant to the Rules of AAA, the parties may subpoena witnesses and documents for presentation at the hearing. 

(d) Case Management. Prompt resolution of any dispute is important to both parties; and the parties agree that the arbitration of any
dispute shall be 

  
 11 

 conducted expeditiously. The arbitrators are instructed and directed to assume case management initiative
and control over the arbitration process (including scheduling of events, pre-hearing discovery and activities, and the conduct of the hearing), in order to complete the arbitration as expeditiously as is
reasonably practical for obtaining a just resolution of the dispute. 
 (e) Remedies. The arbitrators may grant any legal or
equitable remedy or relief that the arbitrators deem just and equitable, to the same extent that remedies or relief could be granted by a state or federal court, provided however, that no punitive damages may be awarded. No court action shall be
maintained seeking punitive damages. The decision of any two of the three arbitrators appointed shall be binding upon the parties. Notwithstanding anything to the contrary in this Agreement, prior to or while an arbitration proceeding is pending,
either party has the right to seek and obtain injunctive and other equitable relief from a court of competent jurisdiction to enforce that party’s rights hereunder. In addition, no claim, dispute or controversy that concerns the validity,
enforceability, scope or infringement of a patent, trademark or copyright shall be subject to arbitration or any other provision of this Section 9.2. 

(f) Expenses. The expenses of the arbitration, including the arbitrators’ fees, expert witness fees, and attorney’s fees,
may be awarded to the prevailing party, in the discretion of the arbitrators, or may be apportioned between the parties in any manner deemed appropriate by the arbitrators. Unless and until the arbitrators decide that one party is to pay for all (or
a share) of such expenses, both parties shall share equally in the payment of the arbitrators’ fees as and when billed by the arbitrators. 

(g) Confidentiality. Except as set forth below and as necessary to obtain or enforce a judgment upon any arbitration award, the
parties shall keep confidential the fact of the arbitration, the dispute being arbitrated, and the decision of the arbitrators. Notwithstanding the foregoing, the parties may disclose information about the arbitration to persons who have a need to
know, such as directors, trustees, management employees, witnesses, experts, investors, attorneys, lenders, insurers, and others who may be directly affected. Additionally, if a party has stock which is publicly traded, the party may make such
disclosures as are required by applicable securities laws, but will use commercially reasonably efforts to seek confidential treatment for such disclosure. 

9.3 Entire Agreement; Modification. This Agreement and all of the attached Exhibits set forth the entire agreement and understanding
between the parties as to the subject matter hereof, and supersede all prior or contemporaneous written or oral agreements. There shall be no amendments or modifications to this Agreement, except by a written document which is signed by both
parties. 
 9.4 California Law. This Agreement shall be construed and enforced in accordance with the laws of the State of
California notwithstanding any conflicts or choice of laws provisions. 
 9.5 No Use of Name. The use of the name “The Scripps
Research Institute”, “Scripps”, “TSRI” or any variation thereof in connection with the advertising, sale or performance of products, processes, services, Biological Materials or Research Tools is expressly prohibited. 

  
 12 

 9.6 Headings. The headings for each article and section in this Agreement have been
inserted for the convenience of reference only and are not intended to limit or expand on the meaning of the language contained in the particular article or section. 

9.7 Severability. Should any one or more of the provisions of this Agreement be held invalid or unenforceable by a court of competent
jurisdiction, it shall be considered severed from this Agreement and shall not serve to invalidate the remaining provisions thereof. The parties shall make a good faith effort to replace any invalid or unenforceable provision with a valid and
enforceable one such that the objectives contemplated by them when entering this Agreement may be realized. 
 9.8 No Waiver. Any
delay in enforcing a party’s rights under this Agreement or any waiver as to a particular default or other matter shall not constitute a waiver of such party’s rights to the future enforcement of its rights under this Agreement, excepting
only as to an express written and signed waiver as to a particular matter for a particular period of time. 
 9.9 Notices. Any
notices required by this Agreement shall be in writing, shall specifically refer to this Agreement and shall be sent by registered or certified airmail, postage prepaid, or by telefax, telex or cable, charges prepaid, or by overnight courier,
postage prepaid, and shall be forwarded to the respective addresses set forth below unless subsequently changed by written notice to the other party: 
  

			
	FOR TSRI:	  	The Scripps Research Institute
		  	10550 North Torrey Pines Road, TPC-9
		  	La Jolla, California 92037
		  	Attn: Director, Technology Development
		  	Fax No.:
		
	With a copy to:	  	The Scripps Research Institute
		  	10550 North Torrey Pines Road, TPC-8
		  	La Jolla, California 92037
		  	Attention: Chief Business Counsel
		  	Fax No.:
		
	FOR SPONSOR:	  	Vividion Therapeutics, Inc.
		  	Attn: Chief Executive Officer
		  	C/O Cardinal Partners 230 Nassau Street Princeton NJ 08540

 Notices shall be deemed delivered upon the earlier of (i) when received; (ii) three (3) days after deposit
into the U.S. mail; (iii) the date notice is sent via telefax, telex or cable; or (iv) the day immediately following delivery to an overnight courier guaranteeing next-day delivery (except Sunday and
holidays). 
 9.10 Compliance with U.S. Laws. Nothing contained in this Agreement shall require or permit TSRI or Sponsor to do any
act inconsistent with the requirements of any United States law, regulation or executive order as the same may be in effect from time to time. 

  
 13 

 9.11 Indemnity. Sponsor shall indemnify, defend (by counsel reasonably acceptable to
TSRI) and hold harmless TSRI and any parent, subsidiary or other affiliated entity of TSRI and their trustees, directors, officers, employees, scientists, agents, successors, assigns and other representatives (collectively, the
“Indemnitees”) from and against all claims, suits, actions, damages, liabilities, losses and other expenses, including without limitation reasonable attorney’s fees, expert witness fees and costs incurred by or asserted against the
Indemnitees, whether or not a lawsuit or other proceeding is filed (collectively “Claim”), that arise out of or relate to any third party allegations or suits regarding Sponsor’s use of the Technology or the exercise of its non-exclusive license rights under Section 3.1(b). Sponsor shall not enter into any settlement of such Claims that imposes any obligation on TSRI, that does not unconditionally release TSRI from all liability
or that would have an adverse effect on TSRI’s reputation or business without TSRI’s prior written consent. In the event an Indemnitee seeks indemnification with respect to a Claim under this Section 9.11, it shall notify Sponsor in
writing of such Claim as soon as reasonably practicable after it receives notice of such Claim, shall permit Sponsor to assume direction and control of the defense of the Claim (including the right to settle the Claim solely for monetary
consideration, subject to the limitations of the preceding sentence) using counsel selected by Sponsor and reasonably acceptable to TSRI, and shall cooperate as reasonably requested (at the expense of Sponsor) in the defense of the Claim.
Notwithstanding the above, Indemnitees, at [***] expense, shall have the right to retain separate independent counsel to assist in defending any such Claims. In the event Sponsor fails to promptly indemnify and defend such Claims and/or pay
Indemnitees’ expenses as provided above, Indemnitees shall have the right to defend themselves, and in that case, Sponsor shall reimburse Indemnitees for all of their reasonable attorney’s fees, costs and damages incurred in settling or
defending such Claims within [***] days of each of Indemnitees’ written requests. This indemnity shall be a direct payment obligation and not merely a reimbursement obligation of Sponsor to Indemnitees. 

IN WITNESS WHEREOF, the parties have executed this Agreement by their duly authorized representatives as of the date set forth above. 

 

									
	TSRI:	  		 	SPONSOR:
			
	THE SCRIPPS RESEARCH INSTITUTE	  		 	VIVIDION THERAPEUTICS
					
	By:	 	 /s/ Scott Forrest
	  	        	 	By:	 	 /s/ John K. Clarke

		 	Scott Forrest	  		 		 	John K. Clarke
	Title:	 	Business Development, VP	  		 	Title:	 	President

  
 14 

 EXHIBIT A 

RESEARCH PROGRAM 
 Vividion SFP –
Bullet-Point Objectives 
 [***] 

 EXHIBIT B 

Principal Investigator/Program Director (Last, First, Middle): Cravatt, Benjamin F. 

 EXHIBIT C 

FORM OF MATERIAL TRANSFER AGREEMENT 

THE SCRIPPS RESEARCH INSTITUTE 

 AMENDMENT TO RESEARCH FUNDING AND OPTION AGREEMENT 

This is an Amendment, dated as of December 13, 2016 (this “Amendment”) to the Research Funding and Option Agreement, dated
September 15, 2014 (the “Funding Agreement”), by and between THE SCRIPPS RESEARCH INSTITUTE, a California nonprofit public benefit corporation (“TSRI”), and VIVIDION THERAPEUTICS, INC., a Delaware corporation
(“Sponsor”). 
 RECITALS 

A. TSRI and Sponsor entered into the Funding Agreement and have been operating under the Funding Agreement since its effective date. 

B. TSRI and Sponsor have determined that it is in the best interest of both TSRI and Sponsor to amend the Funding Agreement as set forth in
this Amendment. 
 AGREEMENT 

NOW, THEREFORE, for good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, TSRI and Sponsor hereby
agree as follows: 
 1. Amendment of Section 3.1 (a). Paragraph (a) of Section 3.1 of the Funding
Agreement is hereby amended by deleting the last sentence of such paragraph. 
 2. Continuation of Funding Agreement. In all other
respects the Funding Agreement remains in full force and effect as originally executed. 
 IN WITNESS WHEREOF, the parties have executed
this Agreement by their duly authorized representatives as of the date set forth above. 
  

									
	TSRI:	 		 	LICENSEE:
			
	THE SCRIPPS RESEARCH INSTITUTE	 		 	VIVIDION THERAPEUTICS, INC.
					
	By:	 	 /s/ Eric Topol
	 		 	By:	 	 /s/ John K. Clarke

	Title:	 	 Vice President
	 		 	Title:	 	 President

 AMENDMENT NO.2 TO RESEARCH FUNDING AND OPTION AGREEMENT 

This is Amendment 2, dated as of February 15, 2017 (this “Amendment”) to the Research Funding and Option Agreement, dated
September 15, 2014, and as amended on December 13, 2016 (the “Funding Agreement”), by and between THE SCRIPPS RESEARCH INSTITUTE, a California nonprofit public benefit corporation (“TSRI”), and VIVIDION THERAPEUTICS,
INC., a Delaware corporation (“Sponsor”). 
 RECITALS 

A. TSRI and Sponsor entered into the Funding Agreement and have been operating under the Funding Agreement since its effective date. 

B. TSRI and Sponsor have determined that it is in the best interest of both TSRI and Sponsor to extend the term of the Funding Agreement and
amend the scope of the Research Program as set forth in this Amendment for additional funding. 
 AGREEMENT 

NOW, THEREFORE, for good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, TSRI and Sponsor hereby
agree as follows: 
 1. The Funding Agreement is amended to include the attached Exhibit A-2,
which lists additional aims to the Research Program for the Funding Agreement. Exhibit A-2 is incorporated into and made part of the Funding Agreement. References to Exhibit A in Paragraph 1.9 of
the Funding Agreement are amended to also refer to Exhibit A-2. 
 2. The Funding Agreement is
amended to include the attached Exhibit B-2, which lists the applicable cost information for additional aims to the Research Program being added to the Funding Agreement. Exhibit B-2 is incorporated into and made part of the Agreement. References to Exhibit B in Paragraph 2.4 of the Funding Agreement are amended to also refer to Exhibit B-2.

 3. Section 2.4 of the Funding Agreement, entitled “Financial and Staffing Obligations” is hereby amended to include the
following after the sentence “The first payment for the period starting on the Effective Date and continuing through March 15, 2015 shall be $[***] US Dollars.”: 

For the period September 15, 2016 through February 14, 2017 the payment shall be [***]. For each of the six month periods beginning
February 15, 2017 and ending February 14, 2020 the payment shall be $[***]. 
 4. Section 7.2 Term. The date “August 31,
2017” shall be deleted and replaced with February 14, 2020. 
 5. Continuation of Funding Agreement. In all other respects
the Funding Agreement remains in full force and effect as originally executed. 

  
 1 

 IN WITNESS WHEREOF, the parties have executed this Agreement by their duly authorized
representatives as of the date set forth above. 
  

									
	 TSRI:
	  		  	SPONSOR:
			
	 THE SCRIPPS RESEARCH INSTITUTE
	  		  	V1VIDION THERAPEUTICS, INC.
					
	 By:
	  	 /s/ Matt Tremblay
	  		  	 By:
	  	
             

	 Title:
	  	 Vice President, Business Development
	  		  	 Title:
	  	
             

  
 2 

 IN WITNESS WHEREOF, the parties have executed this Agreement by their duly authorized
representatives as of the date set forth above. 
  

									
	TSRI:	 		 	SPONSOR:
			
	THE SCRIPPS RESEARCH INSTITUTE	 		 	V1VIDION THERAPEUTICS, INC.
					
	By:	 	              
	 		 	By:	 	 /s/ John Clarke

					
	Title:	 	          
	 		 	Title:	 	 President

  
 3 

 EXHIBIT A-2 

RESEARCH PROGRAM 

  
 4 

 EXHIBIT B-2 

BUDGET 

  
 5 

 AMENDMENT NO. 3 TO RESEARCH FUNDING AND OPTION AGREEMENT 

This is an Amendment 3, dated as of September 13, 2018 (this “Amendment”) to the Research Funding and Option Agreement, dated
September 15, 2014 (the “Funding Agreement), by and between THE SCRIPPS RESEARCH INSTITUTE, a California nonprofit public benefit corporation (“TSRI”), and VIVIDION THERAPEUTICS, INC., a Delaware corporation
(“Sponsor”). 
 RECITALS 
  

	 	A.	 TSRI and Sponsor entered into the Funding Agreement and have been operating under the Funding Agreement since
its effective date. 

  

	 	B.	 TSRI and Sponsor have determined that it is in the best interest of both TSRI and Sponsor to amend the Funding
Agreement as set forth in this Amendment. 

 AGREEMENT 

NOW, THEREFORE, for good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, TSRI and Sponsor hereby
agree as follows: 
  

	 	1.	 Amendment of Section 3.1 (b). Paragraph (b) of Section 3.1 of the Funding
Agreement is hereby amended by deleting the second sentence of such paragraph and replacing it with the following: “Any transfer of materials from TSRI to Sponsor or from Sponsor to TSRI under this Section 3.1(b) shall require the
execution of a Material Transfer Agreement.” 

  

	 	2.	 Continuation of Funding Agreement. In all other respects the Funding Agreement remains in full force and
effect as originally executed. 

 IN WITNESS WHEREOF, the parties have executed this Agreement by their duly authorized
representatives as of the date set forth above. 
  

									
	TSRI:	 		 	LICENSEE:
			
	THE SCRIPPS RESEARCH INSTITUTE	 		 	VIVIDION THERAPEUTICS, INC.
					
	Title:	 	/s/ Daniel J. Catron	 		 	Title:	 	 /s/ G. Diego Miralles

	Title:	 	  

17-Sep-2018
	 		 	Title:	 	 Chief Executive Officer

 FOURTH AMENDMENT TO 

RESEARCH FUNDING AND OPTION AGREEMENT 

THIS FOURTH AMENDMENT TO THAT CERTAIN RESEARCH FUNDING AND OPTION AGREEMENT (the “Fourth Amendment”) is entered into as of
January 17, 2020 (the “Amendment Effective Date”) by and between THE SCRIPPS RESEARCH INSTITUTE, a California nonprofit public benefit corporation located at 10550 North Torrey Pines Road, La Jolla, California 92037
(“TSRI”), and Vividion Therapeutics, Inc. (“Sponsor”) located at 5820 Nancy Ridge Drive, San Diego, CA 92121. 

RECITALS 

WHEREAS, TSRI and Sponsor entered into that certain Research Funding and Option Agreement
dated as of September 15, 2014 (the “Agreement”; TSRI 2014-0617); 
 WHEREAS,
TSRI and sponsor have amended the Agreement as dated December 13, 2016 (the First Amendment), February 15, 2017 (the Second Amendment; TSRI 2017-0055), and September 13, 2018 (the Third Amendment); 

WHEREAS, TSRI and Sponsor wish to amend the Agreement in the manner set forth in this
Fourth Amendment. 
 AGREEMENT 

NOW THEREFORE, in consideration of the mutual promises hereinafter set
forth, the parties hereto agree as follows: 
  

	1.	 Section 1.2 is hereby deleted in its entirety and replaced by: 

1.2 Agreement Number. The original Agreement has been assigned TSRI number 2014-0617, the Second Amendment has been assigned TSRI number
2017-0055, and the Fourth Amendment has been assigned TSRI number 2020-0015. 
  

	2.	 Term (section 7.2). The date “February 14, 2020” will be deleted and replaced with
February 14, 2022. 

  

	3.	 The Parties agree that Sponsor shall have an option to extend the Term for an additional one (1) year.

  

	4.	 Exhibit A. The Agreement is amended to include the attached Exhibit
A-3, which updates the progress on the original aims. Exhibit A-3 is incorporated into and made part of the Agreement. References to Exhibit A in the
Agreement are amended to also refer to Exhibit A-3. 

  

	5.	 Exhibit B. The Agreement is amended to include the attached Exhibit B-3, which lists the applicable cost information being added to the Agreement. Exhibit B-3 is incorporated into and made part of the Agreement. References to
Exhibit B in the Agreement are amended to also refer to Exhibit B-3. 

  
 1 

	6.	 Payments. The following payments are added to section 2.4(a): 

 

			
	 12th payment: $[***]
	  	Due: [***]
	 13th payment: $[***]
	  	Due: [***]
	 14th payment: $[***]
	  	Due: [***]
	 15th payment: $[***]
	  	Due: [***]

  

	7.	 General Provisions. The Agreement is amended to add the following clause: 

9.13 Export Controls. It is TSRI’s policy to remain fully in compliance at all times with all U.S. export control regulations,
including but not limited to the Export Administration Regulations; International Traffic in Arms Regulations; and embargo sanctions under the Office of Foreign Assets Control (OFAC). All activities and/or transactions contemplated or hereby agreed
to within this Agreement shall be strictly predicated on full compliance with all U.S. and international export control regulations including but not limited to restricted party prohibitions; export license requirements. In the event that Sponsor
will be providing export controlled material to TSRI, Sponsor must first notify TSRI of its intention to provide this material in advance of shipment. Further, diversion of any kind of any item provided to Sponsor contrary to U.S. laws is strictly
prohibited. In the event that such diversion occurs, TSRI shall not be held liable for any consequential liability, penalties, or enforcement actions undertaken by a U.S. Government agency or any other party in relation to such action. 

 

	8.	 Full Force and Effect. Except as specifically amended by this Fourth Amendment, the terms and conditions
of the Agreement shall remain in full force and effect. 

  

	9.	 Counterparts. This Fourth Amendment may be executed in two or more counterparts, each of which shall be
deemed an original, but all of which together shall constitute one and the same instrument. 

 The Agreement, First Amendment, Second
Amendment, Third Amendment, and this Fourth Amendment (hereinafter collectively the “Agreement”) constitute the entire understanding of Sponsor and TSRI with respect to the subject matter hereof and supersede any prior understanding, oral
or written, between the parties with respect hereto. 
 [SIGNATURES BEGIN ON THE FOLLOWING PAGE] 

  
 2 

 IN WITNESS WHEREOF, the
parties have executed this Fourth Amendment on the day and year first written above. 
  

									
	THE SCRIPPS RESEARCH INSTITUTE	 		 	“SPONSOR”
					
	By:	 	 /s/ Nikki Alvarez
	 		 	By:	 	 /s/ Jean Bemis

					
	Name:	 	 Nikki Alvarez
	 		 	Name:	 	 Jean Bemis

					
	Title:	 	 Director, Alliances
	 		 	Title:	 	 Head of Alliance Management

  
 3 

 EXHIBIT A-3: RESEARCH PROGRAM 

  
 4 

 EXHIBIT B-3: BUDGET 

  
 5

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00329-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00329-of-00352.parquet"}]]